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Abstract 
This thesis describes the use of intrinsic fluorescence measurements as a means 
for examining mitochondrial function in different cardiac preparations and 
phenotypes. 
Cardiac myocytes are intrinsically fluorescent and spectroscopic analysis of 
rabbit ventricular myocytes indicated that the majority of this fluorescence 
arises from the metabolic coenzymes nicotinamide adenine dinucleotide in the 
reduced state (NADH) and flavin adenine dinucleotide (FAD) in the oxidised 
state. Calibration of the NADH and FAD fluorescence signal with the 
mitochondrial inhibitors sodium cyanide (NaCN) and carbonyl cyanide p-
(trifluoromethoxy) phenylhydrazone (FCCP) enabled calculation of mitochondrial 
redox states. Redox measurements reflect the balance between reduced and 
oxidised forms of the NAD and FAD pools and provide an index for assessing 
mitochondrial function in cells and tissue. The major advantage of this 
technique is that the intrinsically fluorescent nature of these metabolites 
obviates the need for exogenous indicators of mitochondrial function, which can 
themselves influence mitochondrial behaviour.   
Mitochondrial redox state was established using a variety of fluorescence 
techniques. Values for NADstate represent the proportion of the NADH/NAD+ redox 
couple in the reduced state. Calculation of NADstate using single photon, two 
photon and wide-field epifluorescence microscopy revealed very similar values 
ranging from 0.57±0.18 to 0.59±0.17 (mean±SD). FAD fluorescence 
measurements were used to establish FADstate (the proportion of the FADH2/FAD 
redox couple in the oxidised state). However, FAD fluorescence could only be 
detected by epifluorescence and single photon excitation fluorescence 
microscopy. Once again, comparable values of 0.17±0.10 and 0.18±0.07 
respectively were obtained, thus demonstrating the reproducibility of the 
technique. Attempts were made to perform these measurements in intact 
cardiac tissue preparations. However, difficulties encountered with the delivery 
of mitochondrial inhibitor to specific areas of tissue and problems with inner 
filter effects complicating the interpretation of fluorescence recordings meant 
that this was not possible.  
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Measurements of intrinsic fluorescence were utilised in order to assess the 
mitochondrial redox response of cardiac cells to increased energy demand. 
Isolated rabbit ventricular myocytes were field stimulated and fractional 
shortening was simultaneously recorded with epifluorescence measurements of 
NADH and FAD. Cells were paced at 0.5Hz and the stimulation frequency step 
increased to 1Hz, 2Hz and 3Hz in order to increase work intensity and energy 
demand. Step increasing stimulation frequency resulted in a decrease in NADH 
fluorescence and an increase in FAD fluorescence before reaching an essentially 
steady state. This indicated oxidation of the cell environment, suggesting a 
transient mismatch between metabolite supply and demand. The magnitude of 
this response was related to stimulation frequency, with the biggest responses 
taking place at the highest work intensity. Reducing work intensity back to 0.5Hz 
pacing resulted in immediate recovery of metabolite fluorescence. 
 
Investigation into the redox response to increased work intensity in the stroke 
prone spontaneously hypertensive rat (SHRSP) model of cardiac hypertrophy 
found that energy supply and demand matching was in fact improved in these 
cardiomyocytes compared to Wistar Kyoto (WKY) control myocytes. Work 
intensity was increased from 1Hz to 2, 4 and 6Hz pacing and the oxidative 
response to increased workload was found to be significantly less in SHRSP 
cardiomyocytes compared to WKY myocytes (p<0.01). This was despite similar 
levels of contractile work being performed by the two groups and may be 
related to the young age of the animals (16 weeks). At this age, hypertrophy of 
the SHRSP hearts is likely to still be in the compensated state and mitochondrial 
function may indeed be improved rather than detrimentally affected at this 
stage.    
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CaUP   Calcium uniporter 
CC   Cyclocreatine 
CCD   Charge coupled device 
CK   Creatine kinase 
CLSM   Confocal laser scanning microscopy 
CN   Cyanide 
20 
CO2   Carbon dioxide 
CoA   Coenzyme A   
Cr   Creatine 
Cyto D  Cytochalasin D 
DMBQ   Dimethoxy-1,4-benzoquinone 
E-C   Excitation-contraction  
EF   Ejection fraction 
EGTA   Ethylene glycol bis(2-aminoethyl ether)-N,N,N'N'-tetraacetic 
   acid  
ETC   Electron transport chain 
ETF   Electron transferring flavoprotein 
F   Fluorescence 
FAD   Flavin adenine dinucleotide (oxidised) 
FADH2   Flavin adenine dinucleotide (reduced) 
FADstate  Proportion of the FADH2/FAD redox couple in the oxidised  
   state 
FCCP   Carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone 
FMN   Flavin mononucleotide 
GSH   Glutathione (reduced) 
GSSG   Glutathione (oxidised) 
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H+   Hydrogen ion (proton) 
H2   Hydrogen 
HEPES   4-(2-hydroxyethyl)-1-piperazine-1-ethanesulfonic acid 
HF   Heart failure 
H2O2   Hydrogen peroxide 
Hz   Hertz  
IR   Infrared 
KCl   Potassium chloride 
LED   Light emitting diode 
LipDH   Lipoamide dehydrogenase 
LV   Left ventricle 
LVH   Left ventricular hypertrophy 
Mb   Myoglobin 
Mg2+   Magnesium ion  
MgCl2   Magnesium chloride 
MgSO4   Magnesium sulphate  
mM   Millimolar concentration  
mPTP   mitochondrial permeability transition pore 
NA   Numerical aperture 
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Na+   Sodium ion 
NaCl   Sodium chloride 
NaCN   Sodium cyanide 
NAD+   Nicotinamide adenine dinucleotide (oxidised) 
NADH   Nicotinamide adenine dinucleotide (reduced) 
Na-dithionite Sodium dithionite 
NADP+       Nicotinamide adenine dinucleotide phosphate (oxidised) 
NADPH  Nicotinamide adenine dinucleotide phosphate (reduced) 
NAD(P)H  Nicotinamide adenine dinucleotide and nicotinamide adenine 
   dinucleotide phosphate (reduced) 
NADstate  Proportion of the NADH/NAD+ redox couple in the reduced  
   state 
NaHCO3  Sodium hydrogen carbonate 
NaH2PO4  Sodium dihydrogen orthophosphate 
[Na+]i   Intracellular sodium concentration 
NCX   Sodium/calcium exchanger 
NIR   Near infrared 
nm   Nanometre   
O2   Oxygen 
O2-·   Superoxide anion 
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PCr   Phosphocreatine 
Pi   Inorganic phosphate 
PMT   Photomultiplier tube 
Q   Ubiquinone 
QH2   Ubiquinol 
Redox   Reduction/oxidation 
ROI   Region of interest 
ROS   Reactive oxygen species 
RV   Right ventricle 
RyR   Ryanodine receptor 
SD   Standard deviation 
SEM   Standard error of the mean 
SERCA   Sarco/endoplasmic reticulum calcium adenosine   
   triphosphatase 
SHR   Spontaneously hypertensive rat 
SHRSP   Stroke prone spontaneously hypertensive rat 
SR   Sarcoplasmic reticulum 
TCA    Tricarboxylic acid   
UV   Ultraviolet 
VDAC   Voltage dependent anion channel 
24 
WKY   Wistar Kyoto rat 
∆ψm   Mitochondrial membrane potential 
λ   Wavelength 
µM   Micromolar concentration  
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1 Introduction 
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The heart is a highly metabolic organ that requires a continuous supply of energy 
in order to function. Within the cell, energy is transduced mainly in the form of 
the high energy compound adenosine triphosphate (ATP). The phosphate groups 
of ATP are attached by phosphodiesterase bonds, the resonance structure of 
these bonds is such that their hydrolysis yields a large negative change in free 
energy. The standard free energy change (ΔGo’) for the hydrolysis of ATP to 
adenosine diphosphate (ADP) and inorganic phosphate (Pi) is 30.5 kJ mol-1. The 
energy released can be utilised by the cell to power metabolically demanding 
processes such as contraction of the heart muscle. 
In the presence of oxygen (O2), the majority of ATP is produced by the 
mitochondria, the “powerhouses” of the cell. These organelles have a double 
membrane structure consisting of an outer membrane and a folded inner 
membrane which forms finger-like projections called cristae. Enclosed within 
the inner membrane is the mitochondrial matrix, which contains the respiratory 
enzymes. Mitochondria are particularly abundant in metabolically active cells 
with high energy requirements, such as cardiac myocytes. Mitochondrial volume 
density quantified by ultrastructure morphometry has been reported to be 
between 22% and 37% of left ventricular myocyte volume (depending on species) 
(Barth et al., 1992).  
1.1 Excitation-contraction coupling in cardiac muscle 
Contraction and relaxation of the heart muscle takes place by the process of 
excitation-contraction (E-C) coupling (Figure 1-1). Contraction of a cardiac 
myocyte is initiated by the arrival of an action potential down the transverse 
tubule (T-tubule), depolarising the cell and opening voltage sensitive calcium 
(Ca2+) channels in the membrane (L-Type Ca2+ channels). The subsequent rise in 
intracellular [Ca2+] ([Ca2+]i) activates nearby ryanodine receptors (RyRs) present 
in the membrane of the sarcoplasmic reticulum (SR), leading to the release of 
Ca2+ from SR Ca2+ stores through the RyR channels. The resulting rise in [Ca2+]i 
activates contractile proteins, leading to crossbridge formation and cycling and 
cardiac muscle contraction. Ca2+ ions return to the SR via the Sarco/Endoplasmic 
Reticulum Ca2+-ATPase (SERCA) pump and are removed from the cell via the 
sodium (Na+)/Ca2+ exchanger (NCX) and sarcolemmal Ca2+-ATPase. The fall in 
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[Ca2+]i results in the dissociation of Ca2+ from the myofilaments and subsequent 
relaxation of the cardiomyocyte, allowing the cycle to begin again (Bers, 2002). 
The process of E-C coupling is energy demanding and requires a continuous 
supply of ATP to power contractile proteins and ion pumps. Around 60–70% of 
ATP is used to fuel contractile shortening, and the remaining 30–40% is primarily 
used to power SERCA and other ion pumps (Stanley et al., 2005). 
 
Figure 1-1 E-C coupling in the cardiomyocyte 
The Ca2+ signalling events which occur during E-C coupling. Also shown is the time course 
of the action potential, Ca2+ transient and contraction during one cycle measured in a rabbit 
ventricular myocyte at 37ºC. Reprinted by permission from MacMillan Publishers Ltd: 
[Nature] (Bers, D. M. (2002). Cardiac excitation-contraction coupling. Nature 415, 198-205), 
copyright (2002)  
   
1.2 Cellular respiration in the heart 
ATP is produced by the cell through the process of cellular respiration. This 
consists of a series of reactions that transduce biochemical energy from 
nutrients such as glucose, fatty acids and lactate into ATP. In the presence of O2 
(aerobic conditions), the majority of ATP is produced by the mitochondria. 
However, the initial steps of glucose metabolism are the same in aerobic and 
anaerobic (O2 absent) conditions.    
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1.2.1 Glycolysis 
Glycolysis is an anaerobic process that takes place in the cytoplasm of the cell. 
It involves the breakdown of 6 carbon glucose to 2 molecules of 3 carbon 
pyruvate through a series of reactions. The process leads to the net gain of 2 
ATP molecules and is an example of substrate-level phosphorylation, as the 
phosphate group is transferred directly to ADP to form ATP, without a coupled 
oxidation reaction. Glycolysis also results in the reduction of 2 molecules of the 
electron carrier nicotinamide adenine dinucleotide (NAD+) to form reduced 
nicotinamide adenine dinucleotide (NADH).  
When O2 is limited in the cell, pyruvate is converted to lactate in a reaction 
catalysed by the enzyme lactate dehydrogenase. NADH acts as the reducing 
agent and is oxidised to reform NAD+, resulting in the formation of 2 more 
molecules of ATP. In the presence of O2, pyruvate is transferred to the next 
stage of aerobic respiration (Stryer, 1988).   
1.2.2 Tricarboxylic acid cycle 
Pyruvate enters the mitochondrial matrix where it is oxidised and 
decarboxylated to form acetyl coenzyme A (CoA). This results in the reduction of 
1 molecule of NAD+ to form NADH, and the removal of 1 carbon atom, which is 
released in the form of carbon dioxide (CO2). The 2-carbon acetyl group then 
combines with oxaloacetate to form tricarboxylic acid (citrate). The breakdown 
of citrate to eventually regenerate oxaloacetate by a series of enzymatic steps is 
known as the tricarboxylic acid (TCA) or citric acid cycle, also known as the 
Krebs cycle (Figure 1-2), which was identified by Hans Krebs in the 1930s (Krebs 
et al., 1938). 
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Figure 1-2 The TCA cycle  
4-carbon oxaloacetate condenses with a 2-carbon acetyl unit to form 6-carbon citrate. 
Citrate is broken down through a series of enzymatic reactions to regenerate oxaloacetate. 
In the process, 2 carbon atoms are removed in the form of CO2 and 4 hydrogen molecules (8 
pairs of electrons) are transferred to NAD+ and FAD to form 3 molecules of NADH and one 
molecule of FADH2 (highlighted in blue). One molecule of GTP (highlighted in yellow) is also 
formed through substrate-level phosphorylation. This can be readily converted to ATP. 
Direct formation of ATP has also been demonstrated in some tissues (Weitzman et al., 
1986).   
   
Flavin adenine dinucleotide (FAD) and NAD+ act as hydrogen acceptors (and thus 
electron carriers) and are reduced to FADH2 and NADH respectively. These 
reduced coenzymes have the potential to produce more ATP through the process 
of oxidative phosphorylation.  
As well as glucose, cells can also metabolise other substrates including fatty 
acids and lactate. In fact, the majority of ATP production in the well-perfused 
heart in vivo is due to the oxidation of fatty acids (Stanley et al., 2005). Before 
entering the mitochondria, fatty acids must first be activated in the cytosol to 
form acyl CoA, which is then shuttled (bound to carnitine) into the mitochondrial 
matrix. Here, the long chain fatty acids are split and acyl CoA is converted to 
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acetyl CoA by the process of β-oxidation, which can combine with oxaloacetate 
to enter the TCA cycle. Each cycle of β-oxidation also produces one molecule of 
NADH and one molecule of FADH2 
 
1.2.3 Oxidative phosphorylation 
Oxidative phosphorylation takes place at the electron transport chain (ETC), also 
known as the respiratory chain, located in the inner mitochondrial membrane. 
Oxidative phosphorylation is the process by which ATP is formed as electrons are 
transferred from NADH or FADH2 through a series of electron carriers to the final 
electron acceptor, O2 (Figure 1-3). Unlike with substrate-level phosphorylation, 
oxidative phosphorylation couples oxidation with phosphorylation to produce 
ATP.  
The ETC consists of complexes of integral proteins. Here, hydrogen (H) atoms 
are released by NADH and FADH2 (which are oxidised back to NAD+ and FAD) and 
split into their constituent protons (H+) and electrons. The electrons are 
transferred from one complex of the chain to the next, shuttled by the electron 
carriers ubiquinone (Q) and cytochrome c, through a series of coupled reduction 
and oxidation (redox) reactions. The final electron acceptor is O2, which is 
reduced to form water at complex IV (cytochrome c oxidase, COX). The stepwise 
transfer of electrons generates energy, which is used to pump protons across the 
inner mitochondrial membrane to the intermembrane space. The inner 
mitochondrial membrane is impermeable to protons and an electrochemical 
gradient composed of both the pH gradient and electrical gradient forms, the 
mitochondrial membrane potential (Δψm) being some 150-200mV negative to the 
cytosol. This generates a proton-motive force, which is harnessed as protons 
flow back across the inner membrane through the F1F0-ATP synthase complex, 
driving the synthesis of ATP. This chemiosmotic process powering oxidative 
phosphorylation was first elucidated by Peter Mitchell in the 1960s (Mitchell, 
1961). 
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Figure 1-3 Oxidative phosphorylation 
Electrons are transferred from NADH or FADH2 along the electron transport chain from one 
complex to the next (red arrow indicates electron path). The final electron acceptor is O2, 
which is reduced to from water. Electron transfer along the chain generates energy, which 
is used to pump protons across the inner mitochondrial membrane. The generated proton-
motive force drives the formation of ATP as protons flow back across the membrane via the 
ATP-synthase complex.   
 
Oxidation of NADH has the potential to produce 2.5 ATP, whereas oxidation of 
FADH2 can potentially yield 1.5 ATP. Electrons from NADH enter the ETC at 
complex I (NADH dehydrogenase) and pass through complex III (cytochrome bc1 
complex) and complex IV. Electrons from FADH2 enter at complex II (succinate Q 
reductase complex) and are transferred via an iron-sulphur cluster to Q, 
reducing it to ubiquinol (QH2). FADH2 cannot pump protons across the membrane 
at complex II and thus this electron transfer does not contribute to the proton 
gradient. This is the reason why FADH2 yields less ATP than NADH. QH2 transfers 
electrons to complex III, which then follow the same route as electrons released 
from NADH.  
 
1.2.3.1 Redox potential  
The driving force for oxidative phosphorylation is the electron transfer potential, 
or redox potential, of NADH and FADH2 relative to O2. The redox potential of a 
redox couple (a pair of molecules where one acts as the reductant and the other 
acts as the oxidant) describes the affinity for electrons of the redox couple 
relative to the H2/H+ redox couple. The reduction potentials of selected redox 
couples are shown in Table 1-1. NADH and FADH2 are strong reducing agents (i.e. 
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electron donors), with negative redox potentials and a low affinity for electrons. 
O2 is a strong oxidizing agent with a positive redox potential and high affinity for 
electrons (i.e. electron acceptor). The direction of electron transfer is thus from 
NADH and FADH2 towards O2. The rate of NADH and FADH2 supply from the TCA 
cycle must match the rate of electron flux through the ETC in order to maintain 
the redox potential and allow oxidative phosphorylation to proceed. The redox 
potential can be expressed in terms of the redox state of the cell i.e. the 
NADH/NAD+ and FADH2/FAD ratios.  
Oxidant Reductant N E’0 (V) 
NAD+ 
FAD 
½ O2 + 2H+ 
NADH + H+ 
FADH2 
H2O 
2 
2 
2 
-0.32 
-0.22 
+0.82 
Table 1-1 Standard reduction potentials of selected reactions 
The standard reduction potential (E’0) is measured at pH 7 and 25˚C. N is the number of 
electrons transferred. E’0 refers to the partial reaction written as:  
Oxidant + e- → reductant. 
The standard oxidation potential is the negative of the reduction potential (E’0 values taken 
from (Berg et al., 2006)) 
 
It is thought that the mitochondrial redox state plays an important role in the 
control of oxidative phosphorylation (Balaban, 1990). Increasing the redox 
potential by increasing the supply of the reducing equivalents to the ETC 
increases Δψm. As Δψm is the driving force for proton influx through ATP-
synthase, Δψm must be maintained in order to support ATP production at high 
rates. Measurements of mitochondrial redox state, particularly the NADH/NAD+ 
ratio (NADstate), thus provide a useful tool for evaluating mitochondrial 
energetics in both in vitro and in vivo studies (Mayevsky & Barbiro-Michaely, 
2009; Esumi et al., 1991; Eng et al., 1989; Chance et al., 1962; Chance & 
Schoener, 1962).  
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1.2.4 Regulation of ATP synthesis by mitochondrial Ca2+ 
Work by Denton et al. in the 1970s led to the discovery that a number of rate 
limiting dehydrogenases (pyruvate dehydrogenase, 2-oxoglutarate 
dehydrogenase and NAD+ isocitrate dehydrogenase), critical elements of 
substrate metabolism, are regulated by mitochondrial Ca2+ (McCormack & 
Denton, 1979; Denton et al., 1978; Denton et al., 1972). Mitochondria have Ca2+ 
influx and efflux pathways, and an increase in intramitochondrial Ca2+ 
concentration could therefore stimulate mitochondrial dehydrogenase activity, 
increasing mitochondrial [NADH] and [FADH2], and subsequently increase the 
rate of ATP production. Mitochondrial Ca2+ is also thought to activate F1F0-ATP 
synthase, and thus stimulate ATP synthesis directly (Territo et al., 2000; Das & 
Harris, 1990). Taken together, this suggests that Ca2+ also plays an important 
role in regulating ATP production, for example in response to increasing 
workload, in addition to regulation by ADP and Pi through feedback control. 
1.2.4.1 Mitochondrial Ca2+ influx and efflux pathways 
It has been recognised for a number of decades now that mitochondria have Ca2+ 
signalling capabilities and possess the ability to sequester Ca2+ (Dhalla, 1969; 
Deluca & Engstrom, 1961). Mitochondrial Ca2+ signalling pathways are 
summarised in Figure 1-4. The influx of Ca2+ ions into mitochondria is driven by 
the negative ∆ψm. The outer mitochondrial membrane is freely permeable to 
Ca2+ due to the presence of voltage-dependent anion channels (VDAC), which 
have a cation selective conductance state (Pavlov et al., 2005). However, the 
inner membrane is not freely permeable to Ca2+ and ion uptake must therefore 
be via the mitochondrial Ca2+ uniporter (CaUP). Influx of Ca2+ causes 
depolarisation of ∆ψm, and it has been reported that in the absence of ∆ψm, Ca2+ 
uptake by the uniporter could not occur, even in the presence of an 8 fold 
external to internal concentration gradient (Kapus et al., 1991). Mitochondria 
must therefore also possess Ca2+ efflux systems in order to maintain ∆ψm. 
Ca2+ efflux from the mitochondria is against a concentration gradient and thus 
requires either ATP hydrolysis or energetically favourable exchange with an 
extra-mitochondrial ion travelling down an electrochemical gradient. In the 
heart, brain and skeletal muscle, the NCX predominates (Gunter et al., 1994). 
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However, the stoichiometry of this exchange is still controversial and it is 
unclear if this exchange is Ca2+/2Na+ or Ca2+/3Na+. A Na+ independent efflux 
pathway also exists, involving a Ca2+/2H+ exchanger and this system dominates in 
the mitochondria of the liver and kidney. Mitochondria possess a third 
mechanism for Ca2+ efflux - the Cyclosporin A inhibitable mitochondrial 
permeability transition pore (mPTP). The opening of this pore is triggered by 
Ca2+ overload of the mitochondrial matrix and oxidative stress and results in 
rapid equilibration of ion gradients. Irreversible opening of the mPTP pore 
results in cell death, but a physiological role for transient mPTP opening is still 
controversial. It has recently been shown that mice lacking the cyclophilin D 
gene, an important modulator of mPTP opening, demonstrated elevated 
mitochondrial matrix Ca2+ levels which limited the metabolic flexibility of the 
heart. Thus, the mPTP may play a physiological role in homeostatic control of 
mitochondrial Ca2+ levels to enable metabolism to be matched with alterations in 
myocardial workload (Elrod et al., 2010).    
 
Figure 1-4 Mitochondrial Ca2+ signalling pathways 
The mechanisms by which Ca2+ enters and exits the mitochondria.  
 
1.3 Assessing mitochondrial redox state 
1.3.1 Intrinsic fluorescence in cells 
The mitochondrial redox state of the cell or tissue can be studied using 
fluorescence techniques. This is because NADH (in the reduced state) and FAD 
(in the oxidised state) are intrinsically fluorescent (autofluorescent) when 
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excited at particular wavelengths. Cells consequently have endogenous 
fluorescence without the artificial introduction of fluorescence indicators. 
Both NADH and reduced nicotinamide adenine dinucleotide phosphate (NADPH) 
absorb light in the ultraviolet (UV) region and emit blue fluorescence. However, 
NADH concentrations predominate over NADPH within cardiac mitochondria and 
the NADH fluorescence yield is as much as 4-fold greater than NADPH (Estabrook, 
1962). NADH is present in both cytosolic and mitochondrial compartments, but 
the fluorescence signal is primarily mitochondrial in origin (Nuutinen, 1984). This 
is mainly due to the fact that mitochondrial NADH binding causes fluorescence to 
be enhanced ~10 fold (Jöbsis & Duffield, 1967; Avi-Dor et al., 1962; Estabrook, 
1962). In the cytosol NADH strongly binds to glyceraldehyde phosphate 
dehydrogenase, which diminishes NADH fluorescence (Chapman, 1972). Taking 
these factors into account, around 80% of the UV-excited blue fluorescence 
arises from mitochondrial NADH (Eng et al., 1989). 
The molecular changes that take place when NAD+ is reduced to NADH are shown 
in Figure 1-5. 
 
Figure 1-5 Redox equilibrium of NAD+/NADH 
 
Uptake of hydrogen at position 4 of the pyridine ring (circled) results in the 
appearance of a new absorption band. The fluorescence yield of pyridine 
nucleotides in the oxidised state (NAD+, NADP+) is some 1000 fold less than in the 
reduced state at excitation wavelengths longer than 300nm (Koenig & 
Schneckenburger, 1994). Thus, a shift in the mitochondrial NADH/NAD+ balance 
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towards the reduced state results in an increase in UV-excited blue 
autofluorescence. 
FAD is derived from riboflavin (vitamin B2). Any protein with a flavin, FAD or 
flavin mononucleotide (FMN) moiety attached is described as a flavoprotein. The 
molecular changes that take place when FAD is reduced to FADH2 are shown in 
Figure 1-6. 
 
Figure 1-6 Redox equilibrium of FAD/FADH2 
 
FAD in the oxidised state is excited by blue light and fluoresces in the green. 
Reduction of FAD to FADH2 (positions of H uptake are circled) causes the 
molecular structure to change from a planar into a “butterfly” configuration. 
This results in a decrease in absorption and subsequently a decrease in 
fluorescence emission (Koenig & Schneckenburger, 1994). Thus, a shift in the 
mitochondrial FADH2/FAD balance towards the reduced state results in a 
decrease in green autofluorescence.  
As NADH is fluorescent in the reduced state and FAD is fluorescent in the 
oxidised state, simultaneous measurement of both fluorescent species provides 
an indication of the balance between reduced and oxidised forms of these 
electron carriers in the mitochondria (Chance et al., 1979; Chance et al., 1972; 
Scholz et al., 1969). Fluorometry based on this endogenous fluorescence is 
therefore a valuable tool for assessing the metabolic status of cells and tissue. 
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1.3.2  Mitochondrial redox state values reported in the literature 
A range of values for resting NADstate have been described in the literature. 
Examination of NADH/NAD+ in different cells found some variation between cell 
types (Duchen & Biscoe, 1992). In rat and mouse chromaffin cells isolated from 
the adrenal medulla, NADstate was found to be 0.45, a similar value to that found 
in freshly isolated mouse dorsal root ganglion neurons (0.53). However, type 1 
cells from rabbit carotid body were found to be in a more oxidised state, with 
average NADstate measured as 0.27. This was attributed to higher O2 consumption 
in these cells. FAD fluorescence measurements were also made in these 
experiments, but the signal-to-noise ratio was found to be too low to obtain 
values for FADstate. In resting isolated rat cardiac myocytes, NADstate was found to 
be 0.44 (Eng et al., 1989) and 0.27 (White & Wittenberg, 1993), whereas the 
NADstate in isolated guinea pig ventricular myocytes was 0.31 in the resting state 
(Minezaki et al., 1994) and around 0.2 when paced at 0.1Hz (Jo et al., 2006). 
These values suggest that in isolated cells, 25-50% of the NAD+ pool is in the 
reduced state. The more oxidised NADstate reported in guinea pig 
cardiomyocytes, particularly by Jo et al., points towards substrate limited 
respiration, and may suggest that ATP production by the mitochondria was 
compromised in these experiments. In a rat cardiac trabeculae preparation 
paced at 1Hz, the mitochondria were found to be in a slightly more reduced 
state, with the NADstate quoted as 0.63 (Brandes & Bers, 1996). The same value 
was reported in isolated rat cardiomyocytes stimulated to contract at 1Hz 
(Esumi et al., 1991).  
Although FAD fluorescence measurements have been used to assess 
mitochondrial redox state in isolated cardiac cells (Chorvat et al., 2004; 
Romashko et al., 1998), no values for FADstate have been quoted in the literature 
for this cell type. However in both these studies, the FAD pool was shown to be 
mainly in the reduced state.  
This thesis employs a number of different fluorescence techniques in order to 
simultaneously measure NADH and FAD fluorescence and consequently establish 
both NADstate and FADstate in the same cell. Figure 1-7 summarises the significance 
of the NADstate and FADstate values.  
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Figure 1-7 Meaning of NADstate and FADstate values 
Range of NADH and FAD fluorescence changes and the corresponding metabolic states 
they represent (following calculations described in Figures 2-9 and 2-10). Blue trace 
represents NADH fluorescence and red trace represents FAD fluorescence. When the 
mitochondria are in the fully reduced state, NADH fluorescence is maximal and NADHstate=1. 
Conversely, FAD fluorescence is minimal and FADstate=0. In the fully oxidised state, NADH 
fluorescence is minimal and NADHstate=0, whereas FAD fluorescence is maximal and 
FADstate=1. Grey shaded area gives a rough indication of expected NADHstate and FADstate 
values in the normoxic, actively respiring cell.    
 
1.3.3 Other methods for assessing redox state 
The redox state of the cell can also be determined indirectly by measuring the 
concentrations of metabolite couples in NAD-linked enzyme reactions. In the 
cytosol, the pyruvate/lactate couple can be assayed, whereas measurements of 
the β-hydroxybutyrate/acetoacetate couple reflects the mitochondrial NAD 
redox state (Williamson et al., 1967). These ratios reflect the NADH/NAD+ state 
exclusively in the cytosolic or mitochondrial compartments and distinguish 
between NADH/NAD+ and NADPH/NADP+ redox states. However, real time 
monitoring of redox state is not possible by this method and measurements are 
not sensitive to rapid changes. In addition, in order for this method for assessing 
mitochondrial redox state to be valid, the rate of reaction must be high enough 
to be in equilibrium. The β-hydroxybutyrate dehydrogenase reaction is at 
equilibrium in liver mitochondria, but there is evidence that this is not the case 
in the heart (Nuutinen et al., 1981; Opie & Owen, 1975).     
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1.4 Confocal laser scanning microscopy  
Confocal microscopy was pioneered by Marvin Minsky in 1955 (Minsky, 1988) and 
allows the creation of sharp, high resolution images of a specimen. This is made 
possible by point-by-point illumination of the specimen and use of a pinhole 
aperture to prevent out of focus light reaching the detector. In fluorescence 
confocal microscopy, lasers are used as the light source to excite fluorescence in 
a specimen. Fluorescence confocal microscopy is therefore described as confocal 
laser scanning microscopy (CLSM) and is illustrated in Figure 1-8. A dichroic 
mirror or beam-splitter separates excitation and emission light and emission 
light is directed to the photomultiplier tube (PMT) detector by dichroic mirrors. 
The pinhole aperture improves optical sectioning and ensures that detected light 
is from a thin focal plane. As a result, a sharper, better resolved fluorescent 
image of the focal plane is produced in comparison to wide-field microscopy. 
 
Figure 1-8 Confocal Laser Scanning Microscopy 
The sample is excited by a laser beam and fluorescence emission from the fluorophore is 
directed to the PMT by dichroic mirrors. Only light from the focal plane (red) is directed 
through the pinhole aperture. Out of focus light from above (green) and below (blue) the 
focal plane is rejected. 
 
Iffath Ghouri, 2011  Chapter 1; 40 
1.4.1 Single photon excitation fluorescence microscopy 
In CLSM, the fluorophore in the sample is excited by a laser emitting photons of 
a particular wavelength. The photon is absorbed by the fluorophore molecule 
and it enters a higher energy state (the excited state). Some of the energy is lost 
and the fluorophore enters a semi-stable state. When the fluorophore returns to 
the ground state, it emits a photon of light (fluorescence) of lower energy, and 
consequently longer wavelength (Figure 1-9). If a single high energy photon is 
sufficient to excite the fluorophore molecule, this is known as single photon (1P) 
excitation. 
 
Figure 1-9 Jablonski diagram illustrating principle of 1P fluorescence excitation   
(1) A single photon of light of a particular wavelength is absorbed by the fluorophore 
molecule and an electron enters a higher energy (excited) state. (2) Some loss of energy 
occurs in the vibration state through internal conversion and the electron enters a semi-
stable state. (3) When the electron returns to the ground state, a photon of light of lower 
energy (and thus longer wavelength) is emitted (fluorescence). 
 
1.4.1.1 Problems associated with 1P excitation CLSM  
There are a number of problems associated with CLSM. The use of high intensity 
lasers, particularly when using short wavelengths, can cause severe 
photodamage in living cells by the formation of reactive oxygen species (ROS). 
Laser excitation of chemical structures such as aromatic porphyrins, which are a 
component of haemoproteins including haemoglobin, myoglobin and the 
cytochromes, can lead to the formation of ROS (König, 2006). These ROS can 
cause deoxyribonucleic acid (DNA) damage and oxidation of lipid and protein 
structures within the cell, as well as playing an important role in triggering cell 
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death by apoptosis (König, 2000; Cunningham et al., 1985) Excitation light can 
also cause fluorophores to fade irreversibly, a process known as photobleaching. 
The problems of photodamage and photobleaching can be minimised by reducing 
the laser power used for excitation, but this will limit the intensity of 
fluorescence produced.  
The presence of the detector pinhole means that the number of photons 
reaching the detector is limited and the signal-to-noise ratio may be low. This 
can be improved by increasing the intensity of laser excitation, but this 
increases the likelihood of photodamage and photobleaching occurring. 
Alternatively, the pinhole diameter may be increased in size, but this leads to 
loss of x, y and z resolutions. Another problem with 1P-excitation CLSM is that 
the penetration depth is limited to a maximum of 40-50µm (Centonze & White, 
1998). 
1.4.2 Two photon excitation fluorescence microscopy 
Many of the problems associated with 1P excitation CLSM can be minimised by 
using two photon (2P) excitation fluorescence microscopy. This method requires 
the simultaneous absorption of two lower energy photons in order to excite the 
fluorophore molecule and allows the use of infrared (IR) or near infrared (NIR) 
light (Figure 1-10). As the probability of absorption is proportional to the square 
of the instantaneous light intensity, lasers that generate ultra-short but intense 
pulses are used. Pulses are ~10-13s long and occur at repetition rates of ~100MHz 
(Denk et al., 2006). The instantaneous light intensity is extremely high, but the 
average power reaching the sample is not excessive (Centonze & White, 1998).  
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Figure 1-10 Jablonski diagram illustrating principle of 2P fluorescence excitation  
2P fluorescence excitation requires the simultaneous absorption of 2 longer wavelength 
(lower energy) photons of light by the fluorophore in order for fluorescence to be emitted. 
 
As the probability of two photons being absorbed at the same time is much lower 
than if a single photon was absorbed, fluorescence emission is limited to the 
focal volume of the objective where the intensity is highest (Figure 1-11). The 
lower average power and limited excitation thus restricts photodamage and 
photobleaching to the focal volume of the objective. In addition, IR and NIR light 
is less damaging than shorter wavelengths of light, especially from the UV 
region. In 1P excitation CLSM, fluorescence is emitted from above and below the 
focal plane, but the detector pinhole ensures that only in-focus light is directed 
to the PMT. Because 2P-excitation does not generate out-of-focus fluorescence, 
optical sectioning can be achieved without a detector pinhole, resulting in 
greater fluorescence collection efficiency. This, along with the fact that NIR 
light scatters much less than shorter wavelengths, means that 2P-excitation 
fluorescence microscopy allows for greater imaging penetration depth, around 
10 times deeper or more (Rubart, 2004; Huang et al., 2002; Centonze & White, 
1998; Denk et al., 1990). 2P-excitation fluorescence microscopy can therefore 
be performed on thicker specimens, such as intact tissue, whereas 1P excitation 
CLSM is largely limited to use on single cells. 
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Figure 1-11 Fluorescence emission by fluorescein following 1P and 2P excitation 
A cuvette of fluorescein excited by 1P excitation (right line) and 2P excitation (localised spot 
of fluorescence indicated by arrow) illustrating that 2P excitation is confined to the focus of 
the excitation beam (Amos, 2000). 
 
1.5 Applications for real time monitoring of mitochondrial 
redox state 
1.5.1 O2 availability in intact tissue preparations 
Measurements of NADH fluorescence have been widely used to investigate O2 
availability in whole tissue preparations. Areas of low perfusion and thus low O2 
supply can be identified by increased NADH fluorescence. This is because the 
presence of O2 is required for oxidative phosphorylation to proceed. When the O2 
supply is limited, ETC activity is inhibited and reducing equivalents accumulate, 
resulting in an increase in NADH fluorescence and a decrease in FAD 
fluorescence.  
Early work in a Langendorff-perfused rat heart preparation used the UV- 
component of a xenon flash to excite NADH fluorescence and photographs were 
taken of surface fluorescence emission (Barlow & Chance, 1976). This provided a 
2-dimensional recording of NADH levels on the surface of the heart and 
demonstrated heterogeneity of O2 delivery to the tissue at low perfusion 
pressures. When the coronary artery was ligated to produce local ischaemia, the 
area of tissue in the apex of the left ventricle (LV) where perfusion had been 
blocked could be identified by the strong NADH fluorescence signal in that area.  
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NADH fluorescence measurements have since been used in numerous studies to 
identify areas of ischaemia and hypoxia/anoxia in different tissue types 
(summarised by (Mayevsky & Rogatsky, 2007)). The degree of ischaemia and 
boundaries between well perfused and poorly perfused areas can be identified 
by levels of NADH fluorescence. This information can be utilised to study the 
effect of ischaemia on factors such as electrical activity and Ca2+ signalling in 
the heart (Kay et al., 2008; Swift et al., 2008). Recently, Aldakkak et al. have 
simultaneously measured NADH and FAD fluorescence to monitor mitochondrial 
bioenergetics in isolated perfused guinea pig hearts during ischaemia and 
reperfusion (Aldakkak et al., 2009; Aldakkak et al., 2008). 
1.5.2 Mitochondrial metabolite supply and demand matching 
Real time monitoring of mitochondrial redox state also gives an indication of 
how well cells and tissue are able to match metabolite supply with demand in 
response to increased workload. Contraction of the cell requires energy, so work 
intensity is usually increased by increasing the frequency of contraction (and/or 
afterload in whole heart preparations). When the rate of ATP synthesis is 
increased, there must be a proportional increase in the rate of reducing 
equivalent supply from the TCA cycle. If an increase in work intensity results in 
oxidation of the mitochondrial environment, this suggests that the rate of 
delivery of reducing equivalents is not increasing to the same extent as the rate 
of oxidative phosphorylation is increased to maintain ATP supply. If the 
mitochondrial redox state becomes more reduced, this would indicate an 
increased rate of reducing equivalent supply in excess of the increased rate of 
oxidative phosphorylation. However, in intact tissue preparations, it could also 
indicate a limited O2 supply inhibiting oxidative phosphorylation and ATP 
production. If the redox state does not change, this would suggest that 
metabolite supply and demand are well matched.  
Previous studies in the heart, using measurements of NADH fluorescence alone, 
have demonstrated different oxidative responses to changes in work intensity. 
Some studies have shown no change in the NADH fluorescence upon increased 
stimulation frequency in isolated rat and guinea pig myocytes (Griffiths et al., 
1998) and in a whole rabbit heart preparation (Heineman & Balaban, 1993). 
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Other studies in rat demonstrate a decrease in NADH fluorescence, indicating 
oxidation of the isolated ventricular myocyte (Heinzel et al., 2006; White & 
Wittenberg, 2000; White & Wittenberg, 1993) and whole heart preparation 
(Ashruf et al., 1995) in response to increased workload. A similar response was 
reported in isolated papillary muscle from the rabbit (Chapman, 1972). It has 
also been shown in the guinea pig that NADH fluorescence falls in conditions of 
high intracellular Na+ concentration ([Na+]i), such as in cells from failing hearts, 
in response to increased work intensity, whereas control myocytes with normal 
[Na+]i show no significant change (Liu & O'Rourke, 2008; Maack et al., 2006).    
 
In contrast, an increase in NADH fluorescence has been reported in response to 
increased pacing frequency in glucose perfused rat hearts (Katz et al., 1987) and 
isolated rat cardiomyocytes (Griffiths et al., 1997). Finally, in a series of studies 
performed on isolated trabeculae from rat heart, Brandes et al. demonstrated 
that the initial response to increased work was a fall in NADH/NAD+ ratio, 
followed by a mitochondrial Ca2+ dependent increase in NADH during fast pacing 
(Brandes & Bers, 2002; Brandes & Bers, 1999; Brandes et al., 1998; Brandes & 
Bers, 1997; Brandes & Bers, 1996). These findings were supported by 
experiments performed on isolated guinea pig myocytes (Jo et al., 2006).  
 
To my knowledge, no study has used FAD measurements, or a combination of 
NADH and FAD measurements, to assess changes in redox state in response to 
changes in workload.  
 
1.6 Importance of maintaining redox potential 
As well as being the driving force for oxidative phosphorylation and supplying the 
electrons required to produce ATP, maintenance of the redox potential is also 
important in order to control oxidative stress within the mitochondria. 
1.6.1 ROS 
The electron transfer process of oxidative phosphorylation represents the major 
intracellular source of ROS within the cell (Turrens, 2003).  The respiratory 
complexes of the ETC can leak electrons to O2, mainly producing the superoxide 
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anion (O2-·), which is a mediator of oxidative chain reactions and the precursor 
for most other ROS. Low concentrations of ROS are thought to play a role as 
signalling molecules in some cell signalling pathways (D'Autreaux & Toledano, 
2007) and they have been shown to be involved in the signalling mechanisms 
leading to the cardioprotective effects of ischaemic pre and postconditioning 
(Penna et al., 2009). However, their highly reactive nature can have damaging 
effects on the cell. In oxidative stress conditions, high levels of ROS are 
associated with deleterious effects on DNA, lipids and proteins. To protect 
against this and keep ROS levels low, a number of antioxidant control 
mechanisms exist within the mitochondrial compartment. These include the 
superoxide dismutase, glutathione peroxidase and glutathione reductase systems 
(Sies, 1993). 
1.6.2  Role of NADH in antioxidant control mechanisms 
ROS scavenging mechanisms within the cell are ultimately linked to the 
mitochondrial redox balance (Liu & O'Rourke, 2009). In the reduced state, 
antioxidants can donate electrons to unstable molecules, such as ROS, thereby 
detoxifying them. Glutathione in the reduced state (GSH) is an antioxidant 
involved in the clearance of hydrogen peroxide (H2O2). Two molecules of GSH 
are oxidised to reduce one molecule of H2O2 to two molecules of water in a 
reaction catalysed by glutathione peroxidase. Oxidised glutathione (GSSG) can 
be reduced back to GSH in a reaction catalysed by glutathione reductase, which 
requires NADPH as an electron donor. NADPH is oxidised in the process to NADP+, 
and in order for glutathione to be kept in the reduced state and for the redox 
chain to be maintained, NADPH supply must be preserved. 
There are three main reactions which regenerate NADPH and keep glutathione in 
the reduced state: NADP+-dependent isocitrate dehydrogenase, malic enzyme 
and nicotinamide nucleotide transhydrogenase (Vogel et al., 1999). The NADP+-
dependent isocitrate dehydrogenase and malic enzyme reactions depend on the 
levels of TCA cycle intermediates. However, the nicotinamide nucleotide 
transhydrogenase reaction requires NADH to reduce NADP+ and production of 
NADPH is strongly favoured in the presence of an electrochemical proton 
gradient. Thus, maintenance of NADH/NAD+ plays a role in the mitochondria’s 
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defences against oxidative stress. The role of NADH and NADPH (NAD(P)H) as 
indirect antioxidants is well established. However, there is also some evidence 
to suggest that NAD(P)H may have direct antioxidant actions in the cell (Petrat 
et al., 2003; Kirsch & de Groot, 2001) 
The importance of NADH as an indirect or direct antioxidant has recently been 
shown experimentally. In guinea pig cardiomyocytes, a transient fall in NADH 
fluorescence levels was accompanied by an increase in H2O2 levels detected 
using the H2O2-sensitive dye 5-(and-6)-chloromethyl-2',7'-
dichlorodihydrofluorescein diacetate, acetyl ester (CM-DCF) (Kohlhaas et al., 
2010; Knopp et al., 2009). H2O2 levels returned to baseline when NADH levels 
recovered. In addition, in rat cardiomyocytes, oxidation of NADH in response to 
increased work intensity resulted in an increase in ROS, an effect which was 
attenuated by the antioxidant N-acetylcysteine (NAC) (Heinzel et al., 2006).  
1.7 Energy metabolism in failing hearts 
Heart failure (HF) is a syndrome resulting from the inability of the heart to pump 
blood at a rate sufficient to meet the body’s metabolic demands. Causes of HF 
include past myocardial infarction, hypertension, cardiomyopathy and congenital 
heart disease. Metabolic changes occur in HF which are likely to contribute to 
impaired contractile function of the heart muscle. The failing heart has a 
reduced capacity to transduce the energy from substrates into ATP (Ingwall & 
Weiss, 2004; van Bilsen et al., 2004) and has thus been described as “An engine 
out of fuel” (Neubauer, 2007).  
1.7.1 Altered substrate utilisation 
In the well-perfused healthy heart, over 95% of ATP is produced by oxidative 
phosphorylation and ~60-90% of this is derived from metabolism of fatty acids 
(Stanley et al., 2005). There are conflicting reports of changes in substrate 
utilisation in heart failure. Studies using animal models of cardiac hypertrophy 
and HF performed in the dog (Lei et al., 2004; Osorio et al., 2002; Recchia et 
al., 1998) and rat (Christe & Rodgers, 1994) have shown a switch from fatty acid 
to glucose metabolism. This is often described as a switch to the “foetal 
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phenotype” and has shown to be associated with a down-regulation of genes 
involved in fatty acid β-oxidation (Bugger et al., 2010; Akki et al., 2008; Barger 
& Kelly, 2000; Sack et al., 1996). However, studies of substrate utilisation in 
human HF patients have produced varied results. Some reports reproduce the 
changes seen in animal studies (las Fuentes et al., 2003; Davila-Roman et al., 
2002), some report no change (Funada et al., 2009), while others still report an 
increase in fatty acid uptake in HF patients (Taylor et al., 2001; Paolisso et al., 
1994). The conflicting reports in human studies may be due to differences in the 
severity of HF in the participating patients, or may be due to the influence of 
co-morbidities such as obesity, insulin resistance or Type 2 diabetes (van Bilsen 
et al., 2009). In the advanced stages of HF, glucose uptake is also thought to 
decline due to the development of myocardial insulin resistance (Neubauer, 
2007).  
Recent work by Elrod et al. (2010) using cyclophilin D knock-out mice has shown 
that the increased activity of Ca2+ dependant dehydrogenases, (particularly 
pyruvate dehydrogenase) due to higher mitochondrial matrix Ca2+ levels resulted 
in increased glucose oxidation relative to fatty acids under normal conditions. 
This limited the metabolic flexibility of the heart which is necessary for 
compensation during stress (for example during exercise or in pressure 
overload). As a result, cardiac structure and function was more severely affected 
following pressure overload induced hypertrophy in these animal compared to 
wild type controls.       
It remains unclear whether this switch towards a dependence on glucose 
utilisation is beneficial or detrimental to the heart. Oxidation of glucose is more 
efficient than oxidation of fatty acids. However, the ATP yield of fatty acids 
such as palmitate is much greater than for glucose (~129 ATP compared to ~36 
ATP). Thus many more glucose molecules need to be oxidised to produce the 
ATP produced by oxidation of one molecule of palmitate (van Bilsen et al., 
2009). Ultimately, the increase in glucose oxidation does not fully compensate 
for the decrease in fatty acid oxidation. Therefore, the hypertrophied and failing 
heart remains energy compromised.    
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1.7.2 Impaired oxidative phosphorylation 
Impaired oxidative phosphorylation by the mitochondria also appears to be a 
factor leading to reduced respiratory function in HF. It has been demonstrated 
that mitochondrial protein content and the activity of ETC complexes and ATP-
synthase is reduced in animal models of HF (Bugger et al., 2010; Lin et al., 2007; 
Garnier et al., 2003; Liu et al., 2001; Marin-Garcia et al., 2001). Reduced 
complex IV activity has also been reported in human patients with idiopathic 
dilated cardiomyopathy (Quigley et al., 2000). The efficiency of ATP synthesis 
also appears to be reduced in HF, with reports of increased levels of cardiac 
uncoupling proteins in blood samples from HF patients (Murray et al., 2004), and 
impaired state 3 respiration by isolated mitochondria to a similar extent as in 
the presence of an uncoupling agent (Bugger et al., 2010). When respiration is 
uncoupled, ETC activity is not linked to phosphorylation of ADP, and 
consequently the mitochondria produce heat instead of ATP.  
1.7.3 Derangement of energy transfer systems  
ATP is rapidly transferred out of the mitochondria into the cytosol for utilisation 
by myofibrillar proteins and ion pumps via the creatine kinase phosphocreatine 
shuttle system. The phosphate from ATP is transferred to creatine (Cr) to form 
phosphocreatine (PCr) and ADP, a reaction catalysed by the mitochondrial 
isoform of Cr kinase (CK). PCr is much smaller and less charged than ATP and can 
rapidly diffuse out of the mitochondria via the shuttle system to the myofibrils, 
SR, etc. Here, the myofibrillar isoform of CK catalyses the reformation of ATP 
from PCr, enabling ATP to be utilised by the cell to fuel contraction. The free Cr 
formed by this reaction diffuses back to the mitochondria for rephosphorylation. 
Around two thirds of the heart’s total Cr pool is phosphorylated to PCr, whereas 
around one third remains as free Cr. Cr cannot be synthesised by the cardiac 
myocyte, and enters the cell via the Cr transporter. 
The CK system also plays an important role as an energy buffer. When energy 
demand exceeds supply, such as in bursts of intense activity, PCr can be utilised 
to maintain ATP levels. However, this results in an increase in the free ADP 
concentration, inhibiting the function of many intracellular enzymes and 
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subsequently the contractile function of the heart. Thus, the myocyte is 
adversely affected by a fall in PCr and increase in ADP levels, even when ATP 
levels are maintained. The ratio of PCr to ATP gives a good indication of the 
energetic state of the heart. The CK equilibrium favours ATP synthesis over PCr 
synthesis. When the demand for ATP surpasses supply, PCr levels decline first 
and ATP levels only decline when PCr is substantially depleted (Neubauer, 2007).   
A number of changes in the CK system have been demonstrated in HF. PCr, Cr 
and CK levels are reduced (Beer et al., 2002; Kalsi et al., 1999; Nascimben et 
al., 1996) and down-regulation of the creatine transporter (Neubauer et al., 
1999; Ten Hove et al., 2005) contributes to the reduction in the creatine pool. 
Consequently, ATP transfer within the cell is severely impaired. Taking into 
account the decrease in PCr:ATP ratio which results from the depleted Cr pool, 
it is clear that the metabolic reserves are seriously compromised in HF. 
1.7.4 Effects of metabolic changes on contractile function 
A summary of the metabolic changes that occur over the course of HF 
progression is shown in Figure 1-12 (Neubauer, 2007). The combination of 
mitochondrial dysfunction and defects in energy transfer mechanisms that occur 
in cardiac hypertrophy and HF result in reduced ATP supply and availability. 
Ultimately the contractile function of the heart will be adversely affected as 
myofilaments and ion pumps are unable to receive the fuel they require to 
function effectively.  Although a number of studies have described the changes 
in mitochondrial protein content and activity, very few have looked at how the 
redox state and hence control of oxidative phosphorylation may be affected in 
HF.  
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Figure 1-12 Changes in cardiac energy metabolism in HF 
Panel A shows changes in substrate utilisation, panel B changes in oxidative 
phosphorylation and panel C changes in high energy phosphate metabolism in patients 
with heart failure. PPARα: Peroxisome proliferator-activated receptor alpha, PCG-1α: PPARγ 
coactivator 1 alpha, CKmito: mitochondrial creatine kinase isoenzyme, CKMM: myofibrillar 
creatine kinase isoenzyme. Reprinted with permission (Neubauer, S. (2007). The Failing 
Heart - An Engine Out of Fuel). The New England Journal of Medicine 356, 1140-1151). 
Copyright © [2007] Massachusetts Medical Society. All rights reserved. 
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1.8 Investigating energy supply and demand matching in 
animal models of cardiac hypertrophy 
A number of different methods are employed to develop animal models of 
cardiac hypertrophy and HF. These methods include rapid ventricular pacing, 
myocardial ischaemia and infarction (e.g. by ligation of the coronary artery), use 
of drugs with cardiac toxicity or by inducing volume or pressure overload 
(Monnet & Chachques, 2005). The stroke-prone spontaneously hypertensive rat 
(SHRSP) model is a genetic model of cardiac hypertrophy induced by pressure 
overload.  
1.8.1 The SHRSP model 
The spontaneously hypertensive rat (SHR) was developed from the Wistar-Kyoto 
(WKY) strain by Okamoto and Aoki in the early 1960s (Okamoto & Aoki, 1963). 
Selection and repeated mating of hypertensive WKY offspring eventually gave 
rise to a colony of rats which, without exception, developed hypertension. 
Selective breeding of offspring from SHR rats that died from stroke led to the 
establishment of the SHRSP strain. SHRSP rats develop hypertension at a younger 
age than other SHR strains, frequently over 230mmHg, and this is closely related 
to the high incidence of stroke (Okamoto et al., 1974). These animals develop a 
number of cardiovascular complications, including endothelial dysfunction, 
vascular remodelling and LV hypertrophy and fibrosis (Arribas et al., 1999; 
McIntyre et al., 1999; Dominiczak et al., 1996).   
Some studies have also reported mitochondrial dysfunction in these animals. In 
24 week old SHRSP rats, levels of isocitrate dehydrogenase (related to the TCA 
cycle) and cytochrome c oxidase (complex IV of the respiratory chain) were 
found to be lower compared to WKY controls, suggesting impaired oxidative 
metabolism in SHRSP hearts. In addition, reduced superoxide dismutase activity 
in SHRSP hearts, a potent scavenger of free radicals, is likely to result in 
increased oxidative stress and may be the cause of the abnormalities in SHRSP 
mitochondrial DNA also reported (Tokoro et al., 1996). Cytochrome c oxidase 
was also found to be reduced in the hearts of 16 week old SHRSP rats (Chen et 
al., 1995). Mitochondrial function in SHRSP rat heart has been examined in this 
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thesis and compared to age matched WKY controls. In these experiments, the 
focus was on the mitochondrial redox state and energy supply and demand 
matching, as well as studying differences in contractile function.  
1.8.2 Energy supply and demand matching in pressure overload- 
induced models of LV hypertrophy 
Changes in mitochondrial redox state in response to increased work intensity 
have previously been examined in guinea pig and rat models of cardiac 
hypertrophy. In both cases, aortic banding was used to induce pressure overload 
leading to LV hypertrophy. Guinea pig cardiomyocytes were isolated around 6-8 
weeks after surgery when a decrease in LV ejection fraction was observed (Liu & 
O'Rourke, 2008). It was found that failing cells were unable to match energy 
supply with demand. When workload was increased by increasing stimulation 
frequency to 4Hz in the presence of isoproterenol, NADH fluorescence 
dramatically decreased and did not recover when stimulation was stopped, but 
the redox state was maintained in control cells (Figure 1-13). This difference 
was attributed to higher [Na+]i in failing cells, reducing Ca2+ accumulation by the 
mitochondria due to altered mitochondrial NCX activity. The resultant reduced 
stimulation of Ca2+-sensitive dehydrogenase enzymes of the TCA cycle limits the 
rate of NADH production in failing cells, leading to oxidation of the 
mitochondrial environment when workload and ATP demand is increased. 
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Figure 1-13 NADH fluorescence changes in guinea pig ventricular myocytes in response to 
increased work intensity 
(A) NADH fluorescence is maintained in control cells (B) NADH fluorescence dramatically 
decreased upon increased stimulation frequency in failing cells. Reprinted by permission 
from Wolters Kluwer Health: (Liu, T. & O'Rourke, B. (2008). Enhancing Mitochondrial Ca2+ 
Uptake in Myocytes From Failing Hearts Restores Energy Supply and Demand Matching. 
Circulation Research 103, 279-288). 
 
However, similar experiments performed on isolated trabeculae from rat heart 
produced a somewhat difference response (Brandes et al., 1998). In these 
experiments, trabeculae were isolated 15-18 weeks after aortic banding surgery. 
Stimulation frequency was increased from 0.25Hz to 0.5Hz, 1Hz and 2Hz and 
NADH fluorescence recorded. It was found that immediately after stimulation 
frequency was increased, the fall in NADH fluorescence was much greater in 
trabeculae from hypertrophied hearts. NADH fluorescence then recovered 
towards baseline to around the same steady state level. When stimulation 
frequency was slowed back to 0.25Hz, the NADH fluorescence overshoot on 
recovery was greater in hypertrophied trabeculae (Figure 1-14).  
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Figure 1-14 NADH fluorescence changes in rat isolated trabeculae in response to increased 
work intensity 
Increasing stimulation frequency to 1Hz results in a fall in NADH fluorescence to minimum 
levels (MIN). Fluorescence then recovers (REC) to a new steady state (SS) level. When 
stimulation frequency is slowed back to 0.25Hz, NADH fluorescence overshoots to 
maximum levels (MAX) before recovering to baseline. Solid line represents response in 
control trabeculae, dashed line represents response in trabeculae from hypertrophied 
hearts. NADH reached a lower min and higher max in trabeculae from hypertrophied hearts 
Reprinted by permission from Wolters Kluwer Health: (Brandes, R., Maier, L. S., & Bers, D. 
M. (1998). Regulation of Mitochondrial [NADH] by Cytosolic [Ca2+] and Work in Trabeculae 
From Hypertrophic and Normal Rat Hearts. Circulation Research 82, 1189-1198) 
 
Like Liu & O’Rourke, Brandes et al. demonstrate that there is an initial large 
imbalance between energy production and consumption in cardiac hypertrophy. 
However, they show that there is compensation for this imbalance, and the 
recovery mechanism is enhanced in hypertrophic hearts. Thus the effects of 
cardiac hypertrophy on energy supply and demand matching are inconsistent and 
remain unclear. Therefore, these responses have been further investigated in a 
genetic model of cardiac hypertrophy in this thesis.   
1.9 Aims of the project 
The overall aim of the project was to investigate mitochondrial redox state in 
myocardial cells and tissue using intrinsic fluorescence methods. Spectral 
analysis of the endogenous fluorophores NADH and FAD was first performed in 
order to establish optimal optical settings to simultaneously measure 
fluorescence from both fluorescent species. 
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The individual aims of the project were: 
i. To assess the reproducibility and reliability of the method by measuring 
mitochondrial redox state in isolated LV cells from rabbit hearts using a 
variety of fluorescence techniques. 
ii. To assess if the enzymatic digestion process used to isolate single cells 
affects mitochondrial function by comparing mitochondrial redox state in 
isolated LV cells with intact cardiac tissue preparations.   
iii. To examine the feasibility of using 2P-excitation fluorescence microscopy 
to image local regions within the myocardium 
iv. To investigate how mitochondrial redox state changes in isolated rabbit 
LV cells in response to changes in work intensity, i.e. metabolite supply 
and demand matching. 
v. To investigate metabolite supply and demand matching in a genetic model 
of pressure overload-induced cardiac hypertrophy in the rat.  
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2 Methods 
Iffath Ghouri, 2011  Chapter 2; 58 
 Solutions used 
2.1.1  Extracellular solutions 
Experiments performed on isolated cells used a modified Krebs solution as the 
physiological extracellular solution. For experiments using whole rabbit heart 
and the ventricular wedge preparation, a modified Tyrode’s solution was used. 
All chemicals were obtained from Sigma unless otherwise stated. 
Modified Krebs solution 
120 NaCl, 20 HEPES, 5.40 KCl, 0.52 NaH2PO4, 3.50 MgCl2.6H2O, 20 taurine, 10 
creatine, 11.10 glucose (concentrations in mM).  
Modified Tyrode’s solution 
93 NaCl, 20 NaHCO3, 1 Na2HPO4, 1 MgSO4.7H2O, 5 KCl, 20 Na+ acetate, 50 glucose 
(concentrations in mM). Solution contained 1.8mM CaCl2 unless otherwise stated. 
The solution was filtered through a 5µm filter (Millipore) and continuously 
bubbled with a gaseous mixture containing 95% O2 and 5% CO2 to maintain pH 7.4 
2.1.2 Mitochondrial inhibitors 
Carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone (FCCP) 
Stock solution of FCCP was diluted in water to a concentration of 100µM on each 
experimental day. This FCCP solution was further diluted in Krebs solution 
(containing 1.8mM Ca2+) to 2µM for cell perfusion. 
Sodium cyanide (NaCN)  
NaCN was dissolved in water to a concentration of 300mM on each experimental 
day. This was diluted to 200mM by addition of 1M HEPES solution and pH was 
adjusted to 7.4 with 1M HCl. The NaCN solution was further diluted in Krebs 
solution (containing 1.8mM Ca2+) to 2mM for cell perfusion. 
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2.2 Cell isolation  
2.2.1 Cell isolation procedure for rabbit ventricular myocytes 
Male New Zealand white rabbits were euthanised with 500 IU heparin and an 
overdose of Na pentobarbitone (100mg/kg), delivered via the left marginal ear 
vein. Absence of corneal and pain reflexes was confirmed and the thoracic 
cavity opened. The heart was quickly removed and placed in a beaker of sterile 
Krebs at room temperature. The heart was then mounted via the aorta on to the 
cannula of a Langendorff retrograde perfusion system and securely tied in 
position, ensuring no air bubbles entered the heart. Excess fat and connective 
tissue was trimmed away and the coronary vessels perfused with Ca2+-free sterile 
Krebs solution (maintained at 37˚C) to remove blood and Ca2+. Perfusion was 
then switched to Ca2+-free Krebs solution supplemented with 0.66mg/ml 
collagenase (Worthington Chemicals) and 0.04mg/ml protease. The enzyme 
solution was collected from the heart after 1 minute and re-circulated once the 
initial volume of solution had passed through. When the heart became hard, 
around 2-3 minutes into the digestion process, 0.05mM CaCl2 was added to the 
re-circulating enzyme. Enzymatic digestion was continued for 5-7 minutes, or 
until the right ventricular tissue felt softened to touch. The enzymes were then 
washed out of the heart by perfusing with 50ml sterile Krebs solution containing 
0.1% (w/v) Bovine Serum Albumin (BSA) and 0.075mM CaCl2. 
The heart was taken off the cannula and atrial tissue removed and discarded. 
Digested tissue was finely cut up in BSA solution; ensuring that tissue from the 
LV, right ventricle (RV) and intraventricular septum were kept separate. The 
myocytes were dissociated by gently triturating the tissue in solution with a 
Pasteur pipette. Any undigested tissue was removed by filtering through gauze 
mesh, leaving behind a single-cell solution which was transferred into tubes.  
The isolated cells were allowed to settle, the supernatant removed and the cells 
re-suspended in Krebs solution containing 0.125mM CaCl2. This process was 
repeated 3 times in solutions with progressively higher CaCl2 concentrations, 
until a final concentration of 1.0mM CaCl2 was achieved.  All experiments were 
performed using cells isolated from the LV. 
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2.2.2 Cell isolation procedure for rat ventricular myocytes 
Male WKY and SHRSP rats were stunned by a blow to the head and killed by 
cervical dislocation. The thoracic cavity was opened and heart removed and 
placed in ice-cold Krebs solution. The heart was mounted and tied via the aorta 
on to the cannula of a Langendorff perfusion system and perfused with Krebs 
solution at 37˚C until all the blood had been washed out from the coronary 
vessels and the perfusate from the heart ran clear. The heart was then perfused 
with Ca2+-free Krebs solution containing 0.66mg/ml collagenase and 0.04mg/ml 
protease.  Enzyme solution was collected from the heart and re-circulated once 
the initial solution had passed through. Enzyme digestion was continued until the 
RV tissue felt softened to the touch, at which point perfusion was stopped. 
The heart was taken down, divided into LV and RV tissue sections, and cut up 
finely into Krebs solution containing 0.5% (w/v) BSA. The tissue was gently 
triturated with a Pasteur pipette in order to dissociate the myocytes, and the 
supernatant transferred into tubes. The CaCl2 concentration in the cell solution 
was gradually increased over time until a final concentration of 1.0mM CaCl2 was 
obtained. Experiments were performed on cells isolated from the LV. 
2.3 Left ventricular wedge preparation 
The arterially perfused LV wedge preparation was first developed in canine 
hearts  (Yan & Antzelevitch, 1996) and is a useful model for electrophysiological 
studies. The preparation can also be reproduced in rabbit heart (Yan et al., 
2001), although is technically more difficult to prepare due to the smaller size. 
For the purposes of this project, the rabbit LV wedge preparation was used to 
study mitochondrial redox state in intact tissue. 
Male New Zealand white rabbits were euthanised with 500 IU heparin and an 
overdose of Na pentobarbitone (100mg/kg), delivered via the left marginal ear 
vein. Absence of pain reflexes was confirmed and the thoracic cavity opened. 
The heart was rapidly excised and placed in a beaker of ice cold Tyrode’s 
solution and then transferred to a custom-made Perspex chamber. The 
ascending aorta was opened, the left main coronary ostium identified and the 
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modified cannula passed into the artery and perfused with oxygenated Tyrode’s 
solution maintained at 37˚C. Pressure in the system was continuously monitored 
with an inline pressure monitor.  
Once the cannula was in position, flow rate was increased to 30ml/min. Correct 
positioning of the cannula was confirmed by observing clearance of blood from 
the perfused area of myocardium and an increase in pressure in the system (~50-
60mmHg). The RV outflow tract was removed and the cannula sutured in 
position. A bleb and a black suture marker on the cannula identified how deep 
the cannula needed to be inserted into the vessel. The left and right atria and 
the RV free wall were removed. Any open vessels that resulted when these 
tissues were removed were closed up by suturing to ensure that perfusion 
pressure was maintained. An incision was made through the interventricular 
septum at the base of the aorta and any unperfused tissue removed. Any open 
vessels were sutured closed to prevent myocardial perfusion becoming 
compromised. The wedge preparation was positioned in the chamber, epicardial 
surface facing upwards, and secured in place with metal pins. Perfusion was 
then switched to an oxygenated Tyrode’s solution containing 10µM blebbistatin 
(Biomol International) to inhibit contraction. Once contractions had been 
completely inhibited, the preparation was ready for imaging.    
2.4 Langendorff-perfused whole heart preparation 
Although the LV wedge preparation had the advantage that it could be studied in 
a quiescent state, it was technically difficult to prepare. This led to the 
simplification of the procedure to measure mitochondrial redox state in 
Langendorff-perfused whole heart.  
Male New Zealand white rabbits were euthanised with 500 IU heparin and an 
overdose of Na pentobarbitone (100mg/kg), delivered via the left marginal ear 
vein. Absence of corneal and pain reflexes was confirmed and the thoracic 
cavity opened. The heart was quickly excised and immersed in ice cold Tyrode’s 
solution. The heart was transferred to the custom made Perspex chamber and 
mounted and tied via the aorta to the cannula (a modified 3-way valve) of a 
Langendorff retrograde perfusion system. The heart was perfused with 
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oxygenated Tyrode’s solution maintained at 37˚C. Flow rate was increased to 
30ml/min and any excess fat and connective tissue trimmed away. Pressure in 
the system was continually monitored using an inline pressure monitor.  
Once the blood had been washed from the coronary arteries, a vent was inserted 
into the LV at the apex to release any excess fluid from the LV cavity. If this 
resulted in pressure falling below 20mmHg, flow rate was increased to 35ml/min 
in order to maintain perfusion of the coronary vessels. The solution was then 
switched to one of oxygenated Tyrode’s solution containing 100µM Ca2+ and 
10mM MgCl2. The low [Ca2+] was used to inhibit contraction of the heart and 
prevent movement (Hoenicke & Damiano, 2001; Lansman et al., 1986). At very 
low [Ca2+], Na+ conductance into the cell through the L-Type Ca2+ channel is 
increased and this can influence the action of the mitochondrial NCX (Maack et 
al., 2006). The use of high magnesium (Mg2+) concentrations in the solution, as 
well as the use of low (not zero) [Ca2+] helped protect against this increase in 
Na+ (Chapman et al., 1984).  
The heart was positioned horizontally with the LV facing upwards for imaging 
(Figure 2.1). Once contractions had been completely abolished, the preparation 
was ready to be imaged. 
 
Figure 2-1 Position and orientation of Langendorff-perfused heart for 2P imaging 
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2.5 Fluorescence spectroscopy 
Fluorescence spectroscopy was performed using the Perkin Elmer LS 55 
fluorescence spectrometer. Fluorescence spectroscopy allows light intensity to 
be plotted against wavelength, and thus allows analysis of the spectral 
properties of fluorescent species. Spectroscopic measurements enabled 
determination of excitation and emission spectra of pure NADH and FAD in 
solution, as well as intrinsic fluorescence in cells.   
 
Figure 2-2 LS 55 fluorescence spectrometer setup 
Instrument used a xenon lamp as the light source. White light is directed to the excitation 
monochromater, where it is split into narrow wavebands of light. These individual 
wavebands are directed to the sample. Any fluorescence emission that results is directed to 
the emission monochromater, split into narrow wavebands and directed to the 
photomultiplier detector. Excitation and emission polarisers could be selected if required. 
(Adapted from Perkin Elmer FL WinLab user’s guide) 
 
2.5.1 Determination of excitation spectra 
To obtain an excitation spectrum, 2ml of the solution of interest was placed in a 
plastic cuvette and positioned in the cell holder. The emission wavelength was 
set as the wavelength where the emission peak was known or expected to occur. 
Excitation and emission slit widths were set at 10nm; these are the spectral 
bandwidths of the excitation and emission monochromators. Increasing the 
excitation slit width resulted in a wider waveband (and thus more light) being 
directed to the sample. Increasing the emission slit width resulted in a wider 
waveband of light being directed to the detector. The excitation spectrum 
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resulting from the scan indicated the range of wavelengths of light that excited 
fluorescence in the sample, the peak being the wavelength that most effectively 
excited fluorescence.     
2.5.2 Determination of emission spectra 
Emission spectra were obtained by a similar procedure. For these 
measurements, the information obtained from the excitation spectrum of the 
sample was utilised to set the excitation wavelength. The resultant emission 
spectrum indicated the range of wavelengths at which fluorescence is emitted, 
the peak being the wavelength where most fluorescence is emitted. 
2.6 Fluorescence microscopy 
A number of fluorescence microscopy techniques were performed on single, 
isolated cells. 
2.6.1 1P excitation CLSM 
1P excitation CLSM was performed using the Zeiss LSM 510 META inverted 
confocal microscope. From the lasers available, the 405nm diode laser and the 
488nm argon laser were deemed most suitable for exciting NADH and FAD 
respectively. The high numerical aperture (NA) Zeiss C-Apochromat 40x/1.2 NA 
water-immersion objective lens was used throughout.  
Spectral analysis of intrinsic fluorescence was first performed using the META 
detector on the system. Emission from the sample is directed onto a wavelength 
dispersive element and imaged by the META detector, which consists of 32-
channels. Each channel consists of a PMT and detects emission within a spectral 
range of 10.7nm as described below: 
Iffath Ghouri, 2011  Chapter 2; 65 
 
Figure 2-3 Emission fingerprinting using META detector 
Each photomultiplier detects emission within a spectral range of 10.7nm (indicated by black 
lines). Compiling the total emission detected by each photomultiplier builds a picture of the 
emission spectrum for the sample. 
  
Emission fingerprinting using this system enabled analysis of the intrinsic 
fluorescence emitted by a single cell and comparison with the emission signal 
from pure NADH and FAD. This allowed selection of the most suitable dichroic 
mirrors and emission filters in order to selectively collect fluorescence from 
NADH and FAD in the cell. The overall configurations chosen are illustrated in 
Figure 2-4. 
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Figure 2-4 Optical settings for 1P CLSM 
Excitation light was directed to the specimen and any fluorescence emitted was split from 
the excitation path with the 405/488nm main dichroic mirror. The emission light was split 
with a dichroic mirror at 490nm. Light of wavelengths shorter than 490nm was directed 
towards Ch 1 through a 420nm long-pass emission filter and light of wavelengths longer 
than 490nm was directed towards Ch 2 through a 505nm long-pass emission filter. This 
resulted in Ch 1 emission collection at 420-490nm (corresponding to NADH fluorescence) 
and Ch 2 detecting emission at wavelengths longer than 520nm (FAD fluorescence). The 
optical path to the 32-channel META PMT array is represented by the dashed arrows (the 
mirror was removed from the light path). These detectors were only used for emission 
fingerprinting experiments (in place of Ch 1 and Ch 2).  
 
The time series function enabled multiple fluorescence measurements to be 
made in series over time. Using the multi-track function on the system, laser 
excitation of the specimen could be switched alternately between 405nm and 
488nm excitation, and emission from NADH and FAD split by wavelength and 
imaged separately at different channels. The maximum power of the lasers was 
30mW, but transmission intensity was set at less than 10% for all experiments in 
order to minimise photobleaching and photodamage to the cells. In order to 
maximise fluorescence detection, the PMT gain and pinhole diameter were 
instead increased as required.  
2.6.2 2P laser scanning fluorescence microscopy 
2P excitation fluorescence microscopy was performed on isolated cells, as well 
as on intact tissue preparations. The Zeiss LSM 510 NLO upright microscope 
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equipped with a Coherent Chameleon Titanium-Sapphire tunable laser was used 
for all experiments. For experiments performed on cells, excitation wavelengths 
of 720 and 750nm were used and for tissue experiments, excitation wavelengths 
of 720 and 740nm were used (depending on where the laser was most stable). 
The Zeiss Achroplan IR 40x/0.8 NA and the Zeiss Achroplan 10x/0.3 NA water-
dipping objectives were used for cell and tissue experiments respectively. 
Excitation fingerprinting was performed on cells in order to confirm that NADH 
and FAD fluorescence could be imaged using 2P-excitation, and the appropriate 
wavelengths to achieve this. Fluorescence emission was collected as the laser 
was tuned through a range of excitation wavelengths. The emission 
measurements were collated to produce a 2P-excitation spectrum for the 
sample. It was found that FAD fluorescence could not be detected by 2P-
excitation, so the dichroic mirrors and filters were set to optimally collect NADH 
fluorescence (Figure 2-5). 
 
Figure 2-5 Optical settings for 2P excitation fluorescence microscopy 
Excitation light was focussed on to the specimen and the emitted fluorescence was split 
from the excitation path using a 650nm main dichroic mirror. The emitted fluorescence was 
directed by a mirror to the PMT detector through a 435-485nm band-pass emission filter. 
 
The time series function was used to image fluorescence over time. Maximum 
laser power at the wavelengths used was ~625mW, but transmission intensity 
was set at ~20% for cell experiments, as use of higher laser powers usually 
resulted in cell death. For experiments performed on intact tissue, laser power 
was set at maximum (although technical adjustments to the laser meant that 
maximum laser power at the wavelengths used was now ~1250mW). The PMT 
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gain was increased as required in order to maximise fluorescence detection and 
signal-to-noise ratio improved by scan averaging over 2 scans.  
For experiments involving tissue preparations, the Z-stack mode was used. This 
involves the laser scanning and imaging a thin plane, then displacing vertically 
by a specified amount and scanning and imaging again. This process was 
repeated a specified number of times to build up a 3D-representation of NADH 
fluorescence in the tissue.  Any differences in fluorescence through the different 
layers of the heart could be investigated in this way.  
2.6.3 Wide-field epifluorescence microscopy 
Experiments were performed using a Nikon inverted microscope fitted with a 
Nikon Fluor 40x/1.3 NA oil-immersion objective lens. Epifluorescence 
measurements were made with a Cairn Optoscan epifluorescence system using a 
xenon short arc lamp as light source.  NADH was excited at 340nm and FAD at 
430nm and fluorescence from each detected at two separate PMTs. NADH 
fluorescence was collected between 455 and 480nm and FAD fluorescence 
collected between 520 and 600nm. Excitation was alternately switched at 200ms 
intervals between the two wavelengths by the monochromator. The optical 
settings used for epifluorescence measurements are described in Figure 2-6. 
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Figure 2-6 Optical settings for epifluorescence microscopy  
Light from the xenon lamp was directed to the monochromator where it was split into the 
excitation wavelengths (340 and 430nm) and directed in sequence to the specimen. Emitted 
fluorescence was split from the excitation light with a 455nm dichroic mirror. Emission light 
was split again at 505nm; shorter wavelength light was directed to PMT 1 via a 455/50nm 
(455±25nm) emission filter, corresponding to NADH fluorescence. The longer wavelength 
light was further split at 600nm. Emission light of 505-600nm was directed to PMT 2 via a 
560/80nm (560±40nm) emission filter, corresponding to FAD emission. Light of wavelengths 
longer than 600nm (from the microscope lamp) was directed to the CCD camera to enable 
cell edge detection measurements. 
 
A red disc filter was used on the microscope to prevent light from the 
microscope lamp contaminating the PMT signals. Red coloured room light was 
used and the microscope and PMT setup were draped in thick cloth to prevent 
ambient light leak. These precautions were taken in order to reduce signal noise 
at the PMTs.  
The charge coupled device (CCD) camera (IonOptix Limited) captured a video of 
the cell, which was displayed via the IonWizard software (IonOptix Limited). The 
iris diaphragm was adjusted so that only one cell was in the optical field. 
2.7 Measurements of mitochondrial redox state 
To establish the mitochondrial redox state in rabbit myocardial cells and tissue, 
NADH and FAD fluorescence was calibrated with the mitochondrial inhibitors 
NaCN and FCCP. These inhibitors induced mitochondrial states of maximal 
reduction and maximal oxidation respectively. In the maximally reduced 
mitochondrial state, NADH fluorescence increases and FAD fluorescence 
decreases, whereas maximal oxidation of the mitochondrial environment has the 
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opposite effect on NADH and FAD fluorescence. Calibrating NADH and FAD 
fluorescence in this way gives a measurement of the initial proportion of NAD 
and FAD in the reduced state i.e. the mitochondrial redox state of the cell or 
tissue.  
2.7.1 Mitochondrial redox state measurements using 
fluorescence spectroscopy 
2ml of cell solution was placed in a plastic cuvette and positioned in the cell 
holder of the fluorescence spectrometer. Initial NADH and FAD emission spectra 
were taken at 380nm and 450nm respectively. FCCP was then added to the 
cuvette at a concentration of 2µM and NADH and FAD emission spectra 
immediately taken. NADH and FAD emission spectra were repeatedly measured 
over the course of ~6-7mins to ensure that any effect of FCCP on the spectra was 
recorded. The cell solution was mixed with a pipette between scans to prevent 
the cells settling at the bottom of the cuvette. 
FCCP could not be washed out of the cells in the cuvette, so 2ml of fresh cells 
from the same heart were placed in a new cuvette and the process repeated 
with 2mM NaCN. The concentration of cells was the same for both FCCP and 
NaCN measurements. 
2.7.2 Perfusion system for isolated cardiomyocytes 
A perfusion system was designed for microscopy experiments to allow fast 
switching between solutions (Figure 2.7).  
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Figure 2-7 Apparatus for perfusion of isolated cardiomyocytes 
Each 35ml syringe was filled with solution and perfusion of each solution was controlled by 
a 3-way valve. Perfusion was gravity driven and solutions were directed to the cell bath by 
narrow plastic tubes which converged at the inflow manifold. Heat-shrink tubing and silicon 
were used to create low volume dead space and prevent solution leak at the manifold. 
Outflow from the bath was driven by peristaltic pump. The angle of orientation of the inflow 
tip and the narrow outflow tip minimised disruption to the cells.     
 
A Perspex cell bath was used for 1P and 2P experiments. For experiments 
involving field-stimulation of the cells, a larger aluminium bath was used and 
inflow was through a hole in the side wall of the bath. This is because these 
experiments were required to be performed at 37˚C, and the aluminium cell 
bath could be heated to achieve solution flow at this temperature.  
In order to avoid contamination, each syringe was designated for use as a 
reservoir for a particular solution: control, FCCP or NaCN. The remaining tube 
was used for any other solution. After each experiment, the whole perfusion 
system was washed through with double de-ionised water.     
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2.7.2.1 Perfusion protocol for isolated cardiomyocytes 
The same perfusion protocol was used to establish mitochondrial redox state in 
isolated cardiomyocytes using 1P excitation, 2P excitation and epifluorescence 
techniques.  
Cells were placed in the cell bath with the bottom covered by a glass coverslip 
(thickness 1.5mm); the cell density was such that cells were evenly spread and 
not overlapping. The cells were allowed to settle and stick to the coverslip. 
After 2-3 min, perfusion with Krebs solution containing 1.8mM Ca2+ (control 
solution) was started. Any cells that had not stuck down were allowed to wash 
away before any fluorescence measurements were taken. The focus was set on 
rod-shaped cells with clear striations that appeared to be well adhered to the 
coverslip, preferably in the centre of the bath. For experiments performed using 
1P and 2P excitation fluorescence microscopy, measurements could be made on 
more than one cell during each recording. For experiments using 
epifluorescence, measurements could only be made on one cell at a time. 
Intrinsic fluorescence measurements were taken throughout the perfusion 
protocol. The protocol began by taking baseline fluorescence measurements of 
cells perfused with control solution. This was continued for ~100s, so that the 
rate of any fluorescence bleaching that may have occurred could be calculated 
and corrected for later. Perfusion was then switched to a 2µM FCCP solution (in 
1.8mM Ca2+ Krebs solution) and perfusion continued until fluorescence levels had 
reached a steady state. FCCP was washed out by perfusing with control solution 
for 200-300s, or until the effects of FCCP on intrinsic fluorescence had been 
reversed. Perfusion was then switched to 2mM NaCN solution (in 1.8mM Ca2+ 
Krebs solution) and continued until fluorescence levels reached a steady state. 
Finally, perfusion was switched back to control solution to washout the NaCN 
solution.   
The background fluorescence signal was measured in 1P and 2P experiments by 
selecting a region of interest (ROI) containing no cells. This background signal 
was easily subtracted from the fluorescence signals from the cells. For 
epifluorescence experiments, the background signal had to be taken by moving 
the focus away from the cell and measuring the fluorescence signal from an 
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adjacent area free from any cell or debris. This was done a number of times 
during each recording. The overall background signal was later averaged from 
this and subtracted from the cellular fluorescence signal.  
2.7.3 Delivering mitochondrial inhibitor to tissue preparations 
Measurements of mitochondrial redox state in the whole heart and wedge 
preparations required delivery of mitochondrial inhibitor by a syringe driver 
(Figure 2.8). 
 
Figure 2-8 Mitochondrial inhibitor delivery system for tissue preparations 
A glass syringe was filled with FCCP, NaCN or control solution. A length of silicone tubing 
connected the end of the syringe to a needle, which was inserted into a Y-piece in the 
perfusion system. A digitimer triggered the pulse output generator to deliver trigger 
impulses to the motor on the syringe driver. This turned a screw which moved a sliding 
block behind the syringe, pushing the plunger and delivering the contents of the syringe. 
The cycle length (the length of time between trigger impulses) was set on the digitimer to 
ensure that inhibitor solution was delivered into the perfusing Tyrode’s solution at the 
correct rate in order to achieve the desired concentration in the perfusate.    
 
The control solution in the syringe was the same Tyrode’s solution perfusing 
through the heart.  FCCP solution was placed in the syringe at a concentration of 
400µM and NaCN solution at 400mM. The digitimer cycle length was set at 
255ms, which resulted in the syringe contents being delivered at rate of 
0.3ml/min. As the heart was being perfused with Tyrode’s solution at a rate of 
30ml/min, the dilution factor was 100:1. Thus the FCCP and NaCN concentration 
reaching the coronary arteries was 4µM and 4mM respectively, which is double 
the concentrations used in isolated cells. The higher concentrations were used 
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so that the effective inhibitor concentration reached the tissue as quickly as 
possible. 1.5ml of inhibitor or control solution was placed in the syringe, which 
resulted in delivery for 5 min. 
2.7.3.1 Perfusion protocol for tissue preparations 
For the first measurement on each preparation, control solution was placed in 
the syringe. Initial measurements of baseline NADH fluorescence in the tissue 
layers were made; 4-5 X-Y images of each layer in the Z-stack were taken. 
Delivery of the syringe contents was then started and carried on for ~5mins. 
Control solution was also poured into the Perspex chamber to ensure that the 
heart was immersed in the same solution as was being delivered to the tissue. 
Once the syringe had emptied and delivery stopped, fluorescence measurements 
were continued for 5-10mins to record any fluorescence changes during 
recovery. After recordings were stopped, the syringe was switched to one 
containing NaCN and the process repeated. The process was repeated again with 
FCCP. Sufficient time was left between inhibitors to ensure that the inhibitor 
had been completely washed out of the heart. The solution in the chamber was 
also replaced with fresh Tyrode’s solution. 
At the end of the day’s experiments, the heart was removed from the chamber 
and the fluorescence signal from Tyrode’s solution alone was measured. The PMT 
settings and room light conditions were kept the same as those used during the 
tissue fluorescence measurements. The fluorescence values obtained were taken 
to be background fluorescence and subtracted from the tissue fluorescence 
values. 
2.7.4 Calculation of mitochondrial redox state  
For each experimental recording, background fluorescence measured at each 
wavelength was subtracted from the cell and tissue fluorescence at the 
corresponding wavelength. The fluorescence signal was normalised by 
normalising the initial fluorescence values during control perfusion (or before 
inhibitor injection in tissue preparations) to 1. If any fluorescence bleaching had 
taken place, this was corrected for by subtracting the underlying bleach from 
the trace. The maximum NADH fluorescence was obtained during NaCN perfusion 
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and the minimum fluorescence during FCCP perfusion. Conversely, the maximum 
FAD fluorescence was obtained during FCCP perfusion and the minimum 
fluorescence during NaCN perfusion. The fluorescence values at baseline, 
minimum and maximum were used to calculate NAD and FAD states (Figures 2-9 
and 2-10).  
 
Figure 2-9 Calculation for NADstate 
NADstate for each cell was calculated using the fluorescence measurements at baseline 
(Fcontrol), minimum (FFCCP) and maximum (FCN). 
 
Calculation of NADstate indicates the proportion of NAD in the reduced state, 1.0 
being fully reduced, 0 being fully oxidised. 
 
Figure 2-10 Calculation for FADstate 
FADstate for each cell was calculated using the fluorescence measurements at baseline 
(Fcontrol), minimum (FCN) and maximum (FFCCP). 
 
Conversely, calculation of FADstate gives an indication of the proportion of FAD in 
the oxidised state, 1.0 being fully oxidised and 0 being fully reduced.  
2.8 Electrical stimulation of isolated cardiomyocytes 
Experiments that assessed mitochondrial redox state in response to changes in 
work intensity required cells to be in the contracting state. Cellular contraction 
was induced by electrical field stimulation. A thin layer of cell solution was 
placed on to the coverslip of a metal bath (Figure 2-7). The bath was heated so 
that the extracellular solution was ~37˚C during perfusion. A stimulator 
generated square wave electrical impulses which were delivered to the cells 
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through two narrow platinum electrodes on each side of the bath. A digitimer 
connected to the stimulator set the frequency of stimulus impulses. 
Cell shortening measurements were made using a CCD camera with cell edge 
detection capability (IonOptix Limited). Intrinsic fluorescence measurements 
were simultaneously made using the Cairn Optoscan epifluorescence system (see 
section 2.6.3).   
2.8.1 Pacing protocol for metabolic challenge in isolated 
cardiomyocytes 
The metabolic challenge was designed to step increase the rate of cellular 
contraction, and thus level of work, performed by the cell. Analysis of the 
changes in NADH and/or FAD fluorescence as a result of changes in work 
intensity indicated how well cells were able to match energy supply with 
demand.  
The pacing protocol for rabbit cardiomyocytes began by stimulating the cells at 
0.5Hz for around 100s. Stimulation frequency was step increased to 1Hz and 
pacing was continued at this rate for ~50s, or until fluorescence levels had 
reached a steady state. Stimulation frequency was switched back to 0.5Hz and 
the cell allowed to recover. Stimulation frequency was again increased to 1Hz 
for ~50s before returning to 0.5Hz stimulation. In the same way, the cell was 
subjected to 2 bursts of 2Hz stimulation and 2 bursts of 3Hz stimulation. Each 
burst of fast pacing was interspersed with pacing at 0.5Hz to allow the cell to 
recover (Figure 2-11). Step increasing the frequency of stimulation in this way 
abruptly increased the intensity of work performed by the cell.  
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Figure 2-11 Metabolic challenge stimulation protocol in rabbit cells 
The stimulation protocol for the metabolic challenge involved subjecting the rabbit cell to 
burst pacing at 1Hz, 2Hz and 3Hz. Each burst was interspersed with 0.5Hz pacing (white 
boxes). The length of time the cell was paced at 2Hz and 3Hz was slightly longer, as it took 
longer for NADH and FAD fluorescence levels to reach a steady state at faster stimulation 
rates.   
 
A similar protocol was performed in rat cells (Figure 2-12), but faster pacing 
rates were used. Intrinsic heart rate is faster in rats compared to rabbits, and 
rat cells can therefore contract at faster rates than rabbit cells.  
 
Figure 2-12 Metabolic challenge stimulation protocol in rat cells 
Rat cells were burst paced at 2Hz, 4Hz and 6Hz, each burst interspersed with 1Hz 
stimulation (white boxes). 
 
At the end of the pacing protocol, NADH and FAD fluorescence was calibrated 
with FCCP and NaCN.  A ratio of NADH/FAD fluorescence was also taken in order 
to minimise artefacts in the fluorescence signals caused by movement, changes 
in background signal, etc. 
2.9 Statistical analysis 
Statistical analysis was performed using GraphPad InStat statistical software. All 
data was presented as mean ± standard error of the mean (SEM) unless otherwise 
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stated. Comparison between groups of data was performed by Student’s t-test 
(paired where appropriate). Multiple comparison tests were performed using 
repeated measures one-way ANOVA with Tukey’s multiple comparison post-hoc 
test. A 2-tailed p-value of less than 0.05 was considered statistically significant. 
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3 Characterisation of intrinsic fluorescence in 
ventricular myocytes 
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3.1 Introduction 
It has been established for several decades that cells have autofluorescent 
properties. The source of this autofluorescence has been mainly attributed to a 
number of respiratory enzymes and these properties have been extensively 
studied by Chance and colleagues (Chance, 1952; Chance, 1954; Chance & 
Williams, 1955a; Chance & Williams, 1955b; Chance & Williams, 1955c; Chance & 
Williams, 1955d; Chance et al., 1955).  
In order to confirm that the major source of intrinsic fluorescence arising from 
cardiac cells and tissue was NADH and FAD, it was necessary to characterise the 
excitation and emission properties of this fluorescence. In addition, knowledge 
of the spectral characteristics of intrinsic fluorescence enabled selection of the 
most appropriate excitation wavelengths, dichroic mirrors and emission filters to 
ensure that the maximum fluorescence signal was detected.  
3.2 Methods 
3.2.1 Fluorescence spectroscopy 
3.2.1.1 Preparation of pure metabolites and determination of spectra 
NADH and FAD were obtained in the pure state and dissolved in a basic mock 
intracellular solution containing (in mM) 120 KCl, 1 MgCl2 and 0.05 EGTA. This 
was to recreate the intracellular ionic environment and any possible interactions 
that may occur between the metabolites and ions within the cell. The pH of the 
NADH solution was adjusted to ~9 as more acidic conditions can cause NADH 
decomposition. Excitation and emission spectra were determined as previously 
described. A range of NADH and FAD concentrations were used, but it was found 
that using excitation and emission slits of 10nm and a scan speed of 500nm/min, 
the [NADH] of 5µM and [FAD] of 2.5-3µM produced the clearest spectra without 
saturation of the fluorescence signal.  
For experiments involving oxidising and reducing agents, NADH was diluted in a 
pH 9 buffer solution and FAD was diluted in a HEPES buffered solution at pH 7. 
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This was to ensure any change in spectral properties upon oxidation or reduction 
was not due to changes in pH. 2,6-Dimethoxy-1,4-benzoquinone (2,6-DMBQ) was 
used as an oxidising agent for NADH and sodium dithionite (Na-dithionite) was 
used as a reducing agent for FAD. 2,6-DMBQ was only freely soluble in glacial 
acetic acid, and greatly acidified the cuvette contents upon addition. The 
volume of 10M NaOH solution required to return the pH of 2ml of 5µM NADH 
solution to pH 9 following addition of 0.5mM 2,6-DMBQ was therefore 
determined, and this was added to the cuvette along with 0.5mM 2,6-DMBQ. 
Baseline NADH and FAD emission spectra were first recorded and the 
oxidising/reducing agent was then added to the cuvette and emission spectra 
recorded again. NADH/NAD+ was excited at 340nm and FAD/FADH2 excited at 
450nm. The concentration of 2,6-DMBQ or Na-dithionite was increased in 0.5mM 
and 0.25mM steps respectively, until the full effect was deemed to have 
occurred.     
3.2.1.2 Spectral measurements of intrinsic fluorescence from isolated 
ventricular myocytes 
Rabbit ventricular myocytes were isolated as previously described and the 
excitation and emission spectra of the intrinsic fluorescence from aggregates of 
live and dead cells determined. The same scan settings used for measurements 
in pure metabolites were used for measurements in cells.  
3.2.2 Excitation and emission fingerprinting 
3.2.2.1 Emission fingerprinting using 1P-excitation CLSM  
Emission fingerprinting was performed using the 1P-excitation confocal 
microscope. When excitation was with the 405nm laser, the 405/514/594 main 
dichroic beamsplitter was used. When excitation was with the 488nm laser, the 
405/488 main dichroic beamsplitter was used. These dichroic mirrors were 
chosen so as to cause minimal interference to the transmission of emission light 
from the samples to the detector. The sample of interest (pure metabolite 
solution or cell suspension) was placed in the bath and imaged using the 32-
channel META detector. A wavelength dispersive element split the emission light 
into wavebands of around 10nm, each waveband detected by a different PMT 
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channel. Compilation of the emission detected by all the PMT channels gives a 
picture of the emission spectral characteristics of the sample. For the cell 
measurements, emission fingerprinting was performed on individual rod-shaped 
cells. 
3.2.2.2 2P-excitation fingerprinting  
In order to assess the 2P-excitation characteristics of NADH and FAD, excitation 
fingerprinting was carried out on pure NADH and FAD solutions and on the 
intrinsic fluorescence from single rod-shaped cells. This involved the laser tuning 
through a range of excitation wavelengths and collecting emission at each 
wavelength. The laser power was calibrated through the wavelength range and 
adjusted at each wavelength to ensure that the power remained constant 
throughout. Collating the emission measurements produced a 2P-excitation 
spectrum for the sample.  
3.3 Results 
3.3.1 Pure NADH and FAD spectra 
Initial experiments were performed on pure NADH and FAD samples in solution to 
establish the excitation and emission spectral properties of the metabolites, 
shown in Figure 3-1. From these measurements, it was found that the excitation 
peak for NADH was at 340nm and emission peak was at ~460nm. The main 
excitation peak for FAD was at 450nm and emission peak at 525nm.  
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Figure 3-1 Excitation and emission spectra of pure NADH and FAD in solution  
Excitation spectrum (black) and emission spectrum (grey) of (A) pure NADH and (B) pure 
FAD. 
 
3.3.2 Pure NADH and FAD 2P excitation spectra 
2P-excitation spectra of pure NADH and FAD in solution were taken using the 
excitation fingerprinting function of the 2P fluorescence microscope. These 2P 
spectra were then compared with the predicted 2P-excitation spectra produced 
by doubling of 1P-excitation wavelengths (Figure 3-2).  
 
Figure 3-2 2P-excitation spectra of pure NADH and FAD in solution (predicted and 
measured) 
The 2P-excitation spectra of (A) NADH and (B) FAD were predicted by taking 1P-excitation 
spectra and doubling the wavelengths (black lines). These spectra were compared with 
measured 2P-excitation spectra obtained by 2P-excitation fingerprinting (grey lines). 
 
Measured 2P-excitation spectra of pure NADH and FAD corresponded well with 
the 2P spectra predicted for the fluorophores by doubling 1P-excitation spectral 
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wavelengths. The measured 2P-excitation peak of NADH was red-shifted by ~15-
20nm, whereas the measured 2P-excitation peaks of FAD were blue-shifted by 
~20-30nm compared to the predicted 2P excitation peaks. However, doubling 
the wavelengths of the 1P-excitation spectrum only gives an estimation of the 
2P-excitation spectrum, and the excitation peaks of the predicted and measured 
spectra would not necessarily be expected to match exactly (Xu & Webb, 1996).  
As with the 1P spectral measurements, there are 2 peaks present in the FAD 2P-
excitation spectrum. However, in the 2P-excitation spectrum the first peak is 
larger than the second peak, whereas the opposite is the case in the 1P-
excitation spectrum. The 2P-excitation spectra of pure NADH and FAD obtained 
in these experiments are consistent with previous reports in the literature 
(Huang et al., 2002). 
3.3.2.1 Effect of oxidising agent on NADH fluorescence 
The fluorescent properties of NAD+ were also assessed by spectrophotometry 
using the oxidising agent 2,6-DMBQ to oxidise pure NADH to NAD+. The emission 
spectra of NADH taken before and after addition of 2,6-DMBQ are shown in 
Figure 3-3.  
 
 
Figure 3-3 NADH emission spectra before and after oxidation 
The emission spectrum of pure NADH at excitation 340nm was taken (black line). Addition 
of 1.5mM of the oxidising agent 2,6-DMBQ to the cuvette oxidised NADH to NAD+ and 
decreased fluorescence emission (grey line). 
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The oxidation of NADH to NAD+ results in a considerable decrease in fluorescence 
emission. Thus NAD+ emits little or no fluorescence at an excitation wavelength 
of 340nm.   
3.3.2.2 Effect of reducing agent on FAD fluorescence 
The effect of reducing FAD to FADH2 on the fluorescence signal was also 
examined using the reducing agent Na-dithionite. The emission spectra of FAD at 
450nm excitation, taken before and after addition of Na-dithionite, are shown in 
Figure 3-4. 
 
Figure 3-4 FAD emission spectra before and after reduction 
The emission spectra of pure FAD at excitation 450nm before (black line) and after (grey 
line) addition of 0.75mM of the reducing agent Na-dithionite. The reduction of FAD to FADH2 
causes the fluorescence signal to be virtually eliminated. 
 
Reduction of FAD to FADH2 using the reducing agent Na-dithionite caused the 
fluorescence signal to be abolished. Thus FAD is only fluorescent in the oxidised 
state. 
3.3.3  Fluorescent properties of NADH-FAD solution mixture  
 
A solution containing both pure NADH and pure FAD was also made up and the 
excitation and emission spectra taken at the peak excitation and emission 
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wavelengths for NADH and FAD (Figure 3-5). Pure NADH was used at a 
concentration of 5µM and pure FAD at a concentration of 2.5µM. The same 
concentrations were used in the mixture of solutions and the spectra of the pure 
metabolites were compared with the spectra of the solution mixture. This was to 
assess whether there were any interactions between the two fluorescent species 
causing any unexpected shifts in the spectral properties of the individual 
metabolites.     
 
Figure 3-5 Excitation and emission spectra of pure NADH and FAD solution mixture 
A: Excitation spectra of pure NADH (blue), pure FAD (red) and a mixture of the two 
metabolites (black). Panel (i) emission collected at 460nm, (ii) emission collected at 525nm. 
B: Emission spectra of pure NADH (blue), pure FAD (red) and a mixture of the two 
metabolites (black). Panel (i) excitation at 340nm, (ii) excitation at 450nm. 
 
The excitation and emission spectra of the NADH-FAD solution mixture did not 
show any spectral shifts compared to the excitation and emission spectra of pure 
NADH and pure FAD alone. The spectral effects are additive: where both 
Iffath Ghouri, 2011  Chapter 3; 87 
metabolites are fluorescent at a particular wavelength, the fluorescent peaks in 
the solution mixture represent the peaks seen in both NADH and FAD. 
3.3.4 Comparison of intrinsic fluorescence in cells with pure 
NADH and FAD fluorescence 
3.3.4.1 Spectrophotometer measurements 
It was necessary to confirm that the intrinsic fluorescence arising from 
ventricular myocytes was indeed due to NADH and FAD fluorescence.  In order to 
do this, excitation and emission spectra of intrinsic fluorescence were taken at 
peak excitation and emission wavelengths for NADH and FAD and compared to 
the spectra taken of the pure metabolites (Figure 3-6). 
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Figure 3-6 Spectrophotometric comparison of cellular intrinsic fluorescence with pure 
NADH and FAD 
A: Excitation spectra of intrinsic fluorescence from cells (black), pure NADH (blue) and pure 
FAD (red). Panel (i) emission collected at 460nm, (ii) emission collected at 525nm. 
B: Emission spectra of intrinsic fluorescence (black), pure NADH (blue) and pure FAD (red). 
Panel (i) excitation at 340nm, (ii) excitation at 450nm. 
 
The Y-axis scale was adjusted for the intrinsic fluorescence spectra to ensure 
that the height of the peaks from cell measurements coincided with the height 
of the peak for the metabolite most fluorescent at that particular wavelength. 
This allowed for easier spectral comparison.  
Although the excitation and emission peaks from intrinsic fluorescence arising 
from aggregates of live and dead cells seem to correspond to NADH and FAD, the 
peaks do not match exactly. In particular, the excitation and emission peaks 
likely to correspond to NADH are left-shifted (i.e. at shorter wavelengths) in the 
cells compared to the pure solution. Furthermore, it was found that the turbid 
cell suspension caused excessive light scattering. This was most apparent at FAD 
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excitation wavelengths, and clear intrinsic fluorescence emission spectra could 
not be obtained. The emission peak visible at ~590nm is likely to be due to 
lipofuscin, a pigment associated with aging produced by lysosomes (Gao et al., 
1994), although this was not investigated further and could not be conclusively 
confirmed. Due to the lack of clarity in the spectrophotometer measurements, 
additional spectral analysis of intrinsic fluorescence was performed using the 
META detector on the 1P confocal microscope. 
3.3.4.2 Emission fingerprinting using 1P confocal methods 
Emission fingerprinting was performed on single rod-shaped cells and compared 
with the emission characteristics of pure NADH and FAD (Figure 3-7). 
 
Figure 3-7 Comparison of cellular intrinsic fluorescence with pure NADH and FAD emission 
characteristics using the META detector 
A: Emission fingerprinting of intrinsic fluorescence from a single cell (black), pure NADH 
(blue) and pure FAD (red) using a 405nm laser for excitation. Y-axes scales have been 
adjusted to compare (i) pure NADH peak emission and (ii) pure FAD peak emission with 
intrinsic fluorescence emission peaks. B: Emission fingerprinting using a 488nm laser for 
excitation. 
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Excitation of intrinsic fluorescence using the 405nm laser results in emission 
peaks corresponding to both NADH and FAD. At wavelengths shorter than 
~480nm, intrinsic fluorescence corresponds solely to NADH. At longer 
wavelengths, the intrinsic fluorescence emission signal correlates with FAD 
fluorescence. Excitation at 405nm is suboptimal for NADH, but the lasers 
available on the 1P confocal system meant that this was the only wavelength 
present that could excite NADH. For future experiments, it was therefore 
important to ensure that the emission filters selected collect fluorescence only 
from NADH. When the 488nm laser is used, intrinsic fluorescence arises only 
from FAD. 
A number of points have been excluded from the emission traces obtained by 
405nm excitation. This was because the 405/514/594nm main dichroic 
beamsplitter was used to split the excitation light from the emission path. This 
dichroic mirror was chosen as it caused the least interference at the 
wavelengths where the NADH emission peak was expected. However, it 
prevented a substantial amount of emission light from being transmitted to the 
detectors at and around 514nm and 594nm, thus altering the shape of the 
emission spectra. The points between 492 and 545nm and 577 and 620nm were 
therefore removed to prevent confusion arising. However, this meant that some 
details concerning emission could not be detected (e.g. the FAD emission peak), 
as the dichroic beamsplitter makes it impossible to collect all the emission light 
from the full wavelength range. Ultimately, 405nm was the wavelength used for 
exciting NADH, so it was deemed more important to obtain the emission 
characteristics of this fluorophore.    
3.3.4.3 Excitation fingerprinting using 2P-excitation methods 
The 2P-excitation characteristics of intrinsic fluorescence from single rod-shaped 
cells were assessed using excitation fingerprinting. This was to confirm the 
source of intrinsic fluorescence, as well as to select the most appropriate 
wavelengths for 2P-excitation. The 2P-excitation spectrum from the cell was 
compared to the 2P-excitation spectra of pure NADH and FAD solutions (Figure 3-
8). 
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Figure 3-8 Comparison of cellular intrinsic fluorescence with pure NADH and FAD 2P-
excitation characteristics 
(i) 2P-excitation fingerprinting of intrinsic fluorescence from a cell (black), pure NADH (blue) 
and pure FAD (red). (ii) Enlarged view of spectral region encompassing second FAD 
excitation peak. Y-axes scales have been adjusted to compare excitation peak from intrinsic 
fluorescence with pure FAD excitation peak. Broadband emission was collected between 
400nm and 650nm. 
 
The 2P-excitation spectrum from cellular intrinsic fluorescence seems to 
correlate with NADH, although as with the spectrophotometer measurements, 
the cell spectrum is left-shifted. The slight increase in intrinsic fluorescence 
when excited between 800 and 1000nm (which is not present in the NADH 
solution spectrum) corresponds well to the second peak in the FAD excitation 
spectrum. However, there appears to be a further source of intrinsic 
fluorescence at wavelengths longer than 900nm. This is possibly arising from 
lipofuscin granules.      
3.4 Discussion 
The purpose of this set of experiments was to characterise the excitation and 
emission spectra of NADH and FAD in the pure state and to confirm that the 
intrinsic fluorescence from cardiac myocytes corresponded to these metabolites. 
As well as confirming the source of intrinsic fluorescence, these experiments 
also provided information about the possibility to simultaneously (but 
separately) visualise NADH and FAD fluorescence from the cells using a variety of 
fluorescence techniques, and the most suitable optical settings to achieve this. 
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A number of problems were encountered when measuring excitation and 
emission spectra from intrinsic fluorescence using the spectrophotometer. 
Firstly, when emission spectra were taken at 340nm excitation, an additional 
peak can be seen at 380nm. This was attributed to an instrument artefact, as it 
was evident even in non-fluorescent solutions such as water. Secondly, these 
measurements were made on 2ml volumes of cell suspension containing a 
mixture of live and dead cells in a cuvette. The turbidity of this suspension 
meant that light scattering was a problem, and clear, precise excitation and 
emission spectra could not be obtained. This was particularly a problem when an 
emission spectrum was taken from the cells at 450nm excitation, and it was not 
possible to see an emission peak from cellular intrinsic fluorescence that 
corresponded to FAD. However, 1P-excitation emission fingerprinting performed 
using the META detector on the confocal system revealed close correlation 
between the emission spectra of intrinsic fluorescence excited at 488nm and 
pure FAD fluorescence, with no contribution from NADH fluorescence. 
Excitation and emission peaks from intrinsic fluorescence did seem to correspond 
to NADH fluorescence, although in both cases this peak was left-shifted by 
~20nm in the cells. A possible explanation for this could be protein-binding of 
NADH within the mitochondria of the cells, a situation that does not arise with 
the pure metabolite in solution (Blinova et al., 2005; Avi-Dor et al., 1962; 
Chance & Baltscheffsky, 1958; Duysens & Amesz, 1957). This left-shifting of 
NADH fluorescence was also evident in the 2P-excitation spectrum of intrinsic 
fluorescence from single cells. However, this was not apparent in 1P emission 
fingerprinting. A possible reason for this could be because there are 11nm gaps 
between each measured point in the emission spectrum with 1P emission 
fingerprinting using the META detectors. Thus, the peak intrinsic NADH 
fluorescence from the cell may indeed be left-shifted compared to pure NADH, 
but this is not visible because the exact wavelengths where the emission peaks 
arise could have been missed.  
Although 2P-excitation fingerprinting revealed FAD as a source of intrinsic 
fluorescence in the cell, this fluorescence signal was so small that it was not 
possible to separately measure both FAD and NADH signals. All 2P experiments 
were therefore designed to optimise intrinsic fluorescence measurements of 
NADH in cardiac myocytes and tissue.    
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There are a number of limitations with this spectral analysis that need to be 
taken into consideration. Firstly, mitochondrial inhibitors may cause small 
changes in intracellular pH which could influence the spectral properties of 
NADH and FAD and haven’t been taken into account in these measurements. 
Secondly, the spectral properties of NADPH were not measured here. However, 
it is known that they are almost identical to the spectral properties of NADH 
(Koenig & Schneckenburger, 1994), but as discussed previously, the majority of 
fluorescence is likely to arise from mitochondrial NADH (Eng et al., 1989; Jöbsis 
& Duffield, 1967; Avi-Dor et al., 1962; Estabrook, 1962). Finally, although 
spectral measurements were made on NADH and FAD solution mixtures, this may 
not be a true refection of the interactions occurring intracellularly. Within the 
cell, the close proximity of transiently bound NADH and covalently bound FAD in 
flavoproteins such as lipoamide dehydrogenase, together with the overlap of the 
NADH emission spectrum and FAD excitation spectrum may enable fluorescence 
resonance energy transfer (FRET) to take place. In this situation, energy emitted 
by one chromophore may excite fluorescence in another chromophore located in 
very close proximity (~1-10nm). The occurrence of FRET from NADH to FAD may 
vary depending on the redox state of the mitochondria, influencing the 
fluorescence emission from FAD. However, no evidence could be obtained from 
the literature to support this theory. 
The spectral analysis performed in this work could have been improved if 
spectral measurements were made of NADH in the fully reduced state, FAD in 
the fully oxidised state, as well as measurement of these metabolites in 
intermediate redox states. This would provide a better representation of the 
intrinsic fluorescence arising from these metabolites in their intracellular state.  
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4 Establishing mitochondrial redox state in 
isolated rabbit ventricular myocytes 
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4.1 Introduction 
The mitochondrial redox state provides a valuable index for assessing 
mitochondrial function in cells and tissue. These measurements reflect the 
balance between reduced and oxidised forms of the NAD and FAD pools, and 
provide information about O2 availability/consumption, availability of substrate 
and ATP turnover (Mayevsky & Barbiro-Michaely, 2009; Duchen et al., 2003; 
Huang et al., 2002; Eng et al., 1989). The major application of measurements of 
redox state is to monitor changes in these factors during experimental 
manipulations and different cellular conditions, such as in cancer. However, 
initial experiments were performed on quiescent cells in order to establish the 
resting redox state.  
4.1.1 Intrinsic fluorescence arising from cellular flavins 
In the previous chapter, pure FAD was used as a standard for comparison with 
cellular intrinsic fluorescence. However, the fluorescence excited by blue light 
arises from a number of flavoenzymes. Early studies in isolated rat liver 
mitochondria attributed the majority of this fluorescence to the NAD-linked 
flavoprotein α-lipoamide dehydrogenase (LipDH) in the oxidised state (Kunz & 
Kunz, 1985). LipDH is a component of a number of dehydrogenase enzymes, 
including the pyruvate dehydrogenase complex. The redox state of LipDH is in 
direct equilibrium with the redox state of NAD+ by the following simplified 
reaction mechanism: 
LipDH(FADH2) + NAD+ ↔ LipDH(FAD) + NADH + H+ 
The fluorescence intensity of LipDH thus reflects the redox state of NAD. An 
increase in NADH levels results in a change in the redox state of LipDH towards 
the reduced form and hence a decrease in LipDH fluorescence (Rocheleau et al., 
2004). 
Electron transferring flavoprotein (ETF) was also shown to contribute to 
flavoprotein fluorescence. ETF is reducible in a non-NAD-linked reaction and is a 
component of the fatty acid oxidising system. It has a redox association with the 
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ETC through Q. More recent work in isolated rat cardiomyocytes spectrally 
unmixed the intrinsic fluorescence arising from cellular flavins to identify 
individual sources of fluorescence. This identified flavin fluorescence arising 
from bound FAD in the form of LipDH and ETF, as well as from free FAD (Chorvat 
et al., 2004; Chorvat & Chorvatova, 2006; Chorvat et al., 2005). FAD 
fluorescence is blue-shifted when protein bound. However, treatment with the 
mitochondrial uncoupler 2,4 dinitrophenol (DNP), which resulted in an increase 
in oxidised flavin fluorescence, found the emission peak to be shifted to closely 
match the emission peak of oxidised free FAD. This demonstrates the 
contribution of free FAD to cellular flavin fluorescence, as well as its redox 
contact with the respiratory chain. However, the exact location of free FAD 
within the mitochondria is not clear. Henceforth, any reference to FAD 
fluorescence will encompass the fluorescence arising from the FAD cofactor in 
the free and bound (flavoprotein) forms. 
4.1.2 Intrinsic fluorescence measurements as an indicator of 
mitochondrial function 
The main benefit of using intrinsic fluorescence measurements to assess 
mitochondrial function is that it eliminates the need for exogenous dyes and 
labels, which may themselves interfere with normal mitochondrial functioning. 
Most indicators for measuring mitochondrial membrane potential, for example, 
have direct toxic effects on the mitochondria (Duchen et al., 2003). TMRE, 
TMRM and rhodamine 123 all decrease the rate of coupled respiration as they 
accumulate in the mitochondria (Scaduto & Grotyohann, 1999), and rhodamine 
123 is known to have inhibitory effects on F1F0-ATP synthase at high 
concentrations (Emaus et al., 1986; Modica-Napolitano et al., 1984).  
To determine the resting mitochondrial redox state, NADH and FAD fluorescence 
signals in the maximally oxidised and maximally reduced state were established 
to allow for calibration of resting fluorescence levels. This was achieved using 
the mitochondrial inhibitors FCCP and NaCN. Utilising the fluorescence values at 
baseline, minimum and maximum, the resting NADstate and FADstate could be 
calculated.  
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4.1.3 Mechanism of action of mitochondrial inhibitors 
4.1.3.1 FCCP 
FCCP is a mitochondrial uncoupler. It acts as a proton ionophore and carries 
protons across the inner mitochondrial membrane.  The mitochondrial 
membrane potential is abolished, because the inner membrane is no longer 
impermeable to H+ ions. NADH and FADH2 are continuously oxidised in an 
attempt to restore the membrane potential and O2 consumption increases, but 
this is no longer coupled to the phosphorylation of ADP due to the loss of the 
proton gradient (Figure 4-1). This results in a fall in NADH fluorescence and an 
increase in FAD fluorescence. 
 
Figure 4-1 Mechanism of FCCP action on the respiratory chain 
(i) The actions of FCCP are shown in red. The direction of electron transfer is shown by the 
blue arrow. FCCP causes the inner mitochondrial membrane to become freely permeable to 
protons, abolishing the mitochondrial membrane potential and inhibiting ATP synthesis. (ii) 
FCCP is protonated on the positive side of the membrane and moves across the membrane 
in the neutral form. In the mitochondrial matrix, FCCP loses its proton and in its negative 
form, it is driven back across the membrane by the mitochondrial membrane potential. This 
process can be repeated millions of times, which leads to dissipation of the mitochondrial 
membrane potential.  
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4.1.3.2 NaCN 
The cyanide anion (CN-) acts directly on the respiratory chain by combining with 
iron in cytochrome a3, a component of cytochrome c oxidase (complex IV). This 
binding is of high affinity, with a dissociation constant (Kd) of less than 50nM 
(Wainio & Greenlees, 1960; Jones et al., 1984). Inhibition of complex IV prevents 
the oxidation of NADH and FADH2, electron transfer is blocked and reducing 
equivalents accumulate (Figure 4-2). The result is an increase in NADH 
fluorescence and a decrease in FAD fluorescence. Disruption of electron 
transfer, and thus proton pumping across the inner mitochondrial membrane, 
means that the cell can no longer produce ATP aerobically.  
 
Figure 4-2 Mechanism of CN- action on the respiratory chain 
CN- inhibits complex IV of the respiratory chain, blocking electron transfer (blue arrow) and 
causing accumulation of reducing equivalents.  
 
4.1.4 Aims of the chapter 
The main aim of this chapter was to establish mitochondrial redox state in 
isolated rabbit ventricular myocytes under quiescent conditions. A number of 
different fluorescent techniques were employed, allowing comparison of NAD 
and FAD state values in order to assess the reproducibility and reliability of the 
method.          
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4.2 Methods 
All experiments were performed on rabbit ventricular myocytes isolated from 
the heart using the enzymatic digestion procedure described in Section 2.2.1. 
4.2.1 Fluorescence spectroscopy  
Following the isolation procedure, cells were suspended in Krebs solution 
containing 0.125mM CaCl2 and 0.1% BSA. It was found that BSA has fluorescent 
properties, so the cells were spun down and the pellet re-suspended in a BSA-
free Krebs solution.   
4.2.1.1 Cell counting 
The concentration of cells was calculated using an Improved Neubauer 
Haemocytometer (BDH Laboratory Supplies, Poole, England). The 
haemocytometer is a modified microscope slide with two polished sides, each 
displaying a precisely ruled, subdivided grid. Around 30µl of freshly isolated 
cardiac myocytes was loaded into the haemocytometer. Each of the two 
chambers was filled individually by the capillary action created between the 
haemocytometer and coverslip. Care was taken to ensure that the chambers 
were not overfilled and no solution had spread to the lateral grooves. At 100x 
magnification, the number of rod-shaped cells (cells with intact membranes) and 
ball-shaped cells (hyper-contracted cells with damaged membranes) were 
counted using the grid, and added to give a total cell count (number of cells per 
ml). The proportion of cells with intact membranes was also recorded.  
4.2.1.2 Calculating mitochondrial redox state from spectral measurements 
The mitochondrial redox state of cell aggregates containing a known 
concentration of rod-shaped and ball-shaped cells was taken as described in 
section 2.7.1. The fluorescence value at the peak emission wavelength prior to 
the addition of FCCP or NaCN (hereafter referred to as CN) was normalised to 1. 
The subsequent change in fluorescence following treatment with FCCP and CN 
was measured, and the normalised values at baseline, minimum and maximum 
were used to calculate NADstate (Figure 2-9). The mean NADstate was calculated 
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using the NADstate values obtained from cell aggregates from each heart and are 
presented ± standard deviation (SD).     
4.2.2 Fluorescence microscopy 
4.2.2.1 Excitation and emission settings in relation to NADH and FAD 
spectra 
4.2.2.1.1 1P-excitation CLSM 
The optical settings used for 1P-excitation CLSM are described in Figure 2-4. The 
excitation wavelengths used and emission wavelengths detected by the PMTs 
(due to the dichroic mirrors and emission filters used) in relation to the 
excitation and emission spectra of pure NADH and pure FAD are illustrated in 
Figure 4-3. 
 
Figure 4-3 Excitation wavelengths used and emission wavelengths detected with 1P CLSM 
in relation to NADH and FAD spectra 
Arrows indicate excitation wavelengths used corresponding to (i) NADH and (ii) FAD 
excitation spectra (black lines). NADH was excited at 405nm and FAD at 488nm. Shaded 
areas on emission spectra (grey lines) indicate emission wavelengths detected by the two 
PMTs as a result of the selected dichroic mirrors and emission filters. NADH fluorescence 
was collected at 420-490nm by one PMT and FAD fluorescence at wavelengths longer than 
520nm by another PMT. 
 
4.2.2.1.2 2P-excitation fluorescence microscopy 
2P-excitation of the cells was performed using a Coherent Chameleon Titanium-
Sapphire tunable laser. NADH was excited at 720nm and 750nm, but FAD 
fluorescence could not be detected in the cells.  The wavelengths used for NADH 
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excitation and the emission wavelengths collected during experiments with 2P-
excitation fluorescence microscopy are shown corresponding to the NADH 
excitation and emission spectra in Figure 4-4 
 
 
 
 
Figure 4-4 Excitation wavelengths used and emission wavelengths detected with 2P 
excitation fluorescence microscopy 
Arrows on 2P excitation spectrum (black line) indicate 2P excitation wavelengths used to 
excite NADH (720m and 750nm). Shaded area on NADH emission spectrum (grey line) 
indicates emission wavelengths detected by the PMT (435-485nm). Right Y-axis 
corresponds to fluorescence intensity of excitation spectrum, left Y-axis corresponds to 
fluorescence intensity of emission spectrum.  
 
4.2.2.1.3 Wide-field epifluorescence microscopy 
Unlike with laser scanning microscopy, where the excitation wavelength used is 
determined by the lasers present on the system, wide-field epifluorescence 
microscopy uses a xenon lamp as a light source, which provides intense 
broadband illumination. The excitation light could be adjusted (using a 
monochromator) to any wavelength within the near ultraviolet and visible range. 
The excitation wavelengths used in these experiments are therefore much closer 
to the excitation peaks for NADH and FAD, thus exciting more fluorescence. This 
compensated for the fact that the emission wavelengths detected, particularly 
for NADH fluorescence, had to be of a narrower waveband due to the dichroic 
mirrors and emission filters that were required in order to measure fluorescence 
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from both NADH and FAD. The excitation wavelengths used and emission 
wavelengths detected by the PMTs are shown in Figure 4-5. 
 
Figure 4-5 Excitation wavelengths used and emission wavelengths detected with wide-field 
epifluorescence methods in relation to NADH and FAD spectra 
Arrows indicate excitation wavelengths used corresponding to (i) NADH and (ii) FAD 
excitation spectra (black lines). NADH was excited at 340nm and FAD at 430nm. Shaded 
areas on emission spectra (grey lines) indicate emission wavelengths detected by the 2 
PMTs as a result of the selected dichroic mirrors and emission filters. NADH fluorescence 
was collected at 455-480nm by one PMT and FAD fluorescence at 520-600nm by another 
PMT. 
 
4.2.2.2 Calculating mitochondrial redox state in single cells 
Experiments involving microscopy enabled the fluorescence signal from 
individual cells to be measured. With 1P and 2P-excitation laser scanning 
microscopy, this was achieved by selecting a ROI consisting of an individual rod-
shaped cell. With wide-field epifluorescence microscopy, a diaphragm was 
adjusted so that light could only be collected from a single rod-shaped cell. 
The perfusion protocol for delivering mitochondrial inhibitors to the cells is 
described in section 2.7.2.1. The background subtracted normalised 
fluorescence values at baseline, minimum and maximum were used to calculate 
NADstate and FADstate (Figures 2-9 and 2-10). The mean NAD and FAD states were 
calculated using the NADstate and FADstate values obtained individually for each 
cell and are presented ± SD.   
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4.3 Results 
4.3.1 Mitochondrial redox state of cell aggregates assessed by 
fluorescence spectrometry 
The mitochondrial redox state of cell aggregates containing both rod-shaped and 
hyper-contracted cells was assessed by fluorescence spectrometry. Clear 
emission spectra corresponding to FAD fluorescence could not be detected using 
this method due to problems with light scattering (see Chapter 3). The focus was 
therefore directed towards measurements of NADH fluorescence. The effects of 
FCCP and CN on the emission spectrum of NADH at the excitation wavelength (λ) 
380nm were assessed by measuring changes in the amplitude of the emission 
peak following treatment (Figure 4-6).  
The effects of FCCP and CN are shown in separate batches of cells, but the 
number of cells in each cuvette is the same and both batches of cells were 
isolated from the LV of the same heart.  
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Figure 4-6 Effect of FCCP and CN on NADH emission spectrum  
A: Example traces showing the effects of FCCP and CN on the NADH emission spectrum. 
The NADH emission spectrum before addition of mitochondrial inhibitor is shown by the 
black line. The effect of (i) 2µM FCCP and (ii) 2mM CN on NADH emission is shown by the 
grey line. Total cell number was 5.75 x 105 (20.9% rods). B: Mean effect of FCCP and CN on 
normalised NADH fluorescence (n=7 hearts). * P<0.05 versus control; *** P<0.001 versus 
control; ### P<0.001 versus FCCP.     
 
FCCP and CN both have effects on the NADH emission spectrum. Prior to 
treatment, the baseline fluorescence emission was normalised to 1. FCCP causes 
a small decrease in NADH fluorescence, the mean normalised fluorescence value 
was found to be 0.85±0.07. CN has a slightly larger effect, causing NADH 
fluorescence to increase. The mean normalised fluorescence value following CN 
treatment was found to be 1.34±0.16. The mean NADstate from cell aggregates 
isolated from 7 hearts was calculated to be 0.33±0.15. This means that 33% of 
the NAD pool is in the reduced state. 
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4.3.2 Mitochondrial redox state of single cells assessed by 
fluorescence microscopy 
The mitochondrial redox state of single isolated rabbit ventricular myocytes was 
assessed by 1P and 2P-excitation laser scanning microscopy and by wide-field 
epifluorescence microscopy.      
4.3.2.1 1P-excitation CLSM  
Both the NADstate and the FADstate could be measured with 1P-excitation CLSM. 
The effects of FCCP and CN on NADH and FAD fluorescence from single cells are 
shown in Figure 4-7. The mean normalised minimum NADH fluorescence value 
obtained following FCCP treatment was found to be 0.67±0.07 and the mean 
normalised maximum fluorescence value obtained following CN treatment was 
found to be 1.23±0.13. In 22 single cells with intact membranes, the mean 
NADstate was found to be 0.58±0.16 (58% of the NAD pool in the reduced state). 
The mean normalised minimum FAD fluorescence value after CN treatment was 
found to be 0.58±0.14 and the mean normalised maximum fluorescence value 
after FCCP treatment was 2.94 ±0.53. The mean FADstate in the same cells was 
found to be 0.18±0.07 (18% of the FAD pool in the oxidised state, 82% reduced).  
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Figure 4-7 Effect of FCCP and CN on intrinsic fluorescence measured by 1P CLSM 
A: An example trace showing the effect of FCCP and CN on normalised NADH fluorescence 
(black line) and FAD fluorescence (grey line) in a single rod-shaped cell. Images show 
intensity of (B) NADH fluorescence (ex λ 405nm) and (C) FAD fluorescence (ex λ 488nm) 
during each treatment. (i) control (ii) FCCP (iii) CN. D: Mean effect of FCCP and CN on 
normalised (i) NADH fluorescence and (ii) FAD fluorescence (n=22 cells from 5 hearts). *** 
P<0.001 versus control; ### P<0.001 versus FCCP. 
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4.3.2.2 2P-excitation fluorescence microscopy 
Mitochondrial redox state measurements were also made using 2P–excitation 
fluorescence microscopy. FAD fluorescence could not be clearly detected, so 
only the NADstate could be established by this method. The effects of the 
mitochondrial inhibitors on NADH fluorescence in a single rod-shaped cell are 
shown in Figure 4-8. The mean normalised fluorescence value obtained after 
FCCP treatment was 0.47±0.11 and after CN treatment was 1.41±0.35. In 20 
cells, the mean NADstate was calculated to be 0.57±0.18, i.e. 57% in the reduced 
state.  
 
Figure 4-8 Effect of FCCP and CN on NADH fluorescence measured by 2P-excitation 
fluorescence microscopy 
Panel A: Representative trace showing changes in normalised NADH fluorescence from a 
single cardiomyocyte over time following each treatment (excitation λ 720nm). Panel B: 
Images demonstrate intensity of NADH fluorescence during each treatment. (i) Perfused 
with control solution, (ii) decrease in NADH fluorescence following treatment with 2µM 
FCCP solution and (iii) increase in NADH fluorescence following treatment with 2mM CN 
solution. Panel C shows mean effect of FCCP and CN on normalised NADH fluorescence 
(n=20 cells from 7 hearts). *** P<0.001 versus control. ### P<0.001 versus FCCP. 
 
Iffath Ghouri, 2011  Chapter 4; 108 
4.3.2.3 Wide-field epifluorescence microscopy 
Finally, the mitochondrial redox state of single cells was measured using wide-
field epifluorescence methods. As with 1P-excitation CLSM, both NADH and FAD 
fluorescence could be detected and simultaneously measured, thus enabling the 
establishment of both NADstate and FADstate from the fluorescence responses to 
FCCP and CN (Figure 4-9). Following FCCP treatment, the mean normalised NADH 
fluorescence value was found to be 0.38±0.11 and following CN treatment, was 
found to be 1.55±0.46. Mean normalised FAD fluorescence was found to be 
2.23±0.29 in FCCP and 0.75±0.13 in CN. The mean NADstate was found to be 
0.59±0.17 and FADstate was 0.17±0.10.  
 
Figure 4-9 Effect of FCCP and CN on intrinsic fluorescence measured by wide-field 
epifluorescence microscopy  
A: An example trace showing the effect of FCCP and CN on normalised NADH fluorescence 
(black line) and FAD fluorescence (grey line) in a single cardiac myocyte over time. C: Mean 
effect of FCCP and CN on normalised (i) NADH fluorescence and (ii) FAD fluorescence (n=16 
cells from 11 hearts). *** P<0.001 versus control. ### P<0.001 versus FCCP. 
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4.3.3 Summary of mitochondrial redox state values assessed by 
intrinsic fluorescence methods 
Table 4-1 summarises the values obtained for NADstate and FADstate using the 
fluorescence methods described. Experiments on cell aggregates contained both 
rod-shaped cells with intact membranes and hyper-contracted cells with 
damaged membranes, whereas single cell measurements were only performed 
on rod-shaped cells.  
Fluorescence method Cell aggregates/ single cell NADstate FADstate 
Fluorescence 
spectrometry 
Aggregates 0.33±0.06 
n=7 
- 
 
1P-excitation  Single cell 0.58±0.03 
n=22 
0.18±0.01 
n=22 
2P-excitation Single cell 0.57±0.04 
n=20 
- 
Epifluorescence Single cell 0.59±0.04 
n=16 
0.17±0.03 
n=16 
Table 4-1 Summary of mitochondrial redox state values obtained using each fluorescence 
technique 
 
4.4 Discussion 
4.4.1 Reproducibility of technique 
The mitochondrial redox state values obtained in single rod-shaped cells by 
fluorescence microscopy are comparable between all the fluorescence 
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techniques used. The mean NADstate was found to be between 0.57 and 0.59 
using 1P and 2P laser excitation and epifluorescence methods. Mean FADstate, 
measured by 1P laser excitation and epifluorescence methods, was between 0.17 
and 0.18. This confirms the reproducibility of the technique to measure 
mitochondrial redox state, and also shows that there is little variation in 
mitochondrial function between individual live cells. 
However, the mean NADstate value achieved using fluorescence spectrometry was 
considerably lower, suggesting that the mitochondrial NAD+ pool is in a more 
oxidised state in these cells. The most likely reason for this difference is that 
these measurements were performed on cell aggregates, containing a 
heterogeneous population of live, dead and dying cells. In the example trace 
shown in Figure 4-6, only 20.9% of the cells were live. The dead cells are no 
longer metabolically active, and the mitochondrial inhibitors will therefore have 
no effect on these cells. However, some cells may be dying, but may have some 
residual metabolic activity, as was observed in some hyper-contracted cells by 
1P confocal microscopy. These cells are likely to be in a more oxidised state and 
their response to the metabolic inhibitors will reflect this. Consequently, the 
overall NADstate value obtained by spectrophotometry will not be a reflection of 
an entirely healthy population of cells and comparable redox values to those 
obtained in single, healthy cells would not necessarily be expected. In addition, 
the emission spectra produced by this technique are not particularly clear, most 
probably due to the effects of light scattering in the turbid cell suspension. As a 
result, the changes in fluorescence may not be quantitatively accurate enough 
to calculate NADstate. However, the qualitative responses to FCCP and CN confirm 
the source of this intrinsic fluorescence to be NADH. 
4.4.2 Comparison with redox state values in the literature  
The values obtained for NADstate in single ventricular myocytes are comparable to 
other values quoted in the literature for cardiac cells or tissue (Brandes & Bers, 
1996; Duchen & Biscoe, 1992; Esumi et al., 1991; Eng et al., 1989). The redox 
state of these cells at rest corresponds to state 3 respiration in isolated 
mitochondria. This indicates that the cells are actively respiring in aerobic 
conditions with high levels of substrate and ADP availability (Chance & Williams, 
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1955c; Mayevsky & Barbiro-Michaely, 2009). However, isolated mitochondria 
cannot really be compared to cardiac myocytes in terms of relative NAD and FAD 
states. This is because the substrate is in excess in isolated mitochondria and 
thus the limitation of NADH supply is less, leading to a more reduced NAD state 
at the same rate of ATP synthesis and therefore does not reflect the 
physiological situation in intact cells.  
The results show that the FAD pool is in a more reduced state than the NAD+ 
pool. Flavoprotein redox state has been reported to be ~50% reduced in the 
Langendorff-perfused whole heart (Pasdois et al., 2008). No FADstate values have 
been reported in isolated cells. However, studies performed on cardiac 
myocytes, in which flavoprotein autofluorescence and its response to 
mitochondrial inhibitors and uncouplers was measured, suggest that the 
mitochondrial flavoproteins are predominantly in the reduced state at rest 
(Sedlic et al., 2010; Chorvat et al., 2004; Katoh et al., 2002; Romashko et al., 
1998).  
4.4.3 Possible sources of residual fluorescence 
Some residual fluorescence remains even when the ETC is in the completely 
reduced and completely oxidised state. In the completely reduced state, in the 
presence of CN, the residual fluorescence probably originates from other 
flavoproteins with fluorescent properties, but not in redox contact with the 
respiratory chain (Kunz, 1986). This may be attributed to enzymes of fatty acid 
β-oxidation (Chorvat et al., 2005). In the oxidised state (following FCCP 
treatment) the remaining fluorescence is likely to be arising from cytosolic NADH 
and NADPH, which have similar optical properties to mitochondrial NADH, but 
are relatively unaffected by uncoupling of the mitochondria. Cytosolic NADH 
produced by glycolysis may be indirectly affected by mitochondrial uncoupling 
primarily due to the presence of the malate-aspartate shuttle. This complex 
cycle involves a number of metabolites that leads to the transfer of electrons 
from cytosolic NADH to mitochondrial NAD+. The cytosolic NAD+ that results can 
be recycled for glycolytic use and in the mitochondria, NADH can enter the ETC 
for ATP production. Oxidation of mitochondrial NADH with FCCP may shift this 
equilibrium to increase the activity of the shuttle, potentially increasing the rate 
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of NADH transfer from cytosol to mitochondria. This would contaminate the 
mitochondrial NADHstate measurements obtained by calibration with FCCP and CN 
with cytosolic NADH signal. However, there is evidence to suggest that 
uncoupling agents, including FCCP, have inhibitory effects on this shuttle 
(LaNoue & Williamson, 1971), in which case the contribution of cytosolic NADH 
to the calibrated NADH signal would be expected to be small.  
Another factor that should be taken into consideration is that the NAD+/NADH 
and NADP+/NADPH redox couples are also linked via the pyridine nucleotide 
transhydrogenase enzyme. This enzyme catalyses electron transfer from NADH to 
NADPH, which can then act as an electron donor in antioxidant mechanisms such 
as the glutathione peroxidase reaction. However, if NADP+ reduction through this 
enzyme depends on NADH and the protonmotive force (Kohlhaas et al., 2010; Liu 
& O'Rourke, 2009), the presence of FCCP would inhibit this reaction and thus 
there would be no additional contribution expected to arise from NADPH 
fluorescence (over and above any baseline NADPH fluorescence) when the 
mitochondria are uncoupled. However, if oxidation of NADH during FCCP 
treatment subsequently leads to oxidation of NADPH, this would mean that the 
NADH signal calibrated with FCCP would have some contribution from NADPH 
fluorescence. As NADPH is also maintained in the reduced state via the malic 
enzyme and isocitrate dehydrogenase reactions, it is likely that although some 
NADPH oxidation may occur, its contribution to the calibrated signal is expected 
to be small.       
The NADstate and FADstate values were calculated for each cell/batch of cells using 
the normalised fluorescence values in control, FCCP and CN. The mean NAD and 
FADstate were obtained by taking an average of these values, as opposed to using 
the values for average responses to FCCP and CN. The 2 methods for calculating 
mean NAD/FADstate produce slightly different values. However, taking the 
average from individual cells meant that any slight differences in conditions 
between the cells (for example, differences in the rate of fluorescence 
bleaching at the start of the experiment which could affect the baseline 
fluorescence value) were taken into account when the NAD/FADstate was 
calculated.  
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4.4.4 Relationship between NAD and FAD states 
The results of these experiments have demonstrated that FAD is in a more 
reduced state at rest compared to NAD+. These results agree with what would be 
expected; as the standard reduction potential of FAD is more positive compared 
to NAD+ (see Table 1-1), FAD would be expected to be more reduced than NAD+ 
at any given mitochondrial state.   
These experiments have demonstrated the reproducibility of the technique for 
assessing mitochondrial function through measurements of redox state in 
isolated rabbit ventricular myocytes. Using 1P-excitation and epifluorescence 
methods, both NADH and FAD fluorescence could be measured, but only NADH 
fluorescence was visible using 2P-excitation and spectroscopic methods.  In the 
following chapters, intrinsic fluorescence measurements were used to assess 
mitochondrial redox state in intact tissue preparations and to assess energy 
supply and demand matching in isolated cells.  
114 
5 Establishing mitochondrial redox state in intact 
ventricular tissue preparations 
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5.1 Introduction 
The cell isolation procedure involves the dissociation of cardiac myocytes from 
ventricular tissue using the protein digesting enzymes collagenase and protease. 
The crude activity of these enzymes gives rise to the possibility that the 
mitochondria may be damaged by this process. In order to investigate this, 
mitochondrial function in intact ventricular tissue preparations, not exposed to 
the digestion procedure, was assessed using measurements of mitochondrial 
redox state. This would then be compared to mitochondrial redox state values in 
single, isolated ventricular cells in order to establish if there is any difference, 
and thus if the isolation procedure has an effect on mitochondrial function. In 
addition, if measurements of mitochondrial redox state could be achieved in 
different areas and layers of tissue, variations in the metabolic status of local 
regions within the myocardium could be investigated.   
Two intact tissue preparations from the rabbit heart were used in these 
experiments. In the ventricular wedge preparation, the LV is isolated from the 
rest of the heart and the coronary circulation perfused by cannulation of the left 
coronary orifice. The horizontal Langendorff preparation utilises the whole 
heart, retrogradely perfused through the aorta to perfuse the coronary vessels. 
The preparation is placed horizontally and an area of the LV tissue is imaged.  
Imaging of the tissue preparations was made possible with 2P-excitation 
fluorescence microscopy, which enables greater imaging penetration depth due 
to the lack of detector pinhole and reduced scattering of the excitation light 
(Rubart, 2004; Huang et al., 2002; Centonze & White, 1998; Denk et al., 1990). 
However, earlier experiments using isolated cardiomyocytes have shown that the 
use of 2P-excitation methods meant that only measurements of NADH 
fluorescence could be made. 
5.1.1 LV wedge preparation 
The arterially perfused LV wedge preparation was first developed in canine heart 
(Yan & Antzelevitch, 1996) and has since been reproduced in the rabbit heart  
(Yan et al., 2001). As it is directly perfused through the left coronary artery, the 
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tissue remains viable for up to 7 hours (Chen et al., 2006). This preparation has 
predominantly been used in electrophysiological studies, as its transmural 
surface enables the investigation of electrical heterogeneity within the different 
layers of the myocardium. The rationale behind using the LV wedge for 
investigating mitochondrial function is that the relatively flat ventricular 
epicardial surface that results once the preparation is securely pinned down 
produces the ideal surface for imaging. Another advantage of this preparation is 
that the absence of regions of automaticity means that the wedge is not 
spontaneously active and therefore quiescent cardiac preparations can be 
studied without motion artifact (although blebbistatin was still used as a 
precaution). 
5.1.2 Horizontal Langendorff preparation 
The horizontal Langendorff preparation utilises the principle of retrograde 
perfusion of the aorta in order to perfuse the coronary arteries, but instead of 
hanging vertically, the preparation is placed horizontally. Although it is more 
difficult to find a suitably flat ventricular surface for imaging, this preparation 
requires no dissection of the heart, and is thus easier and quicker to set up than 
the arterially perfused LV wedge preparation, and no cut surfaces are left 
exposed. However, spontaneous activity cannot be avoided. To counter this, but 
retain a metabolically active tissue, inhibitors of contractile function were 
required. The loss of contractile function will mean that the rate of respiration 
will be very much lower than in the physiological situation where the heart 
would be beating and the metabolic demand will be higher. However, this 
allowed comparisons of redox state between inactive intact tissue preparations 
and inactive cells to be made.    
5.1.3 Inhibitors of contraction 
Contractile function in the cardiac tissue preparation needs to be inhibited in 
order to suppress movement which causes motion artefacts and interferes with 
imaging. This can be achieved pharmacologically using motion uncouplers.  
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5.1.3.1 2,3-Butanedione monoxime 
2,3-Butanedione monoxime (BDM) is a reversible inhibitor of myofibrillar ATPase 
and is commonly used as an agent to reduce contractile force. However, there 
are reports of BDM having effects on the electrical activity of cardiac muscle at 
concentrations used experimentally. BDM effects on conduction velocity, action 
potential duration and electrical restitution have been reported (Kettlewell et 
al., 2004; Baker et al., 2000; Riccio et al., 1999). More importantly for this 
study, BDM has also been reported to have effects on mitochondrial function.  It 
has been shown to suppress state 3 respiration, having an inhibitory effect on 
complex I of the ETC even at concentrations below 10mM (Scaduto & 
Grotyohann, 2000). Inhibition of ATP transport across the mitochondrial 
membrane by BDM has also been reported (Stapleton et al., 1998; Mojon et al., 
1993). For these reasons, BDM was not used as a movement uncoupler in these 
experiments. 
5.1.3.2 Blebbistatin 
Blebbistatin is a recently discovered movement uncoupler which selectively 
inhibits myosin II ATPase in an actin-detached state (Kovács et al., 2004; 
Straight et al., 2003). Unlike BDM, it has been shown to have no effect on the 
electrical activity of the heart (Fedorov et al., 2007) and no direct effects on 
mitochondrial function have been reported. However, blebbistatin can be 
inactivated by illumination with UV and visible blue light (Kolega, 2004; 
Sakamoto et al., 2004). In addition, blebbistatin has fluorescent properties 
which can interfere with the fluorescence signal of interest. The excitation and 
emission spectra of blebbistatin are shown in Figure 5-1. Blebbistatin has 3 
excitation peaks, the main peak being at 330nm. Peak emission is at ~500nm. 
These fluorescent properties overlap with those of NADH, and the weak intrinsic 
fluorescence signal is likely to be masked by blebbistatin fluorescence. However, 
the fluorescent properties of blebbistatin were not initially known, and the 
experiments performed on the LV wedge preparation used blebbistatin as a 
movement uncoupler.  
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Figure 5-1 Spectral properties of blebbistatin 
Excitation spectrum (black line, emission measured at 500nm) and emission spectrum (grey 
line, excitation at 390nm) of a 10µM blebbistatin solution.  
 
5.1.3.3 Low Ca2+ solution 
In order to avoid the difficulties resulting from the use of pharmacological 
agents to inhibit contractile activity, no external movement uncoupler was 
added during the horizontal Langendorff experiments. In its place, a low 
extracellular [Ca2+] of 100µM (instead of 1.8mM) was used. If a Ca2+ free 
Tyrode’s solution had been used, any subsequent exposure of the heart to 
solutions with higher [Ca2+] would result in the “Ca2+ paradox” and cell death. 
The [Ca2+] used in these experiments is too low for contraction of cardiac 
myocytes to occur, but together with 10mM MgCl2, protects against the calcium 
paradox taking place (Hoenicke & Damiano, 2001; Suleiman & Chapman, 1993; 
Chapman & Tunstall, 1987; Lansman et al., 1986). In addition, by preventing the 
increase in Na+ conductance via the L-Type Ca2+ channel that can occur in low 
extracellular [Ca2+] conditions, the use of high extracellular [Mg2+] also ensures 
that functioning of mitochondrial NCX is not influenced by high intracellular 
[Na+] (Maack et al., 2006; Chapman et al., 1984). Any effect of the altered ion 
concentrations on mitochondrial redox state was evaluated by assessing NADstate 
and FADstate in a few isolated ventricular cells (n=5) using an extracellular 
solution containing 100µM CaCl2 and 10mM MgCl2. The values were found to be 
similar to those seen in isolated cardiomyocytes using normal Krebs solution, and 
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use of this low Ca2+, high Mg2+ solution was deemed to be a suitable means to 
inhibit contraction in the tissue preparation. 
5.1.4 Inner filter effect on NADH fluorescence transmission 
In the thick tissue preparation, the fluorescence emission of NADH may interact 
with other cellular constituents with light absorption capabilities, potentially 
affecting the fluorescence signal being directed to the PMT detector. This inner 
filter effect complicates the interpretation of the changes in the NADH emission 
signal during mitochondrial inhibition. In addition, if the mitochondrial inhibitors 
affect the optical properties of the tissue, this could also potentially influence 
fluorescence detection of NADH. 
Earlier experiments examining the excitation and emission spectrum of FAD show 
that changes in FAD absorption could affect NADH fluorescence transmission 
through the tissue and subsequently its detection. Myoglobin (Mb) also strongly 
absorbs light at wavelengths corresponding to NADH emission wavelengths. Mb is 
an O2-binding haemoprotein found in striated muscle which acts as an 
intracellular storage site for O2. Upon periods of O2 deprivation, oxymyoglobin 
(MbO2) releases its O2, which can then be used by the cell for aerobic 
metabolism. The Mb absorption spectrum is known to shift depending on 
whether it is in the oxygenated or deoxygenated state (Brandes et al., 1994; 
Leisey et al., 1994). Thus the inner filtering effects of Mb would complicate 
interpretation of NADH fluorescence measurements if experimental conditions 
were changing between normoxia and hypoxia/anoxia, as the variation in light 
absorption by Mb at the different conditions would influence the amount of 
NADH emission light reaching the detector. 
5.1.5 Aims of the chapter 
The main aims of this chapter were to establish mitochondrial redox state in 
intact cardiac tissue preparations which could then be compared to redox state 
values obtained in isolated cells to assess if the enzymatic dissociation process 
has an effect on mitochondrial function. In addition the feasibility of using 2P-
excitation fluorescence microscopy to image metabolic state in local regions 
within the myocardium was examined. 
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5.2 Methods 
5.2.1 Preparation and imaging of tissue  
5.2.1.1 Arterially perfused LV wedge preparation 
The LV wedge preparation was set up as described in section 2.3. A glass 
coverslip was attached to a Perspex slide with an ellipsoidal-shaped section cut 
out, and placed on the tissue to create a flat imaging surface. The preparation 
was imaged by 2P-excitation fluorescence microscopy and NADH was excited at 
720nm. The optical settings used are described in Figure 2-5. A 3D-
representation of the tissue was created by sampling images down the Z-stack. 
This involved the laser scanning and imaging a thin plane, displacing vertically 
by 20-25µm and rescanning and imaging. This was repeated until around 10 
layers had been scanned, giving a cross-sectional fluorescence representation 
through around 200µm. These layers included the epicardial surface and a 
number of myocardial layers, as well as images 50-100µm above the surface of 
the tissue to get an indication of the background fluorescence signal.      
5.2.1.2 Horizontal Langendorff preparation 
The horizontally positioned Langendorff-perfused whole heart preparation was 
set up as described in section 2.4. The Perspex slide was placed on the heart to 
hold it in position, but this time without the coverslip attached. This was 
because of the possibility that the pressure of the coverslip over the coronary 
vessels may cause occlusion of the vessels, preventing flow of the mitochondrial 
inhibitor to the area of tissue being imaged. 
The preparation was excited at 720nm and the optical settings used were the 
same as those described for the experiments on the LV wedge (Figure 2-5). 
Occasionally, the laser would not mode-lock at 720nm, in which case excitation 
was performed at 740nm. As with the wedge preparation, the Z-stack function 
was utilised to sample the fluorescence signal through the myocardial layers. For 
this preparation, the distance between each layer was 50µm. This meant that 
more images could be taken from above and deep within the tissue than with 
the wedge preparation, without extending the time taken to scan through all the 
Iffath Ghouri, 2011  Chapter 5; 121 
layers. In total, the Z-scan spanned around 400µm for these experiments, 
encompassing myocardial and epicardial tissue layers, as well as up to 150µm 
above the tissue surface. The background fluorescence was obtained at the end 
of the experimental day after the heart had been removed from the chamber. 
The fluorescence signal from Tyrode’s solution alone (under the same ambient 
light conditions, laser power and PMT settings used during tissue fluorescence 
measurements) was taken and subtracted from the tissue fluorescence values.   
5.2.2 Delivery of mitochondrial inhibitors 
The mitochondrial inhibitors FCCP and CN were delivered to the tissue 
preparations as described in section 2.7.3. For the experiments performed on 
the LV wedge, the same concentration of FCCP (2µM) and CN (2mM) were used 
as was used in isolated cells. For the whole heart experiments, the 
concentration of both inhibitors was doubled to ensure that effective inhibitor 
concentrations were reaching the area of tissue being imaged as quickly as 
possible.  The same concentration of inhibitor was also added to the bathing 
solution surrounding the preparation to achieve maximum exposure to the 
inhibitor. Between each experimental run, the solution in the chamber was 
removed and fresh Tyrode’s solution added. 
5.2.3 Normalisation of fluorescence 
The fluorescence signal arising from the tissue alone was obtained by subtracting 
the background fluorescence signal. For each layer in the Z-stack, the mean 
baseline fluorescence value prior to the delivery of mitochondrial inhibitor was 
determined and normalised to 1. The same method of normalisation was used for 
both the LV wedge and Langendorff perfused whole heart preparations.     
5.2.4 Assessing perfusion through the coronary vessels 
In order to confirm that the coronary vessels were being perfused adequately 
and that the mitochondrial inhibitor was reaching the area of tissue being 
imaged, the fluorescent indicator 5(6)-carboxyfluorescein was used as a tracer. 
Excitation was at 800nm and fluorescence collected at 500-550nm. 100µM of dye 
was injected through the injection port by the syringe driver into the perfusing 
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solution, resulting in a dye concentration of 1µM being delivered to the tissue. 
The appearance of the dye in the vessels and tissue confirmed that the vessels 
were being perfused and the myocardial tissue was receiving an adequate supply 
of perfusate. In addition, any effect of the mitochondrial inhibitor on vascular 
tone was indirectly assessed by injecting inhibitor together with the dye. If the 
presence of the inhibitor prevented or slowed dye uptake by the tissue, this 
would suggest that the inhibitor was causing constriction of the coronary vessels 
and restricting flow. Consequently, this would suggest that the inhibitor was not 
being delivered to the area of tissue being imaged. 
5.2.5 Assessing the effects of mitochondrial inhibitors on light 
transmission through the tissue 
To investigate whether the mitochondrial inhibitors were directly affecting the 
optical properties of the tissue, light transmission through the ventricular 
myocardium was measured. A blue light emitting diode (LED), emitting light at 
450-490nm (corresponding to peak NADH emission) was inserted into the 
ventricle and the effect of the mitochondrial inhibitors on light transmission to 
the PMT detectors was assessed. An additional green LED, emitting light at 500-
550nm was also inserted into the heart. This emission corresponds to the 
downward slope of the NADH emission spectrum, but unlike the blue LED, it does 
not overlap with the FAD excitation spectrum (which could potentially interact 
with NADH emission). The wavebands emitted by these LEDs are spectrally 
adjacent, as light scattering is affected by wavelength. Any change in the LED 
emission signal detected by the PMTs during perfusion with the mitochondrial 
inhibitors would suggest that the inhibitor is affecting transmission of light 
through the tissue, therefore complicating the interpretation of the oxidative 
status of NADH.  
These experiments were performed in the whole heart. The horizontal 
Langendorff-perfusion was setup and contraction was inhibited by perfusing with 
low Ca2+ solution. The measurements were made in both the RV and the LV. The 
LEDs were inserted into the RV through a slit cut into the right atrium. An 
opening was cut at the apex of the heart to allow the LEDs to be inserted into 
the LV. The heart was positioned with either the RV or LV facing upwards, and 
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orientated in a manner so that light from both LEDs could be simultaneously 
detected (Figure 5-2). No laser was used in these experiments. Blue light was 
detected at one PMT using a 435-485nm filter. Green light was detected at 
another PMT using a 505nm long-pass filter.  
 
Figure 5-2 Positioning of LEDs in the LV of the horizontal Langendorff preparation 
The LEDs were inserted into an opening cut at the apex of the LV and pinned into position. 
The heart was imaged in an area where light from both LEDs could be detected by the PMTs 
(indicated by black arrow). 
 
5.2.6 FAD absorption measurements 
The absorption spectrum of FAD was verified using a Shimadzu UV-2401PC UV-VIS 
recording spectrophotometer. 0.1mM of pure FAD was dissolved in a mock 
intracellular solution containing (in mM) 120 KCl, 1 MgCl2, 0.05 EGTA and 25 
HEPES with the pH adjusted to 7.2. The absorption spectrum of 2ml of pure FAD 
was recorded between 300 and 700nm. 1mM Na-dithionite was added to this 
solution to reduce FAD to FADH2, simulating the effect of CN treatment in the 
tissue preparation. The absorption spectrum of the solution was recorded again, 
enabling comparison of absorption profiles of FAD and FADH2. 
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5.2.7 Mb absorption measurements 
Another cellular component potentially capable of complicating intrinsic 
fluorescence measurements due to inner filtering effects is Mb (Brandes et al., 
1994; Leisey et al., 1994). To examine this, Mb from equine heart (Sigma) was 
dissolved in the same mock intracellular solution used in FAD absorption 
measurements. 2ml of Mb at a concentration of 0.01mM was placed in a cuvette 
and the absorption spectrum between 300nm and 700nm was recorded. 4mM 
NaCN was added to the cuvette and the absorption spectrum recorded again to 
assess any effect of CN on the absorption spectrum of Mb.  
5.3 Results 
5.3.1 Mitochondrial inhibitor responses in the LV wedge 
preparation 
An example image of the localisation of NADH fluorescence in intact tissue is 
shown in Figure 5-3.  
 
Figure 5-3 NADH fluorescence localisation in intact tissue 
NADH fluorescence can be clearly seen throughout the myocardial structure; here indicated 
by the blue pseudocolour. At this scale (using a 10x objective), individual cells cannot be 
identified. Image was taken ~50µm below the tissue surface. Excitation was at 740nm, 
emission was collected at 435-485nm.  
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The responses to FCCP and CN in the LV wedge preparation were difficult to 
quantify due to continuous upward movement of the preparation. This meant 
that the plane of focus was constantly changing, resulting in fluorescence 
changes due to areas of tissue coming into/going out of focus, and not due to 
the effect of the mitochondrial inhibitor. No clear response to FCCP was seen in 
any of the preparations (data not shown). However, in some preparations, a 
transient increase in NADH fluorescence in response to CN infusion was seen. An 
example of this response is shown in Figure 5-4. This transient response was only 
apparent in the myocardial tissue layers; images taken from above the tissue 
surface (essentially background fluorescence) did not display the same response. 
This suggests that this response was not simply an artefact due to movement of 
the tissue, and was likely to be a true biological response to CN. Out of four LV 
wedge preparations, this transient response to CN was seen in two. In the other 
preparations, no clear changes in fluorescence could be observed over and above 
those caused by movement of the tissue.   
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Figure 5-4 NADH fluorescence response to CN in LV wedge preparation 
Panel A shows changes in NADH fluorescence and the effect of 2mM CN over time at 
different tissue depths. The difference between each Z-layer is 20µm. The grey bar indicates 
the time period during which CN was delivered. The plane of focus appears to be changing 
over time, suggesting upward movement of the preparation. Black and red bars on right 
indicate images arising from myocardial tissue and above the surface of the tissue 
respectively (at the start of the experiment before any movement of the tissue had 
occurred). B: Collating the mean normalised fluorescence in all the myocardial layers (i) 
indicates a transient response to CN, not seen in the mean normalised fluorescence from 
layers above the tissue surface (ii).     
 
5.3.2 Confirmation of coronary artery perfusion in the horizontal 
Langendorff preparation  
The technical difficulty of preparing the LV wedge, and the lack of consistency 
in the responses to the mitochondrial inhibitors, led to the decision to use the 
horizontal Langendorff preparation for intact tissue experimentation.  
It was necessary to check that the coronary vessels were being effectively 
perfused in this preparation, as inadequate perfusion would result in the tissue 
becoming ischaemic as well as prevent the mitochondrial inhibitors being 
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delivered to the tissue. This was achieved by perfusing with the tracer dye 5(6)-
carboxyfluorescein, which is easily washed into and out of the heart. Perfusion 
of the vessels is illustrated in Figure 5-5. Dye uptake by the tissue can be clearly 
seen in all 3 images, indicating that coronary perfusate was supplying deeper 
layers as well as surface tissue. The tissue surface is not completely flat, and the 
lower part of this image includes areas from above the surface of the tissue. This 
consists of dye in solution which has washed out of the heart and the lack of 
detail in this area distinguishes it from tissue images, where myocardial 
structure is visible.  
 
Figure 5-5 Perfusion of the coronary vessels imaged with 5(6)-carboxyfluorescein 
Presence of the dye within the myocardium shows that the vessels are being perfused and 
the myocardial tissue is receiving an adequate supply of perfusate. Images were taken at 
the tissue surface and 50 and 100µm below the surface. 
 
To investigate whether the mitochondrial inhibitors themselves had any effect 
on vascular tone, the vessels were perfused with 5(6)-carboxyfluorescein dye 
together with 4mM NaCN or 4µM FCCP. Any difference in the rate of tissue 
uptake and washout of the dye in the presence of the inhibitors would suggest 
an effect on vascular tone. Traces showing uptake and washout of the dye alone, 
and in the presence of FCCP and CN, are shown in Figure 5-6. 
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Figure 5-6 5(6)-Carboxyfluorescein uptake and washout in presence and absence of 
mitochondrial inhibitors 
Panel A: Representative trace showing perfusion with 5(6)-carboxyfluorescein alone caused 
an increase in fluorescence as the dye was taken up by the tissue. When perfusion was 
stopped, the fluorescence signal decreased as the dye was washed out of the tissue. 
Similar dye uptake and washout profiles were produced when perfusion of the dye was 
combined with (B) 4µM FCCP and (C) 4mM CN. Black bars indicate period during which 
dye/dye + inhibitor perfusion took place. All traces show dye uptake and washout profiles in 
a single myocardial layer from the same heart.        
 
The dye uptake and washout profiles in the presence and absence of the 
mitochondrial inhibitors were similar between the three conditions. This 
indicated that FCCP and CN did not cause constriction of the coronary vessels 
and therefore did not prevent flow to the tissue.   
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5.3.3 Mitochondrial inhibitor responses in the horizontal 
Langendorff preparation 
Movement of the tissue was still a problem in the Langendorff-perfused 
preparation, making quantifiable measurements of the NADH response to the 
mitochondrial inhibitors difficult to interpret. In addition, no FCCP responses 
could be elicited in the tissue. The fluorescence changes that took place were 
associated with upward movement of the tissue, as the decrease in fluorescence 
in the myocardial layers corresponded to increasing fluorescence in Z-layers 
initially above the tissue surface, indicating a shift in the focal plane (Figure 5-
7). However, a transient increase in fluorescence in response to CN occurred 
consistently in this preparation, and this response was slightly more sustained 
than in the wedge preparation (Figure 5-8). Once again, this response was only 
seen in the myocardial layers, not above the tissue, indicating that this was a 
true biological response to CN and not an optical artefact. In the same heart, 
control treatment (Tyrode’s solution alone delivered by syringe driver) produced 
no change in fluorescence signal over and above the changes caused by tissue 
movement (Figure 5-9). 
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Figure 5-7 NADH fluorescence response to FCCP in the horizontal Langendorff preparation 
Panel A shows changes in NADH fluorescence and the effect of 4µM FCCP over time at 
different tissue depths. The difference between each Z-layer is 50µm. The grey bar indicates 
the time period during which FCCP was delivered. Black and red bars on right indicate 
images arising from myocardial tissue and above the surface of the tissue respectively (at 
the start of the experiment). B: The mean normalised fluorescence in all the myocardial 
layers was collated (i), demonstrating an overall decrease in fluorescence that 
corresponded to an increase in fluorescence seen in the collated mean normalised 
fluorescence from above the tissue surface (ii). 
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Figure 5-8 NADH fluorescence response to CN in the horizontal Langendorff preparation 
Panel A shows changes in NADH fluorescence and the effect of 4mM CN over time at 
different tissue depths. The difference between each Z-layer is 50µm. The grey bar indicates 
the time period during which CN was delivered. Black and red bars on right indicate images 
arising from myocardial tissue and above the surface of the tissue respectively (at the start 
of the experiment). B: Collating the mean normalised fluorescence in all the myocardial 
layers (i) indicates a transient response to CN, not seen in the mean normalised 
fluorescence from layers above the tissue surface (ii).     
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Figure 5-9 NADH fluorescence response to control in the horizontal Langendorff preparation 
Panel A shows changes in NADH fluorescence and the effect of control infusion over time at 
different tissue depths. The difference between each Z-layer is 50µm. The white bar 
indicates the time period during which control solution was delivered by the syringe driver. 
The plane of focus is changing over time, suggesting upward movement of the preparation. 
Black and red bars on right represent images arising from myocardial tissue and above the 
surface of the tissue respectively (at the start of the experiment before movement has 
occurred). B: No additional change in fluorescence can be seen during control treatment in 
(i) the myocardial layers or (ii) above the surface of the tissue. 
 
The decrease in fluorescence over time in the myocardial layers was associated 
with upward movement of the preparation causing the focal plane to shift to 
deeper layers of tissue, where light scattering is greater and fluorescence 
detection is subsequently reduced. In layers that were initially above the surface 
of the tissue, upward movement of the preparation caused the fluorescence 
signal to increase with time as myocardial tissue came into focus.  
After correcting for the fluorescence changes associated with movement of the 
preparation, the mean normalised maximum fluorescence value obtained 
following CN treatment in 3 hearts was found to be 1.19±0.03. 
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5.3.4 Transmission of emission light through the tissue 
The reason for the difference in the profile of response to CN in the intact tissue 
preparation compared to isolated cells was considered to be most likely due to 
inner filter effects that are associated with the use of thicker preparations. 
Transmission of light through the ventricular tissue at wavelengths corresponding 
to NADH emission was therefore examined using LEDs inserted into the 
ventricular chamber. Two LEDs were used – a blue LED (peak emission at 
450nm), the emission from which corresponded to the FAD excitation spectrum 
and a green LED (peak emission at 500nm), which did not correspond to the FAD 
excitation spectrum. The LEDs were orientated to emit light directly to the PMTs 
through the ventricular tissue. Measurements were made in both the RV and the 
LV. The effect of addition of 4mM CN solution on light transmission through the 
tissue at the two emission wavebands was assessed and compared to addition of 
control (Tyrode’s) solution. The effects of CN on transmission of blue light 
through the LV and RV tissue are shown in Figure 5-10.   
 
Figure 5-10 Mean effects of CN on transmission of blue emission light through LV and RV 
tissue 
Panel A: Addition of control solution had no effect on transmission of blue LED light 
through the RV or LV tissue (n=5). Panel B: CN caused a decrease in blue light transmission 
through LV tissue (n=4), but in the majority of experiments caused an increase in 
transmission through RV tissue (panel C, n=4) 
 
Blue light transmission through the LV tissue significantly decreased in response 
to CN treatment. This effect was not seen to be fully reversible in the timescale 
during which measurements were made (up to 15 minutes after CN removal, 
data not shown). In the majority of experiments, treatment with CN caused a 
small, reversible increase in transmission of blue light through the RV tissue. 
Figure 5-10C shows the mean response from these 4 experiments. However, on 2 
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occasions, a biphasic response was observed, in which both a decrease and 
increase in transmission of blue light occurred upon CN treatment (Figure 5-11).  
 
Figure 5-11 Alternative transmission responses to CN treatment in the RV 
In the majority of experiments (n=4), a small increase in blue light transmission through the 
RV occurred in response to CN treatment. Panel A shows an example of such a response. 
However, in a small number of experiments (n=2), a biphasic response took place, where an 
initial decrease in transmission upon CN treatment was followed by an increase in 
transmission (Panel B). 
 
No significant change in green light transmission was found in response to CN 
treatment in the RV or LV tissue (Figure 5-12). 
 
Figure 5-12 Mean effects of CN on transmission of green emission light through the left and 
right ventricular tissue 
Addition of control solution to the RV and LV (panel A, n=3), CN to the LV (panel B, n=2) and 
CN to the RV (panel C, n=5) did not cause a significant change to green light transmission 
through the tissue.   
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5.3.5 FAD absorption properties 
The absorption properties of FAD in the oxidised and reduced state were 
measured to assess if FAD absorption could have any influence on the NADH 
fluorescence changes in response to CN. The absorption spectra of 0.1mM FAD 
and FADH2 (following addition of 1mM Na-dithionite) are shown in Figure 5-13. 
 
Figure 5-13 FAD absorption spectra in the oxidised and reduced state 
Panel A: FAD absorption before (black line) and after addition of the reducing agent Na-
dithionite (grey line). Dashed lines indicate wavelengths at which NADH fluorescence is 
measured. Panel B: Absorption difference between FAD in the reduced and oxidised states 
(FADH2-FAD). At shorter wavelengths (below ~400nm), light absorption by Na-dithionite 
contaminates the trace. However at the wavelengths at which NADH fluorescence was 
collected, clear differences in absorption between FAD in the oxidised and reduced states 
can be seen with little contribution from Na-dithionite absorption.   
 
The absorption peak of FAD is at 450nm. This coincides with the wavelengths at 
which NADH emits fluorescence, measured using a 435-485nm band pass 
emission filter. This means that NADH fluorescence is likely to be absorbed by 
FAD in the tissue before it is transmitted to the detector. When FAD is reduced 
to FADH2, as would be the case following CN treatment, absorption at 435-
485nm is virtually eliminated. Treatment with CN causes an increase in NADH 
fluorescence, but the simultaneous decrease in FADH2 absorption would also 
lead to an increase in NADH fluorescence transmission and thus increased 
fluorescence detection. Therefore the anticipated change in NADH fluorescence 
following CN treatment is unclear.  
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5.3.6 Mb absorption spectra 
The Mb absorption spectrum is known to shift depending on whether Mb is in the 
oxygenated or deoxygenated state. However, there are no reports of how 
infusion of CN in a whole heart preparation might affect Mb absorbance and 
subsequently complicate the interpretation of NADH fluorescence and thus 
measurements of metabolic state. There is some evidence to show that binding 
of CN modifies the absorption spectrum of Mb (Legako et al., 2003; Bowen, 
1949). In order to confirm this, the direct effect of 4mM CN on the absorption 
spectrum of 0.01mM Mb in a mock intracellular solution was examined (Figure 5-
14). 
 
Figure 5-14 Mb absorption spectra in the presence and absence of CN 
Panel A: Mb absorption before (black line) and after (grey line) addition of CN. Dashed lines 
indicate wavelengths at which NADH fluorescence is measured. Panel B: Absorption 
difference between Mb and Mb+CN (MbCN-Mb).  
 
The absorption spectrum of Mb changes on addition of 4mM CN. At the 
wavelength range where NADH fluorescence is measured, absorption of Mb 
bound to CN is clearly greater than the absorption of Mb alone. Therefore 
treatment with CN will lead to increased Mb absorption at 435-485nm, decreased 
transmission of NADH fluorescence and subsequently decreased NADH 
fluorescence detection. Consequently, Mb absorption further complicates the 
interpretation of the NADH fluorescence response to CN in the intact tissue 
preparation.     
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5.4 Discussion 
Values for mitochondrial redox state could not be established in the intact tissue 
preparations. The use of 2P-excitation methods, which were required for 
experiments in thick tissue sections, meant that only NADstate could be 
investigated. However, these measurements were more difficult to achieve in 
tissue than in isolated cells. This was due to changes in the focal plane 
associated with movement of the preparation, as well as inner filter effects 
complicating the interpretation of the fluorescence signal. Finally, with FCCP, 
there appeared to be additional difficulties with delivery of the inhibitor. It was 
therefore found to be unfeasible at this stage to image metabolic state within 
local regions of the myocardium.   
5.4.1 Movement of the preparation 
Movement of the tissue occurred in virtually every preparation and complicated 
the interpretation of the fluorescence signal. The movement was likely to be 
due to progressive oedema of the tissue, resulting in the focal plane shifting. 
This meant that the fluorescence signal was continuously decreasing in deeper Z-
sections due to increasing light scattering as the focus moved deeper into the 
tissue. The fluorescence signal would simultaneously increase in the upper Z-
sections as myocardial and epicardial tissue came into focus in Z-layers that 
were initially above the tissue surface.  
We were unable to completely prevent this movement taking place, although in 
some preparations it was less pronounced than in others. The fluorescence 
changes occurring due to movement were taken into account when interpreting 
the effects of the mitochondrial inhibitors. Images from at least 50-100µm above 
the surface of the tissue were included in the Z-stack to ensure that even if the 
tissue moved upwards, there was still a margin before the layers of tissue in 
focus moved above the limits of the Z-stack. 
5.4.1.1 Viability of the preparation  
In the early stages of developing the horizontal Langendorff preparation, a 
number of problems with the viability of the preparation were experienced. This 
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was likely to be due to the orientation and positioning of the heart occluding 
outflow from the vessels resulting in excessive oedema and progressive increases 
in pressure. To combat this, the moulded nest on which the heart was placed in 
the chamber was manipulated to provide support for the heart with minimal 
restriction to coronary outflow. Insertion of a vent in the apex of the LV also 
eased pressure increases.       
5.4.2 Measurements in the LV wedge preparation 
Blebbistatin was used as a movement uncoupler in the experiments performed in 
the LV wedge preparation. However, we were unaware at this point of the highly 
fluorescence properties of blebbistatin (Figure 5-1). The excitation spectrum of 
blebbistatin overlaps with the excitation spectrum of NADH, thus fluorescence 
emission from the tissue is likely to include both blebbistatin and NADH 
fluorescence. As the intrinsic fluorescence signal of NADH is relatively weak in 
comparison to blebbistatin fluorescence, the proportion of the signal arising 
from NADH was likely to have been small. Thus any changes in NADH 
fluorescence during treatment with FCCP and CN may have been too small to be 
detected.  
In addition, a glass coverslip was attached to the Perspex slide and placed on the 
surface of the heart. This was in order to produce a flat imaging surface; 
however, as the tissue swelled, the coverslip may have applied excessive 
pressure on the tissue and could have compressed the surface coronary vessels. 
Consequently, solution flow through the vessels and delivery of inhibitor may 
have been restricted at the area of tissue being imaged.  
On two occasions, apparent transient responses to CN were observed. The 
increase in NADH fluorescence that took place following application of CN was 
short-lived and recovery was almost immediate. These responses were not 
observed consistently in every preparation, and this may have been due to the 
influence of vessel compression due to the use of the coverslip. However, FCCP 
responses were not observed in any of the tissue preparations. 
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5.4.3 NADH responses to FCCP in intact tissue preparations 
In contrast to single isolated ventricular cells, no NADH response to FCCP 
treatment could be elicited in the intact tissue preparation. A possible reason 
for this could be if FCCP was acting on the coronary vessels and inducing 
vasoconstriction, thereby restricting delivery of the inhibitor to the area of 
tissue being imaged. To investigate if this was the case, uptake of the tracer dye 
5(6)-carboxyfluorescein was measured in the presence of 4µM FCCP (Figure 5-
6B). It was found that FCCP did not prevent dye uptake, and was therefore not 
causing substantial vasoconstriction. However, FCCP is a lipophilic drug and is 
likely to be taken up by any cell it makes contact with.  It may be that all the 
FCCP in the perfusing solution is being absorbed by the vascular tissue and the 
concentrations reaching the myocardial tissue could be too low to have any 
effect. 
Attempts were made to inject a bolus of FCCP directly into the region of 
ventricular tissue being imaged. However, this approach was found to be 
unfeasible, as the needle had to be inserted as close to the imaging surface as 
possible and the pressure of the needle piercing the tissue distorted the image 
to the extent that fluorescence measurements could no longer be made.  
Ultimately, we were unable to elicit FCCP responses and thus could not 
calculate mitochondrial redox state in the intact tissue preparations. Other 
groups have successfully introduced FCCP to intact tissue preparations (Brennan 
et al., 2006; Zuurbier et al., 2003; Rouslin & Broge, 1996), although these were 
not confocal measurements, so targeted FCCP delivery to particular areas of 
tissue were not as critical in these contexts. 
5.4.4 NADH responses to CN in intact tissue preparations 
NADH responses to CN in the intact tissue preparations differed from those seen 
in isolated cells. In cells, treatment with CN leads to an increase in NADH 
fluorescence which is maintained until CN is washed out. In tissue preparations, 
CN treatment caused an increase in NADH fluorescence, but this response was 
only transient and the fluorescence signal returned to baseline whilst CN was 
still being perfused. A possible explanation for this could be that CN caused 
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constriction of the coronary vessels, restricting further flow of the inhibitor to 
the area of tissue being imaged. However, uptake of 5(6)-carboxyfluorescein dye 
by the tissue was not prevented in the presence of 4mM CN in the Langendorff 
perfused preparation (Figure 5.6C); hence CN was not inhibiting coronary flow. 
It is possible that that the contribution of NADPH fluorescence to the NADH 
fluorescence signal may be influencing the observed fluorescence response. CN 
causes an increase in ROS (King et al., 2003), which causes oxidation of NADPH 
to keep ROS levels in the cell low. This increase in ROS may be due to CN 
inhibition of catalase (which is involved in H2O2 clearance) (Kanthasamy et al., 
1997). However, the increase in ROS demonstrated by King et al. occurred 
mainly during CN washout. This would still not explain the transient effects of 
CN on NAD(P)H fluorescence as fluorescence fell while CN was still being 
perfused with no obvious changes in NAD(P)H fluorescence during washout. 
 Another possibility was that the altered CN response may have been due to the 
influence of the inner filter effects in the thick tissue preparation. The 
absorption properties of myocardial tissue were therefore studied and any effect 
of CN on these properties was investigated.  
5.4.5 Examining the influence of inner filter effects on NADH 
fluorescence measurements  
Tissue inner filter effects were examined by inserting LEDs into the left and right 
ventricles and any change in light transmission through the tissue to the PMT 
detectors was assessed. The most likely cellular components to affect NADH 
fluorescence measurements due to inner filter absorbance is Mb (Fralix et al., 
1990; Tamura et al., 1978). This is due to the high concentration of Mb present 
in the heart and the overlap of Mb absorption bands and NADH emission 
wavelengths. The absorption properties of Mb and the effect of CN on Mb 
absorbance were investigated using purified Mb from equine heart and it was 
found that CN caused shifts in the Mb absorption spectrum (Figure 5-14).   
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5.4.5.1 Mb transmission properties 
The shift in the Mb absorption spectrum in the presence of CN suggests that Mb 
absorption would interfere with any measurements of NADH redox state. 
However, the relationship between light absorption and transmission is non-
linear. Therefore, in order to understand the responses to LED emission light 
transmission through the tissue, the absorption properties of Mb expressed in 
terms of light transmission needed to be examined. The transmission profile of 
0.01mM Mb and the effect of 4mM CN on transmission are shown together with 
the emission profiles of the LEDs (Figure 5-15).  
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Figure 5-15 Transmission profile of Mb compared with LED emission profiles 
Panel A: (i) Transmittance of 0.01mM Mb expressed in terms of % light transmittance before 
(black line) and after (grey line) addition of 4mM CN. (ii) Transmission ratio between Mb and 
Mb+CN (MbCN/Mb). Panel B: Transmission ratio enlarged between wavelength range of 400-
600nm. Blue lines indicate wavelength range where blue LED light is detected using a 435-
485nm band pass filter and green lines indicate range where green LED light is detected 
using a 505nm long pass filter. Panel C: Normalised emission profiles of blue (blue line) and 
green (green line) LEDs on the same x-axis scale over the same wavelength range.  Panel D: 
Comparison of mean transmission ratio (MbCN/Mb) at the wavelength ranges where blue 
and green LED emission light is detected.   
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In the LV tissue, transmission of blue light decreases upon perfusion with CN 
(Figure 5-10B). This is most likely due to increased absorption of light at these 
wavelengths by Mb when bound to CN, leading to decreased light transmission 
through the tissue to the detector. However, in the LV, no significant change in 
green light transmission is seen following treatment with CN (Figure 5-12B), 
despite differences in the transmission profiles of Mb in the presence and 
absence of CN in the green spectral region. There are likely to be two reasons 
for this. Firstly, mean transmission ratio in the presence and absence of CN is 
greater over the wavelength range that blue LED light is detected compared to 
the range at which green LED light is detected (Figure 5-15D). Secondly, the 
greatest difference in transmission over the blue spectral region occurs where 
blue LED emission is at its highest (at shorter wavelengths, closer to 450nm); but 
over the green spectral region, occurs where green LED emission is at its lowest 
(at longer wavelengths, closer to 550nm). Consequently, the difference in 
transmission of Mb (before and after CN) over the green LED spectral range is 
most probably too small to be detected as a change in transmission of light 
through the LV tissue.  
It should be acknowledged that the measurements of Mb absorption were made 
in purified Mb extracts. It is not clear whether any shifts in the absorption 
spectrum of Mb occur within the tissue where interactions with other cellular 
components may take place. It is known that the Mb spectrum shifts depending 
on whether it is in the oxygenated or deoxygenated state, so the absorption 
effects of CN binding to Mb when the tissue is in different oxygenation states 
will be even more complicated, but remains to be investigated.  
5.4.5.2 Sources contributing to inner filter effects arising from the 
mitochondria 
The major absorption peak of FAD coincides with the emission peak of NADH. 
Reduction of FAD to FADH2 almost completely eliminates light absorption (Figure 
5-13, the increase in absorbance in the UV region is due to Na-dithionite 
absorbance). Thus FAD is likely to be influencing tissue transmittance of NADH 
fluorescence and subsequently fluorescence detection. In contrast to Mb, FAD 
absorbs less light in the presence of CN, and tissue transmittance is increased. 
This may explain the trend seen in the RV in which detection of blue LED 
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emission increased during CN treatment (Figure 5-10C). This small increase in 
transmission was generally reversible upon CN removal, as shown in Figure 5-
11A, which concurs with the reversible FAD response to CN observed in the 
isolated cells. Similar changes in green LED transmission were not observed 
because FAD does not absorb light at the green LED emission waveband. In two 
experiments, a biphasic transmission response to CN was observed in the RV 
(Figure 5-11B), where transmission initially decreased and then increased. This 
may be a result of opposing effects of changes in Mb and FAD concentrations on 
tissue absorbance.  
The cytochromes of the electron transport chain also have absorption properties 
(Chance, 1954; Dixon et al., 1931), and they may also contribute to the inner 
filter effects of the tissue. However, at the wavelength at which NADH is 
measured, this contribution is likely to be much less than that of Mb (Tamura et 
al., 1978). 
5.4.5.3 Influence of light scattering 
When light propagates through biological tissue, interaction with cellular 
structures with different refractive indexes causes the direction of the light path 
to change. This results in scattering of light. The cellular components which 
contribute most to these local variations in refractive index are thought to be 
the nuclei, cytoplasmic organelles (such as the mitochondria) and connective 
tissue fibres (Schmitt & Kumar, 1998; Wilson & Jacques, 1990).  However, the 
optical changes that affect tissue transmittance when CN is perfused are most 
likely to be mainly due to changes in tissue absorbance and not light scattering. 
If CN was causing a major increase in light scattering in the thicker LV tissue, 
resulting in decreased detection of blue light, similar changes would be 
expected with green light and this was not the case. Light scattering is 
wavelength dependent and is more prominent at shorter wavelengths. However, 
the emission wavebands of the two LEDs are close together on the spectrum 
(~450-490nm and ~500-550nm), so any great change in light scattering at one 
waveband would be expected to be seen, at least in part, at the other.  
Nevertheless, light scattering is a complex phenomenon, and it cannot be ruled 
out that it plays some role in the differences in transmittance that occur upon 
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CN perfusion. This would be particularly important if CN causes changes in the 
structure/size of the mitochondria or other cellular components. There is some 
evidence to suggest that this is indeed the case and anoxia, as well as 
mitochondrial inhibition with CN, causes the mitochondrial matrix to shrink 
(Fujii et al., 2004).   
5.4.5.4 Overall effect on transmission of NADH specific wavelengths 
The Beer-Lambert law states that absorption is proportional to the concentration 
of absorbing species and the light path length. Thus the differences in LED light 
transmission observed in the RV and LV may be due to varying concentrations of 
Mb, FAD and other absorbing species in the two tissue types, or may be 
influenced by the difference in tissue thickness. 
The net effect of CN on transmission of blue light (corresponding to NADH 
emission wavelengths) is likely to be due to the combination of absorbance by 
Mb, FAD and the cytochromes. The differing transmission effects seen in LV and 
RV tissue suggest that different absorbing species predominate in each tissue 
type. In the LV, the decrease in transmittance following CN treatment implies 
that Mb absorbance effects predominate, as CN was shown to cause an increase 
in Mb absorbance, hence reducing transmission of light through the tissue. 
Indeed higher concentrations of Mb have been reported in the LV compared to 
the RV of rat hearts (Frolkis, 1967) and other mammals (Alexander, 1975) due to 
the higher workloads and subsequently greater O2 demands in the LV. Using the 
Beer-Lambert law, the effect of this difference in [Mb] on Mb absorption (and 
hence transmission of light through the tissue) is illustrated in Figure 5-16. The 
molar extinction coefficient value for Mb of 12000M-1 cm-1 was obtained from 
Bowen (1949). The LV [Mb] of 300µM was  used (Wittenberg & Wittenberg, 2003) 
and the RV [Mb]of 180µM was used to reflect that Mb concentrations have been 
measured to be ~40% less in RV compared to LV (Frolkis, 1967).  
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Figure 5-16 Effect of Mb absorption in the LV and RV on light transmission through the 
tissue 
Absorption of light by Mb results in a decrease in the amount of light that is transmitted 
through the tissue (maximum light transmission was normalised to 1). As the light path 
distance increases, more light is absorbed by Mb and thus less light is transmitted. 
Absorption of light through the LV (black trace) is greater than in the RV (grey trace) due to 
the higher concentration of Mb in the LV. Hence transmission is less at a given light path 
distance in the LV compared to the RV.  
 
In contrast, CN caused a small increase in tissue transmittance in the RV, 
suggesting a slight reduction in inner filter effects. This would indicate that FAD 
absorbance predominates in the RV, as CN treatment causes FAD to be reduced 
to FADH2, effectively eliminating absorption by FAD.  
5.4.6 Effects of absorption on NADH fluorescence changes in 
response to CN 
All experiments examining the effects of CN on NADH fluorescence were 
performed in the LV, thus only the effect of CN on tissue transmission in the LV 
needed to be taken into account. The decrease in transmission of light at 
wavelengths corresponding to NADH emission following perfusion with CN is 
likely to mean that the increase in NADH fluorescence in response to CN will be 
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underestimated in the tissue preparation. CN caused a mean increase in NADH 
fluorescence of ~19%, but transmission was reduced by ~19% on average. The 
interactions that occur within the tissue in terms of the inner filter effects and 
light scattering events at different tissue depths are complicated and difficult to 
predict. However, using these values, the true increase in NADH fluorescence 
following CN treatment will be ~38%. Converted to a mean normalised 
fluorescence of 1.38, this value is similar to the mean normalised fluorescence 
value of 1.41, which was obtained in isolated cells following CN treatment 
measured by 2P excitation fluorescence microscopy.   
It was hoped that the effects of CN on light transmission through the tissue may 
be able to explain the transient NADH response to CN observed in the tissue. 
However the rapid timescale of changes in light transmission appear to be too 
fast to explain the decrease in NADH fluorescence, which occurs 90-150s after 
CN perfusion is started. However, as the relationship between light transmission 
and absorption is non-linear, the time course of changes in absorption will be 
different to transmission, and it is unclear how this will affect the NADH 
fluorescence response. 
5.4.7 Conclusions 
We were unable to obtain measurements of mitochondrial redox state in intact 
tissue preparations to allow comparison with isolated cells or within local 
regions of the myocardium. The main reason for this was that no NADH 
fluorescence response to FCCP could be elicited, and a minimum NADH 
fluorescence value could not be established. In addition, the responses to CN 
were influenced by the inner filter effects of the tissue, complicating the 
interpretation of maximum NADH fluorescence. Measurements of redox state in 
isolated cells are not complicated by the inner filter effect because the light 
path distance through the isolated cell is comparatively much smaller (~10µm). 
As shown in Figure 5-17B, Mb absorption causes a negligible decrease in light 
transmission at depths relevant to isolated cells. 
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Figure 5-17 Effect of Mb absorption on light transmission at distances relevant to tissue and 
isolated cell measurements 
Effect of Mb absorption on transmission of light through light path distances relevant to (A) 
tissue measurements and (B) cell measurements. Maximum light transmission was 
normalised to 1 with no transmission equivalent to 0. 
  
However, if the effects of CN on light transmission through the tissue are taken 
into account, the value obtained for mean maximum normalised NADH 
fluorescence by 2P excitation fluorescence microscopy in the horizontal 
Langendorff preparation (~1.38) is similar to the value obtained in isolated cells 
(1.41).  
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6 Mitochondrial redox response to increased work 
intensity in rabbit ventricular myocytes 
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6.1 Introduction 
The heart is a highly metabolic organ and the process of E-C coupling requires a 
constant supply of ATP to power contractile shortening and ion pumps. ATP 
stores within the cardiac myocyte are relatively small, and only sufficient to 
provide energy for a few beats (Ingwall, 2009; Stanley et al., 2005). Any 
increase in myocardial energy demand due to increased force or frequency of 
contraction will therefore require an increase in ATP production to fulfil this 
demand. ATP production by oxidative phosphorylation requires a continuous 
supply of reducing equivalents in order to proceed. If the rate of ATP production 
is increased, a concomitant increase in the rate of the TCA cycle is needed to 
maintain this supply. By measuring changes in oxidative status simultaneously 
with changes in work intensity (by altering the stimulation frequency), energy 
flux and the cell’s ability to match energy supply with demand can be assessed.  
Previous studies, using measurements of NADH fluorescence alone, have found a 
variety of responses in cardiac cells and tissue to changes in work intensity. 
Some studies have reported no change in oxidative status (Griffiths et al., 1998; 
Heineman & Balaban, 1993). Others report oxidation of the cellular environment 
(Ashruf et al., 1995; Chapman, 1972; Heinzel et al., 2006; White & Wittenberg, 
1993; White & Wittenberg, 2000), whereas others still report an increase in 
NADH fluorescence in response to increased work intensity (Griffiths et al., 
1997; Katz et al., 1987). In a series of experiments, Brandes et al. demonstrated 
an initial decrease in NADH fluorescence in rat cardiac trabeculae in response to 
an increase in stimulation frequency, followed by a mitochondrial Ca2+ 
dependent increase in fluorescence (though not to control levels) during rapid 
pacing (Brandes & Bers, 1996; Brandes & Bers, 1997; Brandes et al., 1998; 
Brandes & Bers, 1999; Brandes & Bers, 2002). These findings were supported in 
later work performed on guinea pig ventricular myocytes (Jo et al., 2006). 
The reason for this lack of consistency in responses is unclear. It is unlikely to be 
due to species difference, as all four responses have been reported in the rat. 
One possibility is that it is due to differences in the preparations used, as factors 
such as O2 and substrate supply could influence the metabolic response, 
particularly in tissue preparations.  
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6.1.1 Advantages of simultaneously measuring NADH and FAD 
fluorescence 
All of the studies mentioned above used NADH fluorescence measurements alone 
to assess mitochondrial redox state responses to changes in work intensity. The 
major advantage of our approach is that the NADH and FAD fluorescence signals 
respond oppositely to oxidation and reduction of the cellular environment. When 
a ratio of the two fluorescence signals is taken, true biological responses can be 
distinguished from signal noise and movement artefacts. 
6.1.2 PCr as an energy buffer 
In addition to a small amount of ATP, the cell also possesses PCr stores. PCr acts 
as an energy buffer during acute changes in energy demand. It can be rapidly 
broken down to produce ATP by the following reaction: 
PCr + ADP ↔ Cr + ATP 
Phosphate is transferred from PCr to ADP, forming Cr and ATP. This is a 
reversible reaction catalysed by CK. PCr is formed when ATP levels are high and 
these stores are sufficient to power around 15 beats (Levick, 2003).  
6.1.3 Aim of the chapter 
The main aim of this chapter was to assess the mitochondrial redox response to 
increased work intensity in isolated rabbit ventricular myocytes. From this, the 
cell’s ability to match metabolite supply with demand could be determined.   
6.2 Methods 
All experiments were performed on single rabbit ventricular myocytes isolated 
from the heart using the enzymatic digestion process described in Section 2.2.1. 
Following the isolation procedure, the cells were suspended in Krebs solution 
containing 1mM CaCl2.  
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6.2.1 Stimulation protocol for metabolic challenge   
Cellular contraction was induced by electrical field stimulation. A thin layer of 
cells was placed in the bath and allowed to settle on the coverslip. The cells 
were then perfused with Krebs solution containing 1.8mM CaCl2 using the 
apparatus described in Figure 2-7. Inflow was through a hole in the side of the 
aluminium bath, which was heated to ensure the temperature of extracellular 
solution in the bath was ~37˚C. A stimulator generated square wave electrical 
impulses of 10ms duration which were delivered to the cells through two narrow 
platinum electrodes attached to parallel sides of the bath. Cells were stimulated 
at suprathreshold current intensities (threshold + ~5%). A digitimer connected to 
the stimulator set the frequency of stimulus impulses. 
Cells were deemed suitable for imaging if they had intact membranes, clear 
striations, free edges (no overlapping cells) and if they contracted consistently 
upon stimulus. The selected cell was imaged using a CCD camera with edge 
detection software (IonOptix Limited), allowing cell shortening measurements to 
be made. Simultaneous epifluorescence measurements of NADH and FAD were 
made using the optical settings described in Section 2.6.3. 
The cells were initially stimulated at 0.5Hz for around 100s. The frequency of 
stimulation was then increased to 1Hz for ~50s or until fractional shortening and 
fluorescence levels were judged to have reached a steady state. Pacing 
frequency was returned to 0.5Hz to allow the cell to recover, before delivering 
another burst of 1Hz stimulation for ~50s. This burst pacing was repeated at 2Hz 
and 3Hz (Figure 2-11), each burst interspersed with 0.5Hz pacing. These abrupt 
increases in stimulation frequency constitute rapid increases in work intensity 
and thus increased metabolic demand. The oxidative response to these changes 
demonstrates how well the cell can increase metabolite supply in response to an 
increase in demand.  
The NADH and FAD fluorescence signals were calibrated at the end of the pacing 
protocol by perfusing with 2µM FCCP to induce complete oxidation and 2mM CN 
to induce complete reduction of the mitochondrial environment.  
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6.2.2 Analysis of rate of oxidative change and work performed by 
the cell  
The rate of oxidative change within the cell upon transitions in workload, 
expressed as the NADH/FAD ratio, was analysed using a program written in house 
(LabTalk, Origin 6.1). The rate of change in the NADH/FAD fluorescence ratio at 
2Hz and 3Hz stimulation, and the rate of recovery when stimulation rate was 
decreased back to 0.5Hz was analysed by interpolating the time points at which 
10%, 50% and 90% fluorescence change took place, as well as the time at which 
the new level of work was initiated and terminated. In addition, the mean cell 
length was taken at these time points as an index of contractile work performed 
by the cell. Relative work performed by the cell was expressed as the inverse of 
mean cell length. Contraction of the cell causes a decrease in cell length; hence 
shorter mean cell length would indicate more time spent in the contractile 
state, and consequently more work performed.   
6.2.3 Verifying the mitochondrial origin of the intrinsic 
fluorescence response 
In order to confirm that the fluorescence changes observed during changes in 
metabolic demand were mitochondrial in origin, the cells were metabolically 
challenged in the presence of mitochondrial inhibitors. Initially, the cells were 
perfused with Krebs solution and a metabolic challenge (2 bursts of 3Hz pacing) 
was delivered in this control state. Between each burst of fast pacing, cells were 
stimulated at 0.5Hz. Cells were then perfused with 2mM CN to induce a 
completely reduced mitochondrial state, during which they were subjected to 
the same metabolic challenge. CN was washed out and the cells were allowed to 
recover. Following recovery, a completely oxidised mitochondrial state was 
induced in the cells by perfusion with 2µM FCCP and the metabolic challenge 
was again delivered in this state (Figure 6-1). Throughout this protocol, NADH 
and FAD fluorescence emissions were recorded as previously described. 
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Figure 6-1 Pacing protocol to establish mitochondrial origin of intrinsic fluorescence 
response to increased work intensity 
The cells were metabolically challenged by delivering bursts of 3Hz pacing (represented by 
grey boxes) in the presence of CN and FCCP. Each burst of fast pacing was interspersed 
with 0.5Hz stimulation (white boxes). In the absence of mitochondrial inhibitor, cells were 
perfused with control Krebs solution. 
 
6.2.4 Verifying contractile work to be the source of metabolic 
demand 
In order to confirm that the increased metabolic demand was induced by 
contractile work, metabolic challenges (during which pacing was step increased 
to 3Hz) were performed in the presence and absence of the movement 
uncoupler cytochalasin D (cyto D) (Figure 6-2). Cyto D inhibits contraction by 
impairing actin filament polymerisation (Kettlewell et al., 2004). Cyto D was 
used at a concentration of 20µM, which was sufficient to reduce fractional 
shortening to ~2% at 3Hz stimulation. Complete inhibition of contraction was not 
induced because the residual contractile function was a useful indicator that the 
cells were still electrically active and responding to stimulus impulse. 
 
Figure 6-2 Pacing protocol to establish contractile work as source of metabolic demand 
The cells were given 2 burst of 3Hz pacing (grey boxes) under control conditions and then 
during inhibition of contraction with cyto D. At low work intensities, pacing was reduced to 
0.5Hz (white boxes). Changes in intrinsic fluorescence were recorded throughout. 
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6.2.5 Assessing possible role of PCr in energy supply and 
demand matching 
The role of PCr in energy buffering during increases in work intensity was also 
investigated. CK catalyses the reversible transfer of a high-energy phosphate 
moiety between creatine and ADP. Inhibition of CK thus prevents PCr functioning 
as an energy store. The oxidative response of the cells to increased work 
intensity in the absence of PCr stores was assessed using two inhibitors of CK – 
iodoacetamide and cyclocreatine. Iodoacetamide is an alkylating reagent for 
histidine and cysteine residues. Inhibition by iodoacetamide is irreversible and 
not specific to CK. It also inhibits the glycolytic enzyme glyceraldehyde-3-
phosphate dehydrogenase, although even when glyceraldehyde-3-phosphate 
dehydrogenase was significantly inhibited, it has been shown that glyocolysis 
continues to proceed at the same rate (Tian et al., 1997). In contrast, 
cyclocreatine acts as a competitive inhibitor. It is an efficient substrate for CK 
and is phosphorylated to generate cyclocreatine phosphate.  Cyclocreatine 
phosphate is turned-over 160 fold less efficiently than PCr and thus leads to 
reduced ATP generation by the PCr-Cr system (Teicher et al., 1995). 
 
Iodoacetamide was used at a concentration of 0.4mM, which has been shown to 
reduce CK activity to 3% of control values (Harrison et al., 1999). Initially, the 
cell was perfused with control solution and the metabolic challenge of step 
increasing stimulation frequency from 0.5Hz to 3Hz for 2-3 bursts was delivered. 
The cell was then perfused with iodoacetamide for 10min and the protocol was 
repeated in the presence of the inhibitor. The same procedure was carried out 
using 10mM cyclocreatine instead of iodoacetamide. However, the period of 
time required for cyclocreatine to have its full effect was not known, so some 
cells were also incubated for 1-2 hours with 10mM cyclocreatine prior to the 
metabolic challenge being performed.  
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6.3 Results  
6.3.1 Intrinsic fluorescence response to metabolic challenge 
A typical response to the metabolic challenge protocol in a single left ventricular 
cardiomyocyte is shown in Figure 6-3.  
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Figure 6-3 Representative trace showing effects of metabolic challenge on intrinsic 
fluorescence 
A: Effect of changing stimulation frequency on fractional shortening (upper trace, black), 
NADH fluorescence (lower trace, black) and FAD fluorescence (lower trace, light grey). Red 
box indicates region of trace which has been magnified to show the effect of step 
increasing work intensity to 3Hz in more detail. B: NADH fluorescence signal divided by the 
FAD fluorescence signal to give NADH/FAD ratio (dark grey trace). 
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Increasing stimulation frequency also causes an increase in fractional shortening 
due to the positive force-frequency relationship (Bowditch effect) that occurs in 
rabbit cardiac myocytes. Thus metabolic demand will be enhanced due to the 
increased force and frequency of contractions. As the stimulation frequency is 
increased from 0.5Hz to 2Hz and 0.5Hz to 3Hz, NADH fluorescence clearly 
decreases and FAD fluorescence simultaneously increases, represented by a 
decrease in the NADH/FAD ratio. This indicates oxidation of the cell environment 
and suggests energy supply is not matching demand upon transitions in workload. 
When stimulation frequency is slowed back to 0.5Hz, NADH and FAD fluorescence 
returns to baseline levels, demonstrating recovery of the oxidative status of the 
cell. The mean changes in NADH, FAD and NADH/FAD fluorescence levels at each 
stimulation frequency are shown in Figure 6-4. 
 
Figure 6-4 Mean effect of step increasing stimulation frequency on intrinsic fluorescence 
levels 
Mean % change in (A) NADH fluorescence (B) FAD fluorescence and (C) NADH/FAD 
fluorescence ratio upon increasing stimulation frequency from 0.5Hz to 1Hz, 2Hz and 3Hz 
(n=22). ***p<0.001 versus 1Hz. # p<0.05 versus 2Hz, ### p<0.001 versus 2Hz.  
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6.3.2 Relationship between work and mitochondrial oxidative 
response 
The time taken to reach 10%, 50%, 90% and 100% fluorescence change (in terms 
of the NADH/FAD fluorescence ratio) was established following step increase and 
decrease in workload. The values obtained at 2Hz and 3Hz stimulation were 
compared to assess if the greater metabolic demand expected at 3Hz stimulation 
had any effect on the rate of oxidative response. The rate of recovery was also 
analysed following step down to 0.5Hz stimulation from 2Hz and 3Hz stimulation. 
The relative and normalised fluorescence change over time at 2Hz and 3Hz 
stimulation, as well as the relative and normalised work performed, are shown in 
Figure 6-5.  
 
Figure 6-5 Time course of fluorescence change and work performed upon increase in work 
intensity to 2Hz and 3Hz pacing 
Panel A (i) Mean work performed, expressed as inverse of cell length, during pacing at 2Hz 
(light grey line) and 3Hz (dark grey line). (ii) Against the same timescale, mean relative 
NADH/FAD fluorescence change taking into account the average total fluorescence change 
at 2Hz and 3Hz stimulation (from Figure 6-4). Panel B (i) Normalised work performed with 
work at T0 (onset of increase in stimulation frequency) set as 0 and T100 (termination of 
stimulus train) set as 1. (ii) Against the same timescale, normalised fluorescence expressed 
as percentage of overall fluorescence change during stimulus train (n=20). In all panels, 
points are marked at times where 0, 10, 50, 90 and 100% changes in fluorescence occurred. 
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Figure 6-5 shows that the level of work performed by the cell appears to have 
essentially reached a steady state during the trains of 2 and 3Hz pacing. 
Fluorescence levels also appear to be approaching a steady state, although it is 
unclear if a completely steady state has been reached. Between T0 (onset of 
increased workload) and T10 (time point at which 10% of overall fluorescence 
change during stimulus train occurred), there is a large increase in work for a 
relatively small change in fluorescence. It is during this initial period that the 
cell is thought to utilise PCr as a temporal buffer to fulfil ATP demand, and so 
the mitochondrial oxidative response to the increased work is initially slow. 
Following this, the stable level of work performed indicates that ATP supply is 
matching demand and contractile function is maintained. However, fluorescence 
levels change at a faster rate as the mitochondria are unable to match NADH and 
FADH2 production with the increased rate of their oxidation in order to produce 
sufficient ATP by oxidative phosphorylation, thus leading to progressive 
oxidation of the mitochondrial environment. 
Relative work performed was calculated from the mean cell length over a 5s 
period at each time point. The inverse of mean cell length gives an indication of 
the degree of fractional shortening as well as the length of time spent in the 
contracted state (i.e. performing work). As expected, the level of work 
performed was significantly higher at 3Hz compared to 2Hz when the data was 
paired for each cell (p<0.001).  
When the work performed was normalised to 0 at T0 and 1 at T100 (time at which 
train of stimulation was terminated), the rate at which work increased was 
comparable between 2 and 3Hz. Similarly, when fluorescence change was 
expressed as a percentage of overall fluorescence (0% at T0, 100% at T100), the 
time course of fluorescence change was virtually identical for 2 and 3Hz.  
Analogous analysis was carried out during the recovery period when stimulation 
frequency was stepped down to 0.5Hz and is shown in Figure 6-6.  
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Figure 6-6 Time course of fluorescence change and work performed upon decrease in work 
intensity from 2Hz and 3Hz pacing to 0.5Hz pacing 
Panel A (i) Mean work performed, expressed as inverse of cell length, during pacing at 0.5Hz 
following stimulation at 2Hz (light grey line) and 3Hz (dark grey line). (ii) Against the same 
timescale, mean relative fluorescence change taking into account the mean initial 
NADH/FAD fluorescence level immediately after 2Hz and 3Hz stimulation. Panel B (i) 
Normalised work performed with work at T0 (onset of 0.5Hz stimulation) set as 1 and T100 
(termination of stimulus train) set as 0. (ii) Against the same timescale, normalised 
fluorescence expressed as percentage of overall NADH/FAD fluorescence change during 
stimulus train (n=16). In all panels, points are marked at times where 0, 10, 50, 90 and 100% 
changes in fluorescence occurred 
 
The time scale for recovery of fluorescence and work performed is slower 
following decrease in workload compared to the rate of changes when workload 
is increased. In Figure 6-6, fluorescence and work do not appear to have reached 
a steady state, despite continuing low intensity work for almost 2 min. The 
relative work performed at 0.5Hz is higher following 3Hz pacing compared to 
2Hz. This is because work performed by the cells starts at a higher level 
following 3Hz pacing and remains higher throughout the 0.5Hz stimulus train due 
to the slow recovery.  
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Expressing fluorescence change over the recovery period in percentage terms (T0 
being 0% and T100 being 100%) there is an overlap in time course for recovery 
following 2 and 3Hz stimulation. However, during late recovery, the rate of 
fluorescence change shows a trend towards slower fluorescence recovery at 3Hz. 
The rate of fluorescence change over the period of increased and decreased 
stimulation frequency was further analysed and is shown in Figure 6-7.  
 
Figure 6-7 Rate of fluorescence change following increased and decreased workload 
Panel A: Rate of fluorescence change following increase in stimulation frequency to 2Hz 
(light grey bars) and 3Hz (dark grey bars) (n=20). Panel B: Rate of fluorescence change 
during recovery following 2Hz (light grey bars) and 3Hz (dark grey bars) stimulation (n=17). 
Overall rate of fluorescence change (10-90%), as well as during the early response (10-50%) 
and the late response (50-90%) are shown. * p<0.05 versus 2Hz; ** p<0.01 versus 2Hz; *** 
p<0.001 versus 2Hz. ## p<0.01 versus 10-50%; ### p<0.001 versus 10-50%.  
 
The overall rate of fluorescence change (between T10 and T90) was faster when 
work intensity was increased to 3Hz compared to 2Hz pacing. When the rate of 
the early fluorescence response to increased work intensity (between T10 and 
T50) is compared to the late response (between T50 and T90), it becomes clear 
that the rate of change is non-linear through the entire response and is 
significantly faster at the start. The greatest difference in rate of fluorescence 
change between the 2 workloads is seen in the early response. 
The rate of fluorescence change was faster when pacing was slowed to 0.5Hz 
following pacing at 3Hz compared to 2Hz during early recovery. The late 
response in fact shows a trend towards slower recovery at 3Hz (although this was 
not significant).             
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6.3.3 Mitochondrial origin of fluorescence changes 
To confirm that the changes in intrinsic fluorescence were originating from the 
mitochondria, the cells were metabolically challenged with 2 bursts of 3Hz 
stimulation in the presence of the mitochondrial inhibitors FCCP and CN. 
Example and mean responses to the metabolic challenge under control and 
mitochondrially inhibited conditions are shown in Figure 6-8, expressed as the 
NADH/FAD ratio.   
 
Figure 6-8 Fluorescence responses to 3Hz stimulation in control conditions and in the 
presence of mitochondrial inhibitors 
A: Example trace showing change in fractional shortening (upper black trace) and 
normalised NADH/FAD fluorescence ratio (lower grey trace) during 3Hz stimulation in (i) 
control conditions and in the presence of (ii) 2mM CN and (iii) 2µM FCCP. B: Mean % change 
in NADH/FAD ratio during 3Hz stimulation with each treatment (n=4). *p<0.05. 
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The % change in NADH/FAD fluorescence ratio upon 3Hz stimulation was found to 
be significant only under control conditions following 1-sample t-test (p<0.05). 
When the mitochondria are maximally reduced in the presence of 2mM CN or 
maximally oxidised with 2µM FCCP, there is no significant change in NADH or FAD 
fluorescence when the cell is metabolically challenged. Consequently, the 
fluorescence changes occurring under control conditions must be arising from 
NADH and FAD originating from the mitochondria.     
6.3.4 Contractile work as source of increased metabolic demand 
To verify that the intrinsic fluorescence changes are a response to increased 
metabolic demand, and that the source of this increased demand was indeed 
contractile work, contractile function was inhibited with the movement 
uncoupler cyto D (cyto D itself did not observably have any effect on basal 
fluorescence). The metabolic challenge of 2 bursts of 3Hz stimulation was 
delivered to the cell and oxidative responses recorded. The same metabolic 
challenge was repeated following treatment of the cells with 20µM cyto D and 
the oxidative responses compared between control and cyto D treated cells 
(Figure 6-9).  
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Figure 6-9 Example and mean fluorescence responses to 3Hz stimulation in control 
conditions and with contractile function inhibited with cyto D 
A: Example trace showing change in fractional shortening (upper black trace) and 
normalised NADH/FAD fluorescence ratio (lower grey trace) during 3Hz stimulation under (i) 
control conditions and (ii) in the presence of 20µM cyto D. B: (i) Mean % shortening at 3Hz 
stimulation (ii) mean % change in NADH/FAD ratio during 3Hz stimulation with each 
treatment (n=6). ***p<0.001 versus control. 
 
Fractional shortening was on average ~2.5% at 3Hz following cyto D treatment, 
compared to on average ~10% in the same cells prior to treatment. This residual 
contraction in the presence of cyto D demonstrated that the cells were still 
electrically active and it was only the contractile machinery of the cell that was 
inhibited. The percentage change in NADH/FAD ratio when work intensity is 
increased to 3Hz is significantly less in the cells following cyto D treatment 
compared to the same cells prior to treatment.  Thus when contractile function 
is inhibited, metabolic demand does not increase sufficiently to cause changes in 
the oxidative status of the cell. This indicates that the source of increased 
metabolic demand is indeed contractile work.  
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6.3.5 Interpreting the cause of the delayed oxidative response to 
increased work intensity 
In the majority of cells, there was a delay of up to 25s after stimulation 
frequency was step increased before the redox status of the cell changed. This 
can be seen in Figure 6-3, where there is a delay of ~15s before NADH 
fluorescence decreased and FAD fluorescence simultaneously increased. This is 
consistent with the idea that the cell is initially coping with the increased 
metabolic demand, and indicates that other (non-mitochondrial) sources of ATP 
are immediately utilised to fulfil the increased energy requirements before 
mitochondrial ATP production takes over.  
In cardiac muscle, the CK/PCr system acts both as a high-energy phosphate 
shuttle and as a temporal energy buffer (Wallimann et al., 1992; Jacobus, 1985). 
The PCr pool is therefore the most likely initial source of ATP upon abrupt 
increases in energy demand. To investigate this, the CK/PCr system was 
inhibited to determine if this eliminated the initial delay prior to the occurrence 
of mitochondrial oxidative changes. 
Iodoacetamide was used as a CK inhibitor, thereby preventing PCr acting as an 
energy store. The time delay prior to oxidative changes taking place following 
increased workload, and the magnitude of these changes, was measured under 
control conditions and following iodoacetamide treatment (Figure 6-10). 
Iodoacetamide did not affect contractile function or basal fluorescence when 
used at a concentration of 0.4mM, but did cause oxidation of the cell at higher 
concentrations (see Section 6.4.4).    
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Figure 6-10 Effect of iodoacetamide on fluorescence responses to 3Hz stimulation 
A: Mean % change in NADH/FAD fluorescence under control conditions and following 10 
min perfusion with 0.4mM iodoacetamide. B: Mean duration of delay between initiation of 
3Hz stimulation and occurrence of fluorescence changes under control conditions and in 
the presence of iodoacetamide. *** p<0.001 versus control (n=11). 
 
Inhibition of CK with iodoacetamide caused a decrease in the duration of the 
delay between the initiation of 3Hz stimulation and the point at which intrinsic 
fluorescence changes begin to occur. However, the magnitude of these changes 
was also significantly reduced following iodoacetamide treatment compared to 
controls. 
These differences in the magnitude of intrinsic fluorescence change and duration 
of the delay were not caused by an experimental artefact, for example, due to 
the length of the protocol or the process of solution change. The 3Hz metabolic 
challenge was delivered to the cell whilst perfusing with control Krebs solution 
and intrinsic fluorescence changes measured. The perfusate was then switched 
to the same control solution from an alternative reservoir, and the cells 
perfused for 10 min prior to delivering the same metabolic challenge.  No 
significant difference was found in the magnitude of NADH/FAD response or 
delay prior to fluorescence changes occurring during the metabolic challenge 
before and after the solution change (Figure 6-11).  
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Figure 6-11 Effect of switching between control solutions on fluorescence response to 3Hz 
stimulation 
A: Mean % change in NADH/FAD fluorescence ratio during 3Hz stimulation under control 
conditions and following switching of perfusing solution to the same control solution from a 
different reservoir. Cells were perfused for 10 min before second metabolic challenge was 
performed. B: Mean duration of delay prior to occurrence of fluorescence changes following 
initiation of 3Hz stimulation (n=5).  
 
Another possible reason for the difference in magnitude of fluorescence change 
following treatment with iodoacetamide could be if the effects of 
iodoacetamide are not limited to inhibition of CK, as iodoacetamide is a non-
specific alkylating agent for cysteine and histidine residues in proteins (Smythe, 
1936). To investigate this, the same protocol was repeated, but iodoacetamide 
was replaced with 10mM cyclocreatine, a more specific inhibitor of CK. 
Cyclocreatine did not affect basal fluorescence or contraction at the 
concentrations used. As the period of time required for inhibition of CK with 
cyclocreatine was not known, groups of cells were also incubated with 10mM 
cyclocreatine for 1-2 hours prior to performing the metabolic challenge. 
However, with these cells, it was not possible to measure the response to 
increased work intensity before and after CK inhibition. The mean magnitude of 
redox change and the duration of delay prior to these changes occurring are 
shown in Figure 6-12. 
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Figure 6-12 Effect of cyclocreatine on fluorescence responses to 3Hz stimulation 
A: Mean % change in NADH/FAD fluorescence ratio during 3Hz stimulation under control 
conditions, following 10 min of perfusion with 10mM cyclocreatine (CC) and (in different 
cells) following incubation with 10mM cyclocreatine for 1-2 hours (CC (inc)).  B: Mean 
duration of delay prior to occurrence of fluorescence changes following initiation of 3Hz 
stimulation (n=4); * p<0.05.  
 
There was no significant difference in the magnitude or duration of delay in the 
redox response following increase in workload before and after perfusion with 
10mM cyclocreatine. However, in a different group of cells, which had been 
incubated with 10mM cyclocreatine for 1-2 hours, the duration of delay was 
significantly reduced (though not eliminated). The magnitude of fluorescence 
change was not significantly different between these groups. This suggests that 
the initial delay in mitochondrial oxidative response is due to PCr metabolism, 
and CK is partially (but not completely) inhibited by incubation with 
cyclocreatine for 1-2 hours, resulting in a reduction in the duration of the delay. 
The lack of significant change in the magnitude of oxidative response suggests 
that mitochondrial function has not been affected by cyclocreatine treatment. 
Perfusing the cells for 10 min with cyclocreatine does not seem to inhibit CK 
sufficiently to have any effect on the delayed oxidative response. 
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6.4 Discussion 
6.4.1 Energy supply and demand matching in rabbit ventricular 
myocytes 
The results of these experiments demonstrate that in isolated rabbit ventricular 
myocytes, increasing work intensity causes an initial oxidation of the 
mitochondrial environment before reaching an essentially steady redox state. 
This indicates that there is a mismatch between energy supply and demand upon 
transition to increased workload. Decreasing work intensity back to initial 
stimulation rates causes the redox status of the cell to recover to baseline 
values. There is a linear relationship between the magnitude of oxidative 
response and the level of work performed, with the largest oxidative responses 
taking place at the highest work intensity (3Hz). Surprisingly, this mismatch 
between energy supply and demand occurred at physiological heart rates in the 
rabbit, which suggests that the heart is permanently in a delicate state of 
metabolic balance. 
The intensity of work performed by the heart does not remain constant and 
frequently changes over time. An increase in workload requires an increase in 
ATP supply in order for the heart to maintain function. The mitochondria 
achieve this by increasing the rate of flux of electrons through the ETC. As NADH 
and FADH2 are the sources of these electrons, an increase in the rate of ATP 
production must be accompanied by an increase in the rate of substrate 
dehydrogenation through the reactions of the TCA cycle in order to maintain the 
supply of reducing equivalents. If the rate of production of reducing equivalents 
does not match the rate of mitochondrial ATP production, the mitochondrial 
environment will become progressively oxidised and the loss of redox potential 
will eventually result in the cessation of mitochondrial ATP synthesis.  
The results of these experiments demonstrate that in isolated rabbit ventricular 
myocytes, the rate of oxidative phosphorylation is not well matched with the 
rate of substrate dehydrogenation. However, the cell does not become 
completely oxidised and reaches an essentially steady redox state, despite 
continuous high intensity work. This may be due to the rate of oxidative 
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phosphorylation reaching a steady state that matches the rate of substrate 
dehydrogenation by the TCA cycle. Alternatively, it may be due to control 
mechanisms taking effect, which increase the rate of production of reducing 
equivalents to match the increased rate of their oxidation at the ETC. The exact 
mechanisms by which this may be occurring were not investigated in this 
project. However, one possible mechanism is through an increase in 
mitochondrial [Ca2+] ([Ca2+]m) in response to increased stimulation frequency.     
Mitochondrial Ca2+ plays an important role in the regulation of mitochondrial ATP 
production (Balaban, 2009; Griffiths & Rutter, 2009; Nguyen et al., 2007; 
Cortassa et al., 2006; Balaban, 1990). Three rate limiting dehydrogenases 
(pyruvate dehydrogenase, 2-oxoglutarate dehydrogenase and NAD+ isocitrate 
dehydrogenase), critical elements of substrate metabolism are regulated by 
mitochondrial Ca2+ (Denton et al., 1978; Denton et al., 1972; McCormack & 
Denton, 1979). An increase in [Ca2+]m stimulates mitochondrial dehydrogenase 
activity, increasing the rate of production of reducing equivalents by the TCA 
cycle.  
During cytosolic Ca2+ transients, the mitochondria accumulate and subsequently 
release Ca2+. However, whether the transduction of cytosolic Ca2+ transients 
occurs slowly by accumulation over a number of beats, or rapidly, on a beat-to-
beat basis is a contentious issue (Huser et al., 2000). The slow integration of 
rapid cytosolic Ca2+ transients leading to the slow accumulation Ca2+ by the 
mitochondria may explain the initial oxidation upon increased workload, prior to 
the fluorescence levels reaching a steady redox state. It may take tens of 
seconds before [Ca2]m has increased enough to stimulate dehydrogenase activity 
sufficiently to prevent further oxidation of the mitochondrial environment. This 
temporal integration of cytosolic Ca2+ transients by cardiac mitochondria has 
been demonstrated in a number of studies  (Brandes & Bers, 2002; Zhou et al., 
1998; Leisey et al., 1993; Miyata et al., 1991).  
However, the close proximity of the mitochondria to SR Ca2+ release channels, 
demonstrated by electron microscopy (Sharma et al., 2000) would suggest that 
there is preferential coupling of Ca2+ transport between the SR and 
mitochondria, and the mitochondria are actually exposed to microdomains of 
very high cytosolic [Ca2+]. This may mean that beat-to-beat oscillations in 
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[Ca2+]m are possible, and indeed a number of studies have demonstrated this in 
cardiomyocytes (Maack et al., 2006; Robert et al., 2001; Szalai et al., 2000; 
Duchen et al., 1998). In addition, recent work using a Ca2+ sensitive protein 
sensor targeted to the mitochondria demonstrated mitochondrial Ca2+ 
sequestration was a combination of beat-to-beat oscillations and slow 
integration of mean cytosolic [Ca2+] (Kettlewell et al., 2009).  
The redox response to increased work intensity demonstrated in this study, and 
the time course of fluorescence changes, would suggest that mitochondrial Ca2+ 
uptake corresponding to the slow integration model may be stimulating NADH 
production by the TCA cycle and preventing complete oxidation of the 
mitochondrial environment at high intensity workloads. However, as 
measurements of mitochondrial Ca2+ were not made in this study, it is not 
possible to say for certain that this was the case.  
A summary diagram showing the postulated sequence of metabolic events that 
take place when work intensity is increased is shown in Figure 6-13. The initial 
time delay shown in ATP supply from the mitochondria is consistent with the 
findings of Eijgelshoven et al. (1994), who demonstrated that the decrease in 
[PCr] occurred significantly faster than the increase in O2 consumption 
(representing mitochondrial ATP production) when heart rate was doubled in 
isolated perfused isovolumically contracting rabbit hearts (Eijgelshoven et al., 
1994).   
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Figure 6-13 Summary of postulated sequence of metabolic events that take place upon 
increases in work intensity, as observed in the current study 
Step increase in work intensity (represented by dashed line) results in an increase in ATP 
demand (A). This ATP demand is initially fulfilled by metabolism of PCr stores, and [PCr] 
falls (B). Mitochondrial regulatory mechanisms then take effect and ATP supply from the 
mitochondria increases by increased rate of oxidative phosphorylation (C). This is achieved 
by increased rate of flux of electrons from NADH and FADH2 through the ETC (i.e. increased 
rate of oxidation). This results in an initial net oxidation of the mitochondrial environment 
and a fall in [NADH] (D) and [FADH2] (not shown). However, the rate of fall of [NADH] slows 
and eventually reaches a steady state, indicating that the rate of NADH and FADH2 oxidation 
by oxidative phosphorylation is now matching the rate of NAD+ and FAD reduction by the 
TCA cycle. The period and extent of mismatch between oxidation and reduction is 
represented by the shaded area in (E), obtained by differentiation of trace D.      
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6.4.1.1 Regulation of oxidative phosphorylation 
The control mechanisms that increase the rate of oxidative phosphorylation and 
ATP production upon increases in workload have been studied for many years, 
but as yet, have not been unequivocally shown. The classical feedback 
regulation mechanism was first proposed in the 1950s and states that an increase 
in concentration of the products of ATP hydrolysis (ADP and Pi) stimulates an 
increase in the rate of oxidative phosphorylation. This proposal was in response 
to the observation that in isolated liver mitochondria, addition of Pi (Lardy & 
Wellman, 1952) and ADP (Chance & Williams, 1955c) caused an increase in O2 
consumption, indicating increased rate of oxidative phosphorylation. When ADP 
and Pi concentrations fell, the rate of O2 consumption also fell. However, 
measurements of ATP, PCr, ADP and Pi levels using 31P-NMR in intact hearts 
during workload transitions have revealed conflicting results. Some studies 
report an increase in ADP and Pi concentrations and a fall in PCr when work 
intensity was increased (Eijgelshoven et al., 1994; Elliott et al., 1994), whereas 
others report no significant change in metabolite concentration (Katz et al., 
1989; Katz et al., 1987). If no change in phosphate metabolites occurs during 
workload transitions, this would suggest that the feedback regulation model 
would not adequately explain the increased rate of oxidative phosphorylation 
upon increased work.  
An alternative theory is that an increase in the NADH/NAD+ redox potential 
(secondary to Ca2+ dependent activation of TCA cycle dehydrogenases) 
stimulates an increase in the rate of oxidative phosphorylation (Katz et al., 
1987). However, in order for this to be the primary regulator of oxidative 
phosphorylation, an increase in workload must be accompanied by an immediate 
increase in the NADH/NAD+ ratio. Few studies demonstrate this (Griffiths et al., 
1997; Katz et al., 1987) and this therefore seems to be an unlikely primary 
control mechanism for oxidative phosphorylation.  
The results of our experiments also do not support this theory, as NADH 
fluorescence falls when workload is increased. However, the primary trigger for 
increased ATP production by oxidative phosphorylation could be an increase in 
ADP, causing initial NADH and FADH2 oxidation. The rate of oxidative 
phosphorylation may then be maintained by stimulation of Ca2+ dependent 
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dehydrogenases, preventing complete oxidation of NADH (as discussed earlier). 
What is clear is that the regulation of oxidative phosphorylation is complex and 
more than one control mechanism is likely to be involved (Bell et al., 2006; 
Cortassa et al., 2006; Jo et al., 2006; Korzeniewski et al., 2005).        
6.4.1.2 Comparison of results with previous studies 
Previous studies assessing energy supply and demand matching in cardiac cells 
and tissue have demonstrated a variety of responses. The results of this study 
most closely replicate the results of Heinzel et al. (2006), White & Wittenberg 
(2000), Ashruf et al. (1995), White & Wittenberg (1993) and Chapman (1972). 
However, in contrast to these studies, which only measured NADH fluorescence 
as an indicator of redox state, our study benefited from the advantages of 
simultaneously measuring both NADH and FAD fluorescence responses.  
It is not known why similar experiments have produced different results in other 
studies.  It is unlikely to be due to species difference alone, as a number of 
different oxidative responses upon transitions in workload have been reported in 
rat cardiac myocytes and tissue preparations (White & Wittenberg, 2000; 
Griffiths et al., 1998; Griffiths et al., 1997; Brandes & Bers, 1996; Ashruf et al., 
1995; White & Wittenberg, 1993; Katz et al., 1987). The most likely explanation 
for these variable results would be due to differences in the preparations used 
and experimental conditions. Factors such as limited O2 supply, particularly in 
tissue preparations, would lead to a misleading increase in NADH fluorescence 
upon increased work intensity caused by decreased mitochondrial ATP synthesis 
and not increased NADH production. In addition, limited substrate availability 
would slow down the production of reducing equivalents by the TCA cycle, 
resulting in oxidation of the cell if ATP supply is maintained. 
A possible weakness in this study is that although a constant perfusion of glucose 
was maintained throughout, the perfusing medium was not supplemented with 
pyruvate to ensure that endogenous substrate supply was not limiting. There are 
conflicting reports about the effect of endogenous pyruvate supplementation on 
the response to workload transitions. White and Wittenburg (2000) report that 
the presence of 2mM pyruvate in a superfusing medium containing 5.4mM 
glucose prevented the fall in NADH fluorescence observed upon increased work 
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intensity in isolated rat heart cells. Conversely, Ashruf et al. (1995) report that 
in Langendorff perfused rat hearts, addition of 10mM pyruvate to a Tyrode’s 
solution containing 5.5mM glucose caused an increase in baseline NADH 
fluorescence levels, but did not change the oxidative response upon increased 
work intensity. However, in White and Wittenburg’s study, contractile function 
was reduced when substrate availability was limited. The fact that contractile 
function did not diminish at high intensity work suggests that ATP supply was 
continuously maintained and endogenous substrate supply was not limited to any 
great extent in our study. However, our study could be improved by use of a 
bicarbonate based extracellular solution, which would have recreated more 
physiological conditions. In addition, the solution should be supplemented with 
better physiological substrates such as fatty acids or lactate. 
The intensity of work performed may also determine the redox response to 
workload transitions. In this study, pacing at 3Hz was used as the highest 
intensity workload, as this was the maximum stimulation rate that could be 
achieved with isolated rabbit cardiac myocytes at 37˚C. At higher frequencies 
the cell is unable to contract on stimulus. A range of stimulation frequencies 
were used to increase work intensity in other studies. The highest intensity 
workload achievable is dependent on species as well as the type of preparation 
used – intact tissue preparations are capable of higher stimulation frequencies 
than isolated cells. The work performed in a contracting Langendorff-perfused 
heart (with fluid-filled balloon in the LV), working heart or intact trabeculae 
preparation will also be higher. In these situations contraction is against a load, 
whereas this is not the case with cells. It could therefore be argued that 
increasing stimulation frequency in isolated cells does not significantly increase 
work. However, Heinzel et al. (2006) have shown that despite the unloaded 
conditions, an increase in stimulation frequency is accompanied by an increase 
in O2 consumption (indicating stimulation of oxidative phosphorylation and 
higher ATP production) in isolated cardiomyocytes. Thus, although the work 
intensity may not be as high as in hearts under in vivo or more physiological 
conditions, workload is still being increased in the isolated cells. The advantage 
of using isolated cell preparations is that substrate and O2 delivery can be more 
rigorously controlled than in tissue preparations.  
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Finally, in some studies no oxidative response to transitions in workload was 
observed without the use of inotropic agents such as norepinephrine and 
isoproterenol to further increase workload (Liu & O'Rourke, 2008; Maack et al., 
2006; Griffiths et al., 1997). It is therefore difficult to compare the conditions of 
high intensity work in the various studies and may be a reason why a diverse 
range of responses were observed.  
6.4.2 Analysing the kinetics of oxidative responses upon 
transitions in work intensity 
The time course for changes in intrinsic fluorescence and work performed was 
analysed for each train of 2Hz and 3Hz stimulation, as well as the recovery phase 
immediately following this, during which time the cells were stimulated at 
0.5Hz. It was found that step increasing work intensity to a greater extent i.e. 
up to 3Hz pacing compared to 2Hz pacing, resulted in a greater oxidative 
response from the cells. However, when the data was normalised to percentage 
fluorescence change (during each stimulation frequency), the rate of change was 
almost identical for both work intensities. The difference in the rate of 
fluorescence change only became clear when the magnitude of oxidative 
response at each work intensity was taken into account. This difference was 
greater in the early response (10-50% fluorescence change) compared to the late 
response (50-90% fluorescence change).  
6.4.2.1 Problems associated with the protocol 
During the experimental procedure, stimulus frequency was changed when 
fractional shortening and fluorescence levels were judged (by eye) to have 
reached a steady state. The length of this period varied from cell to cell, but 
upon increase in stimulation frequency was always longer than 45s at 2Hz and 
55s at 3Hz pacing. In order to increase the chances of successfully completing 
the protocol, the metabolic challenge was kept as short as possible. However, 
closer analysis of the fluorescence changes during each stimulus train revealed 
that rate of change in fluorescence levels and work performed had slowed, but 
may not have reached a completely steady state before the stimulation 
frequency was changed. This was particularly apparent during the recovery 
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period, even though the length of time the cells were given to recover was 
longer than the period of high intensity work and as much as 2 min in length. 
This may have led to an accumulation of metabolic deficit over the period of the 
protocol; further metabolically compromising the cells. However, as work 
intensity was increased incrementally (starting at 1Hz) and only two bursts of 
each frequency was delivered, the overall accumulation would be expected to 
be small and not substantially affect subsequent responses to high intensity 
work. In addition, similar responses to 3Hz stimulation were seen even when this 
was the first level of high intensity work delivered to the cell. This would 
suggest that a possible metabolic deficit does not adversely affect subsequent 
cellular responses to increased workload.   
6.4.3 Confirming the cause of increased metabolic demand and 
source of fluorescence changes 
The mitochondrial origin of the fluorescence responses was confirmed by 
performing the metabolic challenge in the presence of mitochondrial inhibitors. 
Under these conditions, where oxidative phosphorylation by the mitochondria 
was blocked, no change in intrinsic fluorescence was observed during high 
intensity work. This demonstrates that the changes in intrinsic fluorescence seen 
under control conditions during transition in workload are arising from the 
mitochondria. It also indicates that under control conditions, the mitochondria 
are the major source of ATP for the cell. Interestingly, inhibition of 
mitochondrial function with CN does not substantially affect contractile activity. 
Under these conditions, the cell must be utilising other, non-mitochondrial, 
sources of ATP to supply contractile fibres, such as glycolysis and PCr 
metabolism. 
The cause of increased metabolic demand was shown to be increased contractile 
work. When contractile function was inhibited with cyto D, the redox changes 
during increased frequency of stimulation were abolished. This was not simply 
due to the design of the protocol allowing the cell to adapt during the long 
period of low intensity work whilst cyto D took effect. When cells were given a 
10 min period of low intensity work whilst being perfused with control solution, 
the redox changes that took place when work intensity was increased were not 
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significantly different to those prior to this 10min period of low work intensity 
(Figure 6-11).     
6.4.4 Investigating the delayed oxidative response following 
workload transitions 
The onset of increased work intensity was associated with a time delay of 
varying length prior to the occurrence of intrinsic fluorescence changes. This 
indicated that non-mitochondrial sources of ATP were utilised in order to fulfil 
the initial increase in energy demand before mitochondrial ATP production takes 
over. The most likely source of this ATP supply is PCr, and the blockade of PCr 
metabolism with CK inhibitors went some way towards conforming this. 
However, problems were encountered with the use of these inhibitors.  
Initially, iodoacetamide was used as a CK inhibitor at concentrations of 0.4mM. 
It was found that perfusion with iodoacetamide at this concentration for 10 min 
almost completely abolished the time delay between workload transition and 
onset of oxidative response. However, iodoacetamide also unexpectedly caused 
a significant decrease in the magnitude of fluorescence response. The reasons 
for this were not completely clear. It may be that the effects of iodoacetamide 
were not specific to CK inhibition, and it may have been having effects on 
mitochondrial and/or glycolytic metabolism. Indeed, when higher iodoacetamide 
concentrations of 1.2mM or greater were tried, complete oxidation of the cell 
took place, before an increase in work intensity was even instigated. 
Alternatively, these effects may actually be a direct result of the loss of PCr 
metabolism, and may not be due to the non-specific action of iodoacetamide. To 
investigate this, the more specific CK inhibitor cyclocreatine was used.  
The same protocol that was used for iodoacetamide treatment was repeated 
with 10mM cyclocreatine. However, it was found that 10 min perfusion with 
cyclocreatine did not cause any significant reduction in duration of delay 
following workload transition. Cells were also incubated with 10mM 
cyclocreatine for 1-2 hours before the metabolic challenge was carried out. This 
method was found to reduce (but not abolish) the delay, without significantly 
affecting the magnitude of oxidative response. Use of cyclocreatine in the 
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literature has been largely limited to studies investigating its role in inhibiting 
tumour growth due to its effects on CK. In these studies, cyclocreatine is either 
included in the diet for a number of weeks, or cancer cell lines are cultured in 
the presence of cyclocreatine for a period of several days. It was therefore 
difficult to establish suitable cyclocreatine concentrations and incubation 
periods in order to acutely inhibit CK dependent ATP generation. The 
concentrations and incubation periods chosen were based on a study performed 
in macrophages in which CK was not completely inhibited (Kuiper et al., 2008). 
However, from the results of the cyclocreatine experiments, it appears that the 
additional effects of iodoacetamide, apart from the abolition of the delay, are 
due to the non-specific actions of the inhibitor.    
6.4.5 Conclusions 
The results of these experiments demonstrate that increasing work intensity by 
increasing stimulation frequency in isolated rabbit ventricular myocytes results 
in oxidation of the cellular environment, indicating a mismatch between 
metabolite supply and demand. This response was shown to be mitochondrial in 
origin and the increase in energy demand was shown to be due to an increase in 
contractile work performed by the cell. The initial delay that precedes the 
oxidative response following transition to higher workload was found to be most 
likely due to metabolism of PCr stores as the initial source of ATP. The degree of 
oxidative response correlated well with the level of work performed by the cell, 
with the oxidative response at 3Hz being greater than at 2Hz pacing.  
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7 Mitochondrial redox response to increased work 
intensity in a rat model of cardiac hypertrophy 
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7.1 Introduction 
The previous chapter demonstrated that metabolite supply is not well matched 
with demand when work intensity is increased in isolated rabbit ventricular 
myocytes. These experiments were performed in normal, healthy rabbits. The 
following chapter describes similar experiments performed in isolated rat 
cardiac myocytes from a genetic model of cardiac hypertrophy induced by 
pressure overload, and the normotensive control model. 
7.1.1 SHRSP model of cardiac hypertrophy 
The SHR rat strain is the most commonly used genetic model of hypertension 
(Pinto et al., 1998), which was generated by selection and inbreeding of WKY 
rats with the highest blood pressure (Okamoto & Aoki, 1963). This strain was 
further developed to produce the SHRSP sub-strain. SHRSP rats develops even 
higher blood pressure and have a strong tendency to die from stroke  (Okamoto 
et al., 1974). The pressure overload induced by hypertension results in 
pathological remodelling of the heart in the form of cardiac hypertrophy.  
7.1.2 Effects of cardiac hypertrophy on mitochondrial function 
Sustained pressure overload on the heart due to chronic hypertension or aortic 
stenosis leads to the LV undergoing concentric hypertrophy, in which the 
ventricular wall grows thicker (due to increase in myocyte size), with no 
increase in chamber size. This is a compensatory mechanism to normalise the 
persistently elevated wall stress that occurs under these conditions, and leads to 
an increase in contractile force. However, over time these compensatory 
mechanism become insufficient and deterioration to decompensation and failure 
may result.    
Mitochondrial dysfunction has been reported in a number of models of cardiac 
hypertrophy induced by pressure overload. Experimental models of hypertrophy 
produced by constriction (banding) of the ascending aorta have shown impaired 
ETC activity in neonatal rabbits with both compensated and decompensated LV 
hypertrophy (LVH) (Griffiths et al., 2010). In addition, LVH induced by the same 
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method in rats has been associated with reduced mitochondrial density, 
impaired substrate oxidation and changes in mitochondrial protein levels 20 
weeks after aortic constriction (Bugger et al., 2010). Impaired fatty acid 
oxidation has been observed as early as 2 weeks after the aortic banding 
procedure in rats, followed by a progressive decrease in glucose oxidation. 
However, respiratory capacity was only significantly reduced after 20 weeks 
when HF had developed and ejection fraction (EF) was impaired (Doenst et al., 
2010).  
Changes in mitochondrial activity have also been reported in genetic models of 
pressure overload induced cardiac hypertrophy. Respiratory assays have shown 
reduced respiratory capacity in 20 month old SHR hearts compared to WKY 
controls, as well as changes in mitochondrial proteins (Jullig et al., 2008). In 
addition, mitochondrial dysfunction has been demonstrated in 12 month old non-
failing SHR hearts after intense work (Hickey et al., 2009). Morphological 
changes have also been reported, with decreases in mitochondria/myofibril 
volume ratios reported in both genetic and experimentally induced models of 
cardiac hypertrophy (Anversa et al., 1979; Lund & Tomanek, 1978).  Indeed, 
impaired oxidative metabolism and increased oxidative stress have also been 
observed in SHRSP hearts (Chen et al., 1995; Tokoro et al., 1996).  
7.1.3 Aim of the chapter 
Previous studies have suggested that energy supply and demand matching is 
adversely affected in hypertrophic hearts induced by aortic banding (Liu & 
O'Rourke, 2008; Brandes et al., 1998) (See section 1.8.2). The aim of this 
chapter was to investigate the mitochondrial redox response to increased work 
intensity in the SHRSP model of cardiac hypertrophy. Comparison of these 
responses with redox responses in the WKY control model would allow 
assessment of how mitochondrial function may be affected in this genetic model 
of cardiac hypertrophy.     
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7.2 Methods 
Cardiac myocytes were isolated from 16 week old SHRSP hearts and age-matched 
normotensive WKY control hearts as described in Section 2.2.2. 
7.2.1 Cell sizing 
Cells were viewed under the microscope and cell size measurements were made 
using an eyepiece graticule. Around 60 cells from each heart were selected 
randomly and the length and width of each cell was read off the graticule. This 
procedure was repeated for each heart in the SHRSP and WKY groups.  
7.2.2 Stimulation protocol for metabolic challenge 
A similar stimulation and perfusion protocol was used for rat cells as was used 
for rabbit cardiac myocytes (Section 6.2.1). However, as rat hearts are capable 
of pacing at faster rates, the baseline stimulation frequency was set at 1Hz and 
step increased to 2Hz, 4Hz and 6Hz in order to metabolically challenge the cells.  
At the end of the stimulation protocol, NADH and FAD fluorescence signals were 
calibrated with FCCP and CN. However, the cell did not always survive the full 
protocol and a calibrated signal could not always be obtained.  
Isolation of cardiomyocytes from SHRSP hearts revealed heterogeneity in cell 
size, with some (but not all) cells displaying obvious hypertrophy. As this study 
was specifically investigating the effect of hypertrophy on energy supply and 
demand matching, only cells with hypertrophic appearance were selected for 
imaging.  
Analysis of contractile work and rate of fluorescence change upon workload 
transitions was performed using the same program as described in Section 6.2.2.   
7.2.3 Statistical analysis 
All statistical analysis comparing SHRSP and WKY cells was performed by 2 
sample t-test.  
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7.3 Results 
7.3.1 Measurements of cell size 
Mean cell size (length and width) was measured in cardiac myocytes isolated 
from WKY and SHRSP hearts and is shown in Figure 7-1 (Data kindly provided by 
Dr Sarah Kettlewell). 
 
Figure 7-1 Mean cardiac myocyte size isolated from WKY and SHRSP hearts 
Mean (A) length and (B) width of cells isolated from hearts from the 2 strains. Sample size in 
brackets represents the number of hearts, with ~60 cells from each heart measured. *** 
p<0.001 versus WKY.  
 
SHRSP cardiac myocytes displayed significant hypertrophy compared to WKY 
controls. This is characteristic of pathological concentric hypertrophy, with 
myocyte width increasing more than length (Heineke & Molkentin, 2006). Mean 
SHRSP myocyte width was ~18% longer than mean WKY myocytes width, whereas 
length was only ~9% longer. Although mean myocyte size was increased in SHRSP 
hearts, a heterogeneous population of hypertrophic and non-hypertrophic 
myocytes was observed. Thus, it may be that hypertrophy does not occur equally 
in all areas and/or layers of the ventricle. 
7.3.2 Redox response to increased work intensity 
The metabolic challenge of step increasing stimulation frequency was carried 
out in hypertrophic cardiac myocytes isolated from SHRSP hearts and non-
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hypertrophic myocytes from WKY control hearts. The mean magnitude of 
intrinsic fluorescence response to each level of work is shown in Figure 7-2. 
 
Figure 7-2 Mean effect of step increasing stimulation frequency on intrinsic fluorescence 
levels in cardiomyocytes isolated from WKY and SHRSP hearts 
Mean percentage change in (A) NADH fluorescence (B) FAD fluorescence and (C) 
NADH/FAD fluorescence ratio following step increase in stimulation frequency (relative to 
basal fluorescence at 1Hz stimulation). Black lines represent mean effect in myocytes 
isolated from WKY hearts and red lines represent myocytes isolated from SHRSP hearts 
(n=13 for each group). ** p<0.01 versus WKY. 
 
In both groups of cells, increasing stimulation frequency causes a small decrease 
in NADH fluorescence and a small increase in FAD fluorescence, indicating slight 
oxidation of the mitochondrial environment when work intensity is increased. 
This percentage change in FAD fluorescence and the NADH/FAD fluorescence 
ratio is significantly greater in WKY cells and indicates a bigger oxidative 
response. This would suggest that energy supply is better matched with demand 
in SHRSP hearts. However, it may also be that the level of contractile work 
performed by the SHRSP cardiomyocytes is not as great as that performed by 
WKY myocytes. The level of contractile work performed by each group of cells 
was therefore also examined.  
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7.3.3 Comparison of work performed by WKY and SHRSP 
cardiomyocytes 
The method of interpreting work performed by the cell as the inverse of cell 
length is only valid when assessing different levels of work performed by the 
same cell. When work needs to be compared between different cells, the fact 
that the initial cell length at rest varies between cells (and SHRSP myocytes 
have been shown to be longer than WKY myocytes), means that using this 
method would misleadingly suggest that SHRSP cells performed less work. 
Instead, work was expressed as the mean cell length at each frequency in 
proportion to the initial cell length at rest. Smaller values represent more time 
spent in the contractile state and thus more work performed. The mean cell 
length in proportion to resting length for each rat strain at each stimulation 
frequency is shown in Figure 7-3. 
 
Figure 7-3 Comparison of work performed by cardiomyocytes isolated from WKY and 
SHRSP hearts 
Mean work performed by each rat strain expressed as mean cell length in proportion to 
resting cell length at each stimulation frequency (WKY n=9, SHRSP n=8). 
 
As stimulation frequency is increased, mean cell length in proportion to resting 
cell length decreases. This means that mean cell length gets shorter at higher 
pacing rates and indicates more contractile work performed.  However, 
statistical analysis found no difference in work performed by cardiomyocytes 
isolated from WKY and SHRSP hearts. Thus the difference in intrinsic 
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fluorescence changes upon transition in workload cannot be explained by 
differences in the amount of work performed. 
7.3.4 Analysis of rate of fluorescence change in response to 
transitions in workload 
The rate of fluorescence change upon increase in workload was compared 
between cardiomyocytes from WKY and SHRSP hearts. The time taken to reach 
10%, 50%, 90% and 100% fluorescence change (in terms of the NADH/FAD 
fluorescence ratio) when work was increased to 4Hz and 6Hz was plotted to 
assess if there was any difference in the profile of the fluorescence response 
between the two groups. The rate of recovery response when workload was 
reduced to 1Hz was also analysed (Figure 7-4). 
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Figure 7-4 Mean time course of fluorescence changes following workload transitions in 
WKY and SHRSP cardiomyocytes 
Panel A: Mean time taken for 0, 10, 50, 90 and 100% fluorescence changes to occur (as 
indicated by points) in a single stimulus train in WKY and SHRSP cardiomyocytes when 
pacing was increased to (i) 4Hz and (ii) 6Hz. Panel B: Time taken for fluorescence to recover 
when work intensity was reduced to 1Hz pacing from (i) 4Hz and (ii) 6Hz. WKY n=10, SHRSP 
n=8.  
 
There is no difference in the rate of normalised fluorescence changes that take 
place in WKY and SHRSP cardiomyocytes following increase in stimulation 
frequency to 4Hz and 6Hz. In both groups of cells, fluorescence changes take 
place as soon as work intensity in increased, with no delay, and the time courses 
of fluorescence changes that follow are virtually identical. There was no 
significant difference in the rate of fluorescence recovery when workload was 
reduced to 1Hz pacing, although there was a trend towards faster recovery by 
SHRSP cells. 
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As the magnitude of fluorescence response differed between the two groups, the 
rate of fluorescence change (10-90%) was also compared with the magnitude of 
fluorescence change taken into account (Figure 7-5). 
 
Figure 7-5 Mean rate of fluorescence changes in WKY and SHRSP cardiomyocytes following 
workload transitions 
Panel A: Mean rate of decrease in NADH/FAD fluorescence ratio when workload is increased 
to 4Hz and 6Hz in WKY and SHRSP cardiomyocytes. Panel B: Mean rate of NADH/FAD 
fluorescence recovery when pacing is slowed to 1Hz following stimulation at 4Hz and 6Hz. 
WKY (open bars) n=10, SHRSP (grey bars) n=8. 
 
Taking into account the differences in magnitude of fluorescence changes that 
take place during workload transitions, there is still no difference in the rate of 
NADH/FAD fluorescence change in WKY and SHRSP myocytes when work intensity 
is modified. The rate of fluorescence recovery appears to be slower in SHRSP 
cardiomyocytes when work intensity is reduced following pacing at 6Hz. 
However, this difference was found to be not significant following 2 sample t-
test (p>0.05). 
7.4 Discussion 
Investigation into the redox response to increased work intensity found that 
energy supply and demand matching was not impaired in cardiac myocytes 
isolated from hypertrophic SHRSP hearts compared to WKY controls. In fact, 
energy supply and demand was found to be better matched in SHRSP myocytes, 
with a significantly smaller mean oxidative response to increased work intensity 
observed in these cells compared to WKY control cells. The rate of fluorescence 
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changes upon transition in workload and the amount of work performed by the 
cells was not different between the two strains.   
The reason for this unexpected observation may be that at 16 weeks the SHRSP 
hearts are still in a phase of compensated cardiac hypertrophy. Although 
mitochondrial dysfunction has been shown in some models of cardiac 
hypertrophy prior to the development of HF (Griffiths et al., 2010), other studies 
have found that respiratory capacity is maintained until HF develops  with 
impaired EF (Doenst et al., 2010). Indeed, maximal respiratory capacity was 
significantly greater in mitochondria isolated from hypertrophic cells prior to the 
development of HF compared to controls. Fibres from non-failing SHR hearts also 
showed higher maximal respiratory flux rates and marginally higher state 3 
respiration than fibres from WKY hearts (Hickey et al., 2009). This suggests that 
the mitochondria adapt in response to pressure overload induced hypertrophy, 
and in the early stages mitochondrial function may even be improved. Protein 
expression of a number of enzymes of the TCA cycle was found to be elevated in 
mitochondria from failing SHR hearts (Jullig et al., 2008). At this stage, the 
activity of these enzymes was found to be reduced. However, if in the early 
stages of compensated cardiac hypertrophy protein expression is increased 
without substantial decrease in enzyme activity, this could potentially explain 
why energy supply and demand are better matched in SHRSP cardiomyocytes 
compared to WKY controls. Indeed, SHRSP cells are working against a greater 
pressure than WKY cells in vivo, but this is not the case when the cells are 
isolated. Thus any compensatory increase in mitochondrial function in the SHRSP 
cells will give a greater respiratory reserve in the isolated cells, as observed 
here. 
7.4.1 Comparison with guinea pig model of cardiac hypertrophy 
Liu et al. (2008) clearly demonstrated that in their guinea pig model of pressure 
overload induced LVH, energy supply and demand was well matched in controls 
but poorly matched in hypertrophic cardiomyocytes. In hypertrophic cells, NADH 
fluorescence fell upon increased work intensity, with no recovery of 
fluorescence when returned to resting state (Figure 1-13). There are a number 
of reasons for the difference in response observed in this model compared to 
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those seen in our rat model of hypertrophy. Firstly, cells were only isolated from 
guinea pig hearts when a decrease in EF was observed during echocardiography, 
demonstrating that the heart was in a failing state. This was around 6-8 weeks 
after the aortic constriction procedure.  
Secondly, impaired energy supply and demand matching was attributed to an 
increase in intracellular [Na+] ([Na+]i) from ~5mmol/L in control cells to 
~17mmol/L in failing cells. This increase in [Na+]i would cause the mitochondrial 
NCX pump to increase Ca2+ extrusion from the mitochondria due to the altered 
Na+ gradient, thus limiting the Ca2+ stimulated activity of mitochondrial 
dehydrogenase enzymes. The result of this would be an inadequate increase in 
the production of reducing equivalents by the TCA cycle to match the increased 
rate of oxidative phosphorylation when work was increased. Consequently, net 
oxidation of the mitochondrial environment occurred, observed by a decrease in 
NADH fluorescence.  
However, [Na+]i is known to be much higher in rat cardiac myocytes, in the range 
of 10-15mmol/L (Bers et al., 2003; Despa et al., 2002; Donoso et al., 1992; 
Shattock & Bers, 1989). The activity of the mitochondrial NCX exchanger is 
therefore likely to be different in rat compared to guinea pig cardiomyocytes. 
No reports of measured differences in [Na+]i in WKY and SHRSP cardiac myocytes 
could be found in the literature, but it is unlikely that any difference between 
the two models would be to the same extent as in the guinea pig model of 
cardiac hypertrophy. 
7.4.2 Comparison with rat model of cardiac hypertrophy induced 
by aortic banding 
Brandes et al. (1998) also reported altered control of mitochondrial [NADH] in 
their model of cardiac hypertrophy induced by aortic banding in the rat. They 
demonstrated in isolated trabeculae that increasing work intensity from 0.25Hz 
to 0.5Hz, 1Hz and 2Hz resulted in a greater fall in NADH fluorescence compared 
to controls. The overshoot in NADH fluorescence when workload was reduced 
was also enhanced in the hypertrophic trabeculae, indicative of a compensatory 
response to this imbalance (Figure 1-14).     
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Experiments were performed 15-18 weeks after the banding procedure, at which 
point hypertension, LVH and impaired cardiac function was evident. Unlike in 
the SHRSP model of hypertrophy, the initial fall in NADH fluorescence upon 
increased work intensity was larger in the hypertrophic hearts. The impaired 
cardiac function following aortic banding indicates that these hearts had 
progressed to decompensated hypertrophy, and may explain the difference in 
these findings compared to our own.  
Possible explanations suggested by the investigators for the larger imbalance in 
[NADH] in hypertrophic trabeculae include reduced NADH production, increased 
NADH consumption (possibly due to higher [ADP] in hypertrophic cells causing 
increased stimulation of oxidative phosphorylation), or a higher rate of 
uncoupled respiration by mitochondria in hypertrophic cells. In addition, a 
decrease in mitochondrial versus myofilament volume has been shown in this 
model of hypertrophy (Anversa et al., 1979; Lund & Tomanek, 1978). Therefore, 
an increase in ATP consumption by myofilaments may be expected to result in a 
greater fall in [NADH] due to the presence of relatively fewer mitochondria. 
Interestingly, NADH recovery when work intensity was decreased showed a 
greater overshoot in hypertrophic trabeculae compared to controls. The 
investigators propose that this is due to increased [Ca2+]m or increased sensitivity 
to [Ca2+]m in hypertrophic cells, causing greater stimulation of dehydrogenase 
enzymes and greater NADH production. However, this is in direct contrast to the 
explanations of Liu et al. (2008), who propose that stimulation of dehydrogenase 
enzymes by mitochondrial Ca+ is reduced in hypertrophic hearts. 
7.4.3 Comparison of intrinsic fluorescence responses to 
increased workload in rat and rabbit cardiac myocytes 
The profile of intrinsic fluorescence response to increased work intensity showed 
some differences in rat and rabbit cardiomyocytes.  
7.4.3.1 Differences in magnitude of oxidative response 
The magnitude of response was much greater in rabbit cardiomyocytes, with a 
mean NADH/FAD fluorescence decrease of ~20% at the highest stimulation 
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frequency (3Hz) in rabbit cells compared to ~8% at the highest stimulation 
frequency (6Hz) in WKY rat cells. A possible reason for this disparity could be 
due to the amount of work performed by the cells. Most mammalian cardiac 
myocytes, including rabbit, demonstrate a positive force-frequency relationship 
due to the Bowditch effect. This means that as frequency of stimulation is 
increased, the force of contraction also increases. Both of these factors 
contribute to the amount of work performed by the cell. Conversely, cardiac 
myocytes from the rat tend to demonstrate a negative force-frequency 
relationship (Hoffman & Kelly, Jr., 1959), as was the case with the vast majority 
of cells isolated from rat hearts in our experiments.   
The positive force-frequency relationship observed in rabbit myocardium is 
thought to be due to an increase in [Na+]i that has been shown to occur as 
stimulation rate is increased (Cohen et al., 1982). Efflux of Ca2+ via the 
sarcolemmal NCX decreases due to the reduced Na+ gradient, and Ca2+ uptake by 
the SR via the SERCA pump predominates (Maier et al., 2000). Consequently, 
increased SR Ca2+ load allows for increased systolic SR Ca2+ release and greater 
force of contraction at higher stimulation frequencies. In rat cells that exhibit a 
negative force frequency relationship, little or no increase in intracellular Na+ 
activity was found in response to faster pacing, and the duration of the [Ca2+]i 
transient was found to be shorter, with no change or a decrease in the 
amplitude of the transient (Frampton et al., 1991).  
Thus the negative force-frequency relationship exhibited by rat cardiac 
myocytes will limit the increase in contractile work performed when stimulation 
frequency is increased. This may help explain why the oxidative response is 
smaller upon increased pacing rate in rat compared to rabbit cardiac myocytes. 
However, it may also be that subtle differences in the control of energy 
metabolism exist between species, and the magnitude of oxidative response 
would not necessarily be expected to be the same in rat and rabbit cells.  Indeed 
the mean initial NAD and FAD states were more oxidised in rat compared to 
rabbit. Mean NADstate assessed by epifluorescence methods was 0.59 in rabbit 
myocytes compared to 0.46 in rat and mean FADstate was 0.17 in rabbit myocytes 
compared to 0.28 in rat (WKY and SHRSP combined). It may be that the more 
oxidised initial redox state in rat cells influences the extent of oxidation and 
timescale for oxidative control mechanisms to take effect when workload is 
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increased. There is also some evidence to suggest that beat-to-beat 
mitochondrial Ca2+ transients may be species dependent (Griffiths, 1999), with 
beat-to-beat oscillations occurring in guinea pig but not rat cardiomyocytes. 
Beat-to-beat oscillations have also been demonstrated in rabbit cardiomyocytes 
(Kettlewell et al., 2009; Trollinger et al., 1997; Chacon et al., 1996). If 
differences in mitochondrial Ca2+ uptake exist, this could mean differences in 
control of oxidative phosphorylation exist between species. Thus, the same 
response to increases in stimulation frequency would not necessarily be 
expected in rat and rabbit cardiac myocytes.          
7.4.3.2 Delay in oxidative response following increase in work intensity 
Another difference observed in the profile of oxidative responses to increased 
workload was that in rabbit cardiomyocytes, a clear delay of up to 25s occurred 
following increase in stimulation frequency before any changes in intrinsic 
fluorescence occurred. This was attributed to initial metabolism of PCr stores as 
an ATP source before changes in mitochondrial ATP production were effected. 
However, this delay was not present in rat cardiac myocytes (Figure 7-6). 
 
Figure 7-6 Comparison of time course of intrinsic fluorescence response to increased 
workload in rabbit and rat cardiomyocytes 
Mean time taken for 0, 10, 50, 90 and 100% fluorescence changes to occur (as indicated by 
points) in a single stimulus train in rabbit and WKY rat cardiomyocytes following increase in 
stimulation frequency to the highest level of work (3Hz in rabbit cells, 6Hz in rat cells). 
Rabbit n=16, rat n=10. 
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The lack of delay in rat cardiac myocytes would suggest that PCr energy stores 
are much smaller in these cells following the isolation procedure. However, 31P- 
NMR studies suggest that comparable levels of PCr and ATP exist in rat and 
rabbit hearts (Gard et al., 1985; Hoerter et al., 1988). Other possible reasons for 
the lack of delay in rat cardiomyocytes could be if irreversible depletion of PCr 
stores or inactivation of the CK enzyme occurs in isolated rat myocytes.  
7.4.4 Problems encountered 
The isolation procedure for rat cardiomyocytes produced a very low yield of live 
cells. The procedure itself would usually give sufficient numbers of live cells. 
However, these cells had very low Ca2+ tolerance, and increasing [Ca2+] led to 
the majority of cells dying off. This limited the number of cells that could be 
used for experimentation and on several occasions, no usable cells remained 
after Ca2+ had been increased to the required concentration. As a consequence, 
the number of cells obtained from both WKY and SHRSP hearts from which 
measurements could be made was very low.  
Ideally, a greater number of cells would have improved the reliability of the 
results. However, the availability of animals and time constraints meant that 
this was not possible. In addition, a number of cell shortening traces could not 
be analysed due to the loss of edge tracking in some cells (although fluorescence 
measurements could still be made). This reduced the sample size for comparison 
of certain factors even further.       
7.4.5 Conclusions 
These experiments examined metabolite supply and demand matching in 
cardiomyocytes from the SHRSP model of cardiac hypertrophy in comparison to 
cardiomyocytes from control WKY hearts. Previous studies had shown that 
cardiac hypertrophy was associated with mitochondrial dysfunction and a 
decrease in mitochondria/myofibril volume ratio, as well as effects on the 
oxidative response to increased work intensity. It was therefore hypothesised 
that cardiac myocytes from SHRSP hearts would demonstrate impaired 
metabolite supply and demand matching compared to controls.  
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However, the results in fact demonstrated the opposite. SHRSP cells exhibited 
better metabolite supply and demand matching than WKY cells, with similar 
amounts of contractile work performed by both groups. This is likely to be due 
to the SHRSP hearts being in a state of compensated hypertrophy at 16 weeks of 
age when the myocytes were isolated. It is probable that at this early stage the 
mitochondria are still functioning well, and may even show improved function as 
a compensatory response to hypertrophy.    
7.4.6 Future Studies 
In the future these experiments could be performed in older SHRSP animals, 
where compensated hypertrophy has progressed to HF. This would provide a 
better comparison with other studies investigating the oxidative response to 
increased work intensity in models of cardiac hypertrophy induced by aortic 
constriction.  
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8 General Discussion 
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This thesis describes the use of intrinsic fluorescence measurements as a 
technique to study mitochondrial redox state in cardiac muscle. The intrinsic 
fluorescent properties of the metabolites NADH and FAD enabled redox state to 
be established in isolated ventricular myocytes and these measurements were 
also attempted in intact tissue preparations. Measurements of redox state in 
isolated ventricular myocytes were correlated with contractile shortening to 
assess the cell’s ability to match metabolite supply with demand. Finally, the 
ability of the SHRSP model of cardiac hypertrophy to match metabolite supply 
with demand was examined.  
8.1 Establishing mitochondrial redox state in isolated 
rabbit ventricular myocytes 
The mitochondrial redox state was established in ventricular myocytes isolated 
from the rabbit heart by a standard enzymatic dissociation procedure. 
Characterisation of the intrinsic fluorescence arising from the cells by 
spectrophotometry and excitation and emission fingerprinting confirmed that 
the major source of fluorescence was NADH (reduced) and FAD (oxidised). This 
characterisation of NADH and FAD fluorescence also enabled selection of the 
most effective excitation wavelengths and emission filters and dichroic mirrors 
required to simultaneously measure fluorescence signals from both metabolites 
by a variety of fluorescence techniques. It was found that FAD fluorescence 
could not be detected by 2P-excitation methods. The reason for this is unclear, 
but not all fluorophores are easily excited by 2P methods (Xu et al., 1996), and 
it may be that FAD in the cellular environment is just not as easily accessible to 
2P-excitation as it is to 1P-excitation or in the pure state in solution.   
Calibration of NADH and FAD fluorescence signals with the mitochondrial 
inhibitors FCCP and CN allowed for calculation of NAD and FAD redox states. Any 
fluorescence arising from non-mitochondrial sources such as lipofuscin or 
cytosolic NAD(P)H should not respond to the mitochondrial inhibitors to any 
great extent. Thus by calibrating fluorescence with FCCP and CN, the 
fluorescence arising from mitochondrial origins can be isolated and 
measurements of redox state are therefore a specific indicator of mitochondrial 
function.     
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Mitochondrial redox state of cell aggregates containing a heterogeneous 
population of live, dead and dying cells was established by fluorescence 
spectrometry. Mitochondrial redox state of individual rod-shaped cells with 
intact membranes was performed by fluorescence microscopy using 1P, 2P and 
epifluorescence methods. Using fluorescence spectrometry, NADstate was 
calculated to be 0.33 (33% of the NAD pool in the reduced state). This value was 
lower than those calculated in individual cells and this difference is likely to be 
due to the presence of a large population of cells of varying metabolic state. As 
a result, the overall NADstate value obtained by spectrophotometry will not be a 
reflection of an entirely healthy population of cells and comparable redox values 
to those obtained in single, healthy cells would not necessarily be expected. 
However, calculation of NADstate in single rod shaped cells by fluorescence 
microscopy produced similar values by all three techniques. The range of these 
NADstate values was between 0.57 and 0.59 (57-59% in the reduced state). FADstate 
values established by 1P confocal and epifluorescence methods were also 
similar, calculated as 0.17 and 0.18 (17% and 18% of the FAD pool in the oxidised 
state, i.e. 83% and 82% in the reduced state). The similarity of the values 
obtained for NADstate and FADstate by different fluorescence methods confirmed 
the reproducibility and reliability of the technique to establish mitochondrial 
redox state. These values were also similar to those quoted in the literature 
(Brandes & Bers, 1996; Duchen & Biscoe, 1992; Esumi et al., 1991; Eng et al., 
1989). 
8.2 Establishing mitochondrial redox state in intact tissue 
preparations from rabbit heart 
Similar measurements of mitochondrial redox state were attempted in the 
isolated LV wedge preparation and the Langendorff perfused whole heart using 
2P excitation fluorescence microscopy. However, it was found that these 
measurements were greatly complicated by movement of the preparation and 
the inner filter effect produced in the thick tissue preparation by other cellular 
constituents with light absorption properties. In addition, no response to FCCP 
could be elicited in the tissue, and thus calculations of NADstate were not 
possible. We were therefore unable to compare mitochondrial redox state in 
intact tissue and isolated cells to assess if the enzymatic digestion procedure has 
Iffath Ghouri, 2011  Chapter 8; 201 
a detrimental effect on mitochondrial function. However, if the mean effect of 
CN in the tissue preparations was corrected for movement and the mean inner 
filter effect in the LV was taken into account, a similar mean magnitude of 
increase in fluorescence would result in both tissue and isolated cell 
preparations (~38% and 41% increase respectively).  
8.3 Mitochondrial redox responses to increased work 
intensity in isolated rabbit ventricular myocytes 
Real time monitoring of NADH and FAD fluorescence signals in synchrony with 
measurements of contractile work enabled energy supply and demand matching 
to be assessed in ventricular myocytes. The ability of the mitochondria to match 
production of reducing equivalents through the reactions of the TCA cycle with 
their consumption by oxidative phosphorylation is crucial in order to maintain an 
adequate redox potential to continue ATP production at the required rate. 
It was found that step increasing work intensity by increasing stimulation 
frequency resulted in oxidation of the cellular environment. This was 
demonstrated by a decrease in NADH fluorescence and a simultaneous increase 
in FAD fluorescence. The magnitude of the oxidative response was related to the 
intensity of work performed, with the largest responses taking place at the 
highest work intensities. This indicates that the production of reducing 
equivalents by the TCA cycle was not well matched to the increased rate of their 
consumption in order to produce the required supply of ATP at higher workloads. 
However, complete oxidation of the cellular environment did not take place and 
NADH and FAD signals reached an essentially steady state whilst workload was 
still high. This may either be due to the rate of oxidative phosphorylation 
reaching a steady state, or may be due to the presence of some sort of control 
mechanism, increasing the rate of TCA cycle reactions in order to maintain 
redox potential. It is thought that this may be due to increased uptake of Ca2+ by 
the mitochondria, stimulating a number of dehydrogenase enzymes and 
increasing the rate of NADH and FADH2 production. When the intensity of work 
was reduced, the oxidative status of the cell recovered to initial levels. The 
reversibility of this response demonstrates that the fluorescence changes are 
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caused by a temporary metabolite imbalance and that the cell is not 
permanently damaged by the experimental manipulation.   
Prolonged periods of oxidation may have detrimental effects on the cell, as 
NADH plays a role in antioxidant control mechanisms through the maintenance of 
glutathione in the reduced state via NADPH (Section 1.6.2). A fall in [NADH] and 
sustained periods of mitochondrial oxidation could therefore result in an 
increase in oxidative stress and the harmful effects associated with this (Knopp 
et al., 2009; Liu & O'Rourke, 2009; Heinzel et al., 2006).     
No consistent oxidative response to increased work intensity has been reported 
in the literature. However, the results presented in this thesis are in closest 
agreement with those of Heinzel et al. (2006), White & Wittenberg (2000), 
Ashruf et al. (1995), White & Wittenberg (1993) and Chapman (1972). Previous 
studies looking at the oxidative response to transitions in workload only 
measured changes in NADH fluorescence. However, in this study, fluorescence 
measurements were optimised to monitor both NADH and FAD, and this has the 
additional advantage of enabling a fluorescence ratio of the signals to be taken. 
As a result, the signal to noise ratio was increased and the effects of movement 
and other artefacts associated with single wavelength measurements were 
minimised.   
8.4 Mitochondrial redox responses to increased work 
intensity in cardiac myocytes from the SHRSP model 
of cardiac hypertrophy compared to WKY controls  
The mitochondrial redox response to increased work intensity was also 
investigated in the SHRSP genetic model of hypertension. Rats of this strain 
demonstrate clear cardiac hypertrophy as a consequence of sustained pressure 
overload. It was hypothesised that cardiac myocytes from these animals would 
show impaired energy supply and demand matching for a number of reasons. 
Firstly, mitochondrial dysfunction has been reported in cardiac myocytes from 
SHRSP rats (Chen et al., 1995; Tokoro et al., 1996). Secondly, changes in the 
oxidative response to increased work intensity have been shown in models of 
cardiac hypertrophy induced by aortic banding (Brandes et al., 1998; Liu & 
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O'Rourke, 2008). Finally, the reduced mitochondria/myofibril volume ratio 
reported in both genetic and experimentally induced models of cardiac 
hypertrophy (Anversa et al., 1979; Lund & Tomanek, 1978) would suggest that 
energy supply and demand matching would be detrimentally affected in cardiac 
hypertrophy due to the presence of relatively fewer mitochondria. 
However, it was found that this was not the case and indeed the mitochondrial 
oxidative response to increased work intensity was less in SHRSP rat hearts 
compared to WKY controls, indicating improved matching of metabolite supply 
to demand. This is most probably due to the SHRSP hearts being in a state of 
compensated hypertrophy when the cells were isolated at 16 weeks of age. In 
this state, mitochondrial dysfunction may not have yet occurred, and any 
changes in mitochondrial function may actually be a compensatory 
improvement.    
8.5 Further work 
The results of this investigation could be further developed to examine the 
cellular mechanisms of matching metabolic supply with demand. In particular, 
simultaneous measurements of redox state with [Ca2+]m would provide more 
insight into the role of mitochondrial Ca2+ uptake in regulating mitochondrial  
metabolism. This could be achieved using a targeted mitochondrial Ca2+ probe 
developed in our lab (Kettlewell et al., 2009), although currently this probe is 
transfected into freshly isolated myocytes and cultured for 48 hours before use. 
This situation is not ideal, as by this stage mitochondrial function may have 
deteriorated.  Alternatively, mitochondrial Ca2+ measurements could be made 
with synthetic fluorescent Ca2+ indicators such as Rhod-2, Indo-1 or Fluo-3, 
although precautions would need to be taken when using these dyes to avoid 
contamination with the cytosolic Ca2+ signal. In addition, simultaneous 
measurements of redox state with mitochondrial membrane potential or O2 
consumption would add another dimension to the measurements and would 
provide a clearer picture of the mitochondrial functional changes occurring 
during transitions in workload. Mitochondrial membrane potential can be 
measured using fluorescent indicators such as TMRM and TMRE (but should be 
used at very low concentrations to avoid affecting mitochondrial function 
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(Scaduto & Grotyohann, 1999)). However, real time measurements of O2 
consumption in isolated single cells are extremely difficult to achieve. 
Experiments examining the effects of cardiac hypertrophy on energy supply and 
demand matching were performed in hearts in a state of compensated 
hypertrophy. These experiments could be repeated in older animals, where 
progression to decompensated hypertrophy and HF has taken place. 
Furthermore, other models of HF could be used, such as the rabbit model of 
myocardial infarction induced by coronary artery ligation. This would help 
improve our understanding of how energy metabolism is affected in HF.  
8.6 Summary of conclusions 
The majority of intrinsic fluorescence from isolated heart cells could be 
attributed to the metabolic coenzymes NADH and FAD. Metabolic inhibition 
enabled modulation of the oxidative status of these enzymes, allowing for 
calculation of relative redox state in isolated ventricular myocytes. However, 
similar measurements of mitochondrial redox state could not be made in intact 
tissue preparations, mainly due to difficulties directing mitochondrial inhibitor 
to the area of tissue being imaged and to the inner filter effect that exists when 
thicker specimens are imaged. Simultaneous measurements of redox status and 
fractional shortening in field-stimulated cells have demonstrated that rabbit 
ventricular myocytes become oxidised when work rates are increased, suggesting 
a transient mismatch between metabolite supply and demand. Cardiac myocytes 
isolated from hypertrophic SHRSP hearts did not demonstrate impaired matching 
of metabolite supply with demand compared to WKY control cardiomyocytes and 
in fact, smaller oxidative responses were observed in these cells. However, 
these hearts were still in a state of compensated hypertrophy and at this stage it 
may be too early for any deleterious effects on mitochondrial function to have 
taken place. 
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